Mokslinė literatūra

Barrier Code ingredientų vertinimai remiasi šiuose šaltiniuose surinktais duomenimis: 662 moksliniais straipsniais, 158 saugos vertinimais ir Europos Sąjungos teisės aktais. Visi jie išvardyti šiame puslapyje.

Kaip naudojame šaltinius

Kas yra šaltinis

Šaltinis yra recenzuojamas mokslinis leidinys arba institucijos dokumentas: Europos Komisijos ir jos mokslinių komitetų nuomonės, saugos vertinimai, farmakopėjos, klinikinių draugijų gairės, medicinos ir dermatologijos žurnalų straipsniai, sisteminės apžvalgos.

Šaltiniais nelaikome tinklaraščių, prekės ženklų puslapių, ingredientų portalų, parduotuvių aprašymų ir dirbtinio intelekto santraukų.

Paieškos sistema nėra šaltinis

PubMed, Scopus ir panašios sistemos padeda straipsnį surasti. Šaltinis visada yra žurnalas, kuriame straipsnis paskelbtas. Leidinys turi būti įtrauktas bent į vieną pripažintą mokslinių leidinių rodyklę arba būti įvardytos institucijos leidinys.

Kiekvienas įvertinimas atsekamas

Perskaitytą šaltinį saugome savo archyve kartu su pažodine citata, kuria remiamės. Taip kiekvieną įvertinimą galima patikrinti: kas parašyta, kur ir kokiomis sąlygomis tirta.

Kiekvienam klausimui — tinkamas šaltinis

  • Ar ingredientas leidžiamas, ribojamas ar draudžiamas — tik pagal Europos Sąjungos teisės aktus.
  • Ar ingredientas dirgina ar sukelia alergiją — pagal saugos vertinimus ir klinikinius tyrimus.
  • Ką ingredientas daro odai — pagal jo chemiją, funkciją ir veikimo mechanizmą, aprašytą moksliniuose straipsniuose.

Tyrimo kokybę įvertiname, o ne atmetame tyrimą

Kiekvienam tyrimui užrašome, kas jame tirta: kiek žmonių, ar buvo palyginimas, kokia koncentracija, kokia odos būklė. Šie trūkumai nurodomi šalia išvados, bet tyrimo neišbraukia. Gamintojo finansuotas tyrimas vertinamas taip pat, pagal jo dizainą; finansavimas pažymimas.

Kai tyrimo nėra

Ne kiekvienam ingredientui yra atliktas tyrimas. Tada įvertinimas remiasi ingrediento chemija ir veikimo mechanizmu, o tai pažymime. Atsiradus tyrimui, jis pakeičia tokį įvertinimą. Tai, kad tyrimo neradome, nedaro produkto prastesnio.

Atsargumo kryptis

Kad ingredientą įvertintume palankiau, reikia įrodymų. Atsargesnis įvertinimas gali remtis pagrįstu samprotavimu, nes klaidingas nuraminimas vartotojui kainuoja daugiau nei perdėtas atsargumas.

Teisės aktai ir registrai

Europos Sąjungos teisės aktai ir dokumentai 8
  1. Tarybos direktyva 76/768/EEB dėl valstybių narių įstatymų, susijusių su kosmetikos gaminiais, suderinimo. OL L 262, 1976-09-27, p. 169.
  2. Europos Parlamento ir Tarybos reglamentas (EB) Nr. 1223/2009 dėl kosmetikos gaminių (nauja redakcija). OL L 342, 2009-12-22, p. 59. Naudojami II (draudžiamos medžiagos), III (ribojamos medžiagos), IV (dažikliai), V (konservantai) ir VI (UV filtrai) priedai.
  3. Europos Parlamento ir Tarybos reglamentas (EB) Nr. 1272/2008 dėl cheminių medžiagų ir mišinių klasifikavimo, ženklinimo ir pakavimo (CLP), VI priedas — suderinta klasifikacija.
  4. Komisijos reglamentas (ES) Nr. 655/2013, kuriuo nustatomi bendri teiginių apie kosmetikos gaminius pagrindimo kriterijai. OL L 190, 2013-07-11, p. 31.
  5. Komisijos reglamentas (ES) 2017/776, kuriuo dėl prisitaikymo prie technikos ir mokslo pažangos iš dalies keičiamas Reglamentas (EB) Nr. 1272/2008 (10-asis CLP pritaikymas).
  6. Komisijos reglamentas (ES) 2023/1545, kuriuo iš dalies keičiamas Reglamentas (EB) Nr. 1223/2009 dėl kvapiųjų alergenų ženklinimo kosmetikos gaminiuose. OL L 188, p. 1.
  7. Komisijos reglamentas (ES) 2023/2055 dėl sintetinių polimerų mikrodalelių (REACH XVII priedas).
  8. Darbo grupės kosmetikos teiginiams techninis dokumentas „Technical document on cosmetic claims“ (2017-07-03 redakcija).
Kitų institucijų dokumentai 8
  1. JAV maisto ir vaistų administracija (FDA). Guidance for Industry: Labeling for Cosmetics Containing Alpha Hydroxy Acids. 2005.
  2. FDA. Alpha Hydroxy Acids; Beta Hydroxy Acids (informaciniai puslapiai apie kosmetikos ingredientus). 2022.
  3. FDA. Over-the-Counter (OTC) Monograph M017: External Analgesic Drug Products for Over-the-Counter Human Use. 2023.
  4. FDA / DailyMed. Differin (adapalene) gel; Retin-A (tretinoin) cream and gel — vaisto informacinis lapelis. 2024.
  5. OECD. SIDS Initial Assessment Report for SIAM 14: Linalool. 2002.
  6. Europos cheminių medžiagų agentūra (ECHA). REACH registracijos dokumentacija: linalool (EC 201-134-4).
  7. NITE (Japonija). GHS Classification Result — Linalool. 2012.
  8. NICNAS (Australija). Common skin sensitisers. 2005.

Registrai ir standartai

  • CosIng — Europos Komisijos kosmetikos ingredientų duomenų bazė (ingredientų funkcijos, nuorodos į reglamento priedus).
  • IFRA standartai (Tarptautinė kvapiųjų medžiagų asociacija): Nr. 032 trimetilbenzenpropanolis, 037 geraniolis, 063 metiljononas, 067 ąžuolų kerpių ekstraktai, 080 medžių kerpių ekstraktai, 097 serenčių aliejus ir absoliutas, 151 hidroabietilo alkoholis, 184 pušinių augalų dariniai, 186 limonenas, 187 linalolis; IFRA standartų taikymo gairės (51-asis pakeitimas).
  • PubChem — JAV nacionalinės medicinos bibliotekos cheminių medžiagų registras (medžiagos tapatybė ir fizikinės savybės).

Saugos vertinimai

Dokumentų iš viso: 158.

SCCS — ES Vartotojų saugos mokslinis komitetas 26Nepriklausomų mokslininkų komitetas, rengiantis nuomones Europos Komisijai apie kosmetikos ingredientų saugą (įskaitant ankstesnius ES komitetus).
  1. SCC (Scientific Committee on Cosmetology). S66: 4-tert-Butyl-4′-methoxydibenzoylmethane. Opinion, 50th plenary meeting. 1992.
  2. SCCNFP. Position paper concerning the safety of alpha-hydroxy acids. SCCNFP/0370/00. 2000.
  3. SCCNFP. Opinion concerning the determination of certain formaldehyde releasers in cosmetic products. SCCNFP/586/02. 2002.
  4. SCCNFP. Updated position paper concerning consumer safety of alpha-hydroxy acids. SCCNFP/0799/04. 2004.
  5. SCCS. Opinion on the mixture of 5-chloro-2-methylisothiazolin-3(2H)-one and 2-methylisothiazolin-3(2H)-one. SCCS/1238/09. 2009.
  6. SCCS. Opinion on Quaternium-15 (cis-isomer). SCCS/1344/10. 2011.
  7. SCCS. Opinion on fragrance allergens in cosmetic products. SCCS/1459/11. 2012.
  8. SCCS. Opinion on methylisothiazolinone (P94), submission II (sensitisation only). SCCS/1521/13, revision of 27 March 2014. 2014.
  9. SCCS. Opinion on the safety of the use of formaldehyde in nail hardeners. SCCS/1538/14. 2014.
  10. SCCS. Opinion on α-arbutin. SCCS/1552/15. 2015.
  11. SCCS. Opinion on methylisothiazolinone (MI) (P94), submission III (sensitisation only). SCCS/1557/15. 2015.
  12. SCCS. Opinion on phenoxyethanol. SCCS/1575/16. 2016.
  13. SCCS. Opinion on skin sensitisation quantitative risk assessment for fragrance ingredients (QRA2). SCCS/1589/17. 2018.
  14. SCCS. Opinion on the safety of aluminium in cosmetic products, submission II. SCCS/1613/19. 2020.
  15. SCCS. Opinion on benzophenone-3. SCCS/1625/20. 2021.
  16. SCCS. Opinion on homosalate. SCCS/1622/20. 2021.
  17. SCCS. Opinion on octocrylene. SCCS/1627/21. 2021.
  18. SCCS. Scientific advice on the threshold for the warning „contains formaldehyde“ in Annex V, preamble point 2, for formaldehyde-releasing substances. SCCS/1632/21. 2021.
  19. SCCS. Revision of the scientific opinion (SCCS/1576/16) on vitamin A (retinol, retinyl acetate, retinyl palmitate). SCCS/1639/21. 2022.
  20. SCCS. Opinion on the safety of alpha-arbutin and beta-arbutin in cosmetic products. SCCS/1642/22. 2023.
  21. SCCS. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 12th revision. SCCS/1647/22. 2023.
  22. SCCS. Opinion on salicylic acid. SCCS/1646/22. 2023.
  23. SCCS. Opinion on benzyl salicylate. SCCS/1656/23. 2023.
  24. SCCS. Opinion on methylparaben. SCCS/1652/23, corrigendum February 2024. 2024.
  25. SCCS. Scientific advice on the safety of diethylamino hydroxybenzoyl hexyl benzoate (DHHB, S83). SCCS/1678/25. 2025.
  26. SCCS. Scientific opinion on tea tree oil. SCCS/1681/25. 2025.
CIR — Kosmetikos ingredientų peržiūra (JAV) 132Nepriklausoma ekspertų grupė, vertinanti kosmetikos ingredientų saugą.
  1. Cosmetic Ingredient Review. Final Report of the Safety Assessment for PEG-75 Lanolin, PEG-20 Lanolin, PEG-27 Lanolin, PEG-30 Lanolin, PEG-40 Lanolin, PEG-50 Lanolin. 1982.
  2. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Carbomers-934, -910, -934P, -940, -941, and -962. 1982.
  3. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Myristyl Myristate and Isopropyl Myristate. 1982.
  4. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Squalane and Squalene. 1982.
  5. Cosmetic Ingredient Review. Final Report on the Safety Assessment of PEG-2, -6, -8, -12, -20, -32, -40, -50, -100, and -150 Stearates. 1983.
  6. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Candelilla Wax, Carnauba Wax, Japan Wax, and Beeswax. 1984.
  7. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Fossil and Synthetic Waxes. 1984.
  8. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Butyl Stearate, Cetyl Stearate, Isobutyl Stearate, Isocetyl Stearate, Isopropyl Stearate. 1985.
  9. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Stearyl Alcohol, Oleyl Alcohol, and Octyl Dodecanol. 1985.
  10. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Cholesterol. 1986.
  11. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Hydroxyethylcellulose, Hydroxypropylcellulose, and Related Cellulose Ethers. 1986.
  12. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Phenyl Trimethicone. 1986.
  13. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid, and Stearic Acid. 1987.
  14. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Retinyl Palmitate and Retinol. 1987.
  15. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Sodium Sesquicarbonate, Sodium Bicarbonate, and Sodium Carbonate. 1987.
  16. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Cetearyl Alcohol, Cetyl Alcohol, Isostearyl Alcohol, Myristyl Alcohol, and Behenyl Alcohol. 1988.
  17. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Polyquaternium-10. 1988.
  18. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Jojoba Oil and Jojoba Wax. 1992.
  19. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Sodium Cocoyl Isethionate. 1993.
  20. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Bisabolol. 1999.
  21. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Lecithin and Hydrogenated Lecithin. 2001.
  22. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Trilaurin, Triarachidin, Tribehenin, Tricaprin, Tricaprylin, Trierucin, Triheptanoin, Triheptylundecanoin, Triisononanoin, Triisopalmitin, Triisostearin, Trilinolein. 2001.
  23. Cosmetic Ingredient Review. Final report on the safety assessment of Arnica montana extract and Arnica montana. Int J Toxicol. 2001. PubMed 11558636 · doi:10.1080/10915810160233712
  24. Cosmetic Ingredient Review. Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate. Int J Toxicol. 2001. PubMed 11766131 · doi:10.1080/10915810152630729
  25. Cosmetic Ingredient Review. Final report on the safety assessment of Malic Acid and Sodium Malate. Int J Toxicol. 2001. PubMed 11358110 · doi:10.1080/109158101750300946
  26. Cosmetic Ingredient Review. Final Report on the Safety Assessment of EDTA, Calcium Disodium EDTA, Diammonium EDTA, Dipotassium EDTA, Disodium EDTA, TEA-EDTA, Tetrasodium EDTA, Tripotassium EDTA, Trisodium. 2002.
  27. Cosmetic Ingredient Review. Final report on the safety assessment of Tocopherol, Tocopheryl Acetate, Tocopheryl Linoleate, Tocopheryl Linoleate/Oleate, Tocopheryl Nicotinate, Tocopheryl Succinate, Dioleyl Tocopheryl Methylsilanol, Potassium Ascorbyl Tocopheryl Phosphate, and Tocophersolan. Int J Toxicol. 2002. PubMed 12537931 · doi:10.1080/10915810290169819
  28. Cosmetic Ingredient Review. Final Report of the Safety Assessment of Niacinamide and Niacin. 2005.
  29. Cosmetic Ingredient Review. Final Report of the Safety Assessment of Urea. 2005.
  30. Cosmetic Ingredient Review. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics. Int J Toxicol. 2005. PubMed 16154915 · doi:10.1080/10915810590953851
  31. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Sodium p-Chloro-m-Cresol, p-Chloro-m-Cresol, Chlorothymol, Mixed Cresols, m-Cresol, o-Cresol, p-Cresol, Isopropyl Cresols, Thymol, o-Cymen-5-ol, and Carvacrol. 2006.
  32. Cosmetic Ingredient Review. Amended Final Report on the Safety Assessment of Glyceryl Dilaurate, Glyceryl Diarachidate, Glyceryl Dibehenate, Glyceryl Dierucate, Glyceryl Dihydroxystearate, Glyceryl Diisopalmitate, Glyceryl Diisostearate, Glyceryl. 2007.
  33. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid. 2007.
  34. Cosmetic Ingredient Review. Final Report of the Cosmetic Ingredient Review Expert Panel Safety Assessment of Glycyrrhiza Glabra (Licorice) Rhizome/root. 2008.
  35. Cosmetic Ingredient Review. Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Polyisobutene and Hydrogenated Polyisobutene as Used in Cosmetics. 2008.
  36. Cosmetic Ingredient Review. Final Report of the Safety Assessment of Alcohol Denat., Including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the Denaturants. 2008.
  37. Cosmetic Ingredient Review. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol. 2009. PubMed 19636067 · doi:10.1177/1091581809337738
  38. Cosmetic Ingredient Review. Final Report of the Safety Assessment of Allantoin and Its Related Complexes. 2010.
  39. Cosmetic Ingredient Review. Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. Int J Toxicol. 2010. PubMed 21164072 · doi:10.1177/1091581810384883
  40. Cosmetic Ingredient Review. Amended Final Safety Assessment Diethanolamides as Used in Cosmetics. 2011.
  41. Cosmetic Ingredient Review. Final Safety Assessment On the Safety Assessment of Alkyl Glyceryl Ethers As Used in Cosmetics. 2011.
  42. Cosmetic Ingredient Review. Amended Safety Assessment of Alkyl Esters as Used in Cosmetics. 2012.
  43. Cosmetic Ingredient Review. Final Amended Report On the Safety Assessment of Ethanolamides as Used in Cosmetics. 2012.
  44. Cosmetic Ingredient Review. Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Methyl Acetate. 2012.
  45. Cosmetic Ingredient Review. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of cocamidopropyl betaine (CAPB). Int J Toxicol. 2012. PubMed 22869896 · doi:10.1177/1091581812447202
  46. Cosmetic Ingredient Review. Safety Assessment of Alkyl PEG Ethers as Used in Cosmetics. 2012.
  47. Cosmetic Ingredient Review. Safety Assessment of Cyclomethicone, Cyclotetrasiloxane, Cyclopentasiloxane, Cyclohexasiloxane, and Cycloheptasiloxane. 2012.
  48. Cosmetic Ingredient Review. Safety Assessment of Dimethicone Crosspolymers as Used in Cosmetics. 2012.
  49. Cosmetic Ingredient Review. Safety Assessment of Panax spp. Root-Derived Ingredients as Used in Cosmetics. 2012.
  50. Cosmetic Ingredient Review. Safety Assessment of α-Amino Acids as Used in Cosmetics. 2012.
  51. Cosmetic Ingredient Review. Amended Safety Assessment of Achillea Millefolium-Derived Ingredients as Used in Cosmetics. 2013.
  52. Cosmetic Ingredient Review. Safety Assessment of Ammonium Hectorites as Used in Cosmetics. 2013.
  53. Cosmetic Ingredient Review. Safety Assessment of Decyl Glucoside and Other Alkyl Glucosides as Used in Cosmetics. 2013. doi:10.1177/1091581813497764
  54. Cosmetic Ingredient Review. Safety Assessment of Isoparaffins as Used in Cosmetics. 2013.
  55. Cosmetic Ingredient Review. Safety assessment of alkyl glyceryl ethers as used in cosmetics. Int J Toxicol. 2013. PubMed 24174475 · doi:10.1177/1091581813497766
  56. Cosmetic Ingredient Review. Safety Assessment of Anthemis Nobilis-Derived Ingredients as Used in Cosmetics. 2014.
  57. Cosmetic Ingredient Review. Safety Assessment of Citric Acid, Inorganic Citrate Salts, and Alkyl Citrate Esters as Used in Cosmetics. Int J Toxicol. 2014. PubMed 24861367 · doi:10.1177/1091581814526891
  58. Cosmetic Ingredient Review. Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics. 2014.
  59. Cosmetic Ingredient Review. Safety Assessment of Tripeptide-1, Hexapeptide-12, their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics. 2014.
  60. Cosmetic Ingredient Review. Safety Assessment of Alkyl Esters as Used in Cosmetics. 2015.
  61. Cosmetic Ingredient Review. Safety Assessment of Centella asiatica-derived Ingredients as Used in Cosmetics. 2015.
  62. Cosmetic Ingredient Review. Safety Assessment of Galactomannans as Used in Cosmetics. 2015.
  63. Cosmetic Ingredient Review. Safety Assessment of Glycerin as Used in Cosmetics. 2015.
  64. Cosmetic Ingredient Review. Safety Assessment of Lecithin and Other Phosphoglycerides as Used in Cosmetics. 2015.
  65. Cosmetic Ingredient Review. Safety Assessment of Polysaccharide Gums as Used in Cosmetics. 2015.
  66. Cosmetic Ingredient Review. Amended Safety Assessment of Chamomilla Recutita-Derived Ingredients as Used in Cosmetics. 2016.
  67. Cosmetic Ingredient Review. Re-Review Summary 40th Anniversary Overview and Rereview Summaries From 2011 to 2015. 2016.
  68. Cosmetic Ingredient Review. Safety Assessment of Methyl Glucose Polyethers and Esters as Used in Cosmetics. 2016.
  69. Cosmetic Ingredient Review. Safety Assessment of Microbial Polysaccharide Gums as Used in Cosmetics. 2016.
  70. Cosmetic Ingredient Review. Amended Safety Assessment of Isethionate Salts as Used in Cosmetics. Int J Toxicol. 2017. PubMed 28553736 · doi:10.1177/1091581816685552
  71. Cosmetic Ingredient Review. Safety Assessment of Amino Acid Alkyl Amides as Used in Cosmetics. 2017.
  72. Cosmetic Ingredient Review. Safety Assessment of Benzyl Alcohol, Benzoic Acid and its Salts, and Benzyl Benzoate. Int J Toxicol. 2017. PubMed 29243541 · doi:10.1177/1091581817728996
  73. Cosmetic Ingredient Review. Safety Assessment of Butyrospermum parkii (Shea)-Derived Ingredients as Used in Cosmetics. 2017.
  74. Cosmetic Ingredient Review. Safety Assessment of Ethers and Esters of Ascorbic Acid as Used in Cosmetics. 2017.
  75. Cosmetic Ingredient Review. Safety Assessment of Plant-Derived Fatty Acid Oils. 2017.
  76. Cosmetic Ingredient Review. Amended Safety Assessment of Mentha piperita (Peppermint)-Derived Ingredients as Used in Cosmetics. 2018.
  77. Cosmetic Ingredient Review. Safety Assessment of Alkane Diols as Used in Cosmetics. 2018.
  78. Cosmetic Ingredient Review. Safety Assessment of Alkyl Betaines as Used in Cosmetics. 2018.
  79. Cosmetic Ingredient Review. Safety Assessment of Panthenol, Pantothenic Acid, and Derivatives as Used in Cosmetics. 2018.
  80. Cosmetic Ingredient Review. Safety Assessment of Tromethamine, Aminomethyl Propanediol, and Aminoethyl Propanediol as Used in Cosmetics. 2018.
  81. Cosmetic Ingredient Review. Amended Safety Assessment of Parabens as Used in Cosmetics. 2019.
  82. Cosmetic Ingredient Review. Amended Safety Assessment of Salicylic Acid and Salicylates as Used in Cosmetics. 2019.
  83. Cosmetic Ingredient Review. Safety Assessment of Alkyl Phosphates as Used in Cosmetics. 2019.
  84. Cosmetic Ingredient Review. Safety Assessment of Avena sativa (Oat)-Derived Ingredients As Used in Cosmetics. 2019.
  85. Cosmetic Ingredient Review. Safety Assessment of Brown Algae-Derived Ingredients as Used in Cosmetics. 2019.
  86. Cosmetic Ingredient Review. Safety Assessment of Camellia sinensis–Derived Ingredients As Used in Cosmetics. 2019.
  87. Cosmetic Ingredient Review. Safety Assessment of Citrus-Derived Peel Oils as Used in Cosmetics. 2019.
  88. Cosmetic Ingredient Review. Safety Assessment of Fatty Acid Amidopropyl Dimethylamines as Used in Cosmetics. Int J Toxicol. 2019. PubMed 31170841 · doi:10.1177/1091581819836089
  89. Cosmetic Ingredient Review. Safety Assessment of Fatty Acids & Fatty Acid Salts as Used in Cosmetics. 2019.
  90. Cosmetic Ingredient Review. Safety Assessment of Glycerin as Used in Cosmetics. Int J Toxicol. 2019. PubMed 31840548 · doi:10.1177/1091581819883820
  91. Cosmetic Ingredient Review. Safety Assessment of Monosaccharides, Disaccharides, and Related Ingredients as Used in Cosmetics. 2019.
  92. Cosmetic Ingredient Review. Safety Assessment of PCA (2-Pyrrolidone-5-Carboxylic Acid) and Its Salts as Used in Cosmetics. 2019.
  93. Cosmetic Ingredient Review. Safety Assessment of Sorbitan Esters as Used in Cosmetics. 2019.
  94. Cosmetic Ingredient Review. Squalane and Squalene — Re-Review Summary. 2019.
  95. Cosmetic Ingredient Review. Safety Assessment of Ascorbyl Glucoside and Sodium Ascorbyl Glucoside as Used in Cosmetics. 2020.
  96. Cosmetic Ingredient Review. Safety Assessment of Ceramides as Used in Cosmetics. 2020.
  97. Cosmetic Ingredient Review. Safety Assessment of Monoglyceryl Monoesters as Used in Cosmetics. Int J Toxicol. 2020. PubMed 33203266 · doi:10.1177/1091581820966951
  98. Cosmetic Ingredient Review. Safety Assessment of Polyaminopropyl Biguanide (Polyhexamethylene Biguanide Hydrochloride) as Used in Cosmetics. 2020.
  99. Cosmetic Ingredient Review. Safety Assessment of Inorganic Hydroxides as Used in Cosmetics. 2021.
  100. Cosmetic Ingredient Review. Safety Assessment of Saccharide Esters as Used in Cosmetics. 2021.
  101. Cosmetic Ingredient Review. Amended Safety Assessment of Malic Acid and Sodium Malate as Used in Cosmetics. Int J Toxicol. 2022. PubMed 35993419 · doi:10.1177/10915818221117535
  102. Cosmetic Ingredient Review. Amended Safety Assessment of Triglycerides as Used in Cosmetics. 2022.
  103. Cosmetic Ingredient Review. Safety Assessment of Acrylamide/Acrylate Copolymers as Used in Cosmetics. 2022.
  104. Cosmetic Ingredient Review. Safety Assessment of Ethers and Esters of Ascorbic Acid as Used in Cosmetics. Int J Toxicol. 2022. PubMed 35549580 · doi:10.1177/10915818221093545
  105. Cosmetic Ingredient Review. Safety Assessment of Glyceryl Acrylates as Used in Cosmetics. 2022.
  106. Cosmetic Ingredient Review. Safety Assessment of Panthenol, Pantothenic Acid, and Derivatives as Used in Cosmetics. Int J Toxicol. 2022. PubMed 36177798 · doi:10.1177/10915818221124809
  107. Cosmetic Ingredient Review. Safety Assessment of Phenyl-Substituted Methicones as Used in Cosmetics. 2022.
  108. Cosmetic Ingredient Review. Safety Assessment of Plant-Derived Proteins and Peptides as Used in Cosmetics. 2022.
  109. Cosmetic Ingredient Review. Safety Assessment of Skin and Connective Tissue-Derived Proteins and Peptides as Used in Cosmetics. 2022.
  110. Cosmetic Ingredient Review. Safety Assessment of Alkyl Sultaines as Used in Cosmetics. 2023.
  111. Cosmetic Ingredient Review. Safety Assessment of Cocos nucifera (Coconut)-Derived Ingredients as Used in Cosmetics. Int J Toxicol. 2023. PubMed 36862031 · doi:10.1177/10915818231157751
  112. Cosmetic Ingredient Review. Safety Assessment of Eucalyptus globulus (Eucalyptus)-Derived Ingredients as Used in Cosmetics. 2023.
  113. Cosmetic Ingredient Review. Safety Assessment of Hyaluronates as Used in Cosmetics. 2023.
  114. Cosmetic Ingredient Review. Safety Assessment of Polyglyceryl Fatty Acid Esters as Used in Cosmetics. 2023.
  115. Cosmetic Ingredient Review. Amended Safety Assessment of Lanolin and Lanolin-Derived Ingredients as Used in Cosmetics. 2024.
  116. Cosmetic Ingredient Review. Safety Assessment of Alkane Diols as Used in Cosmetics. Int J Toxicol. 2024. PubMed 38174390 · doi:10.1177/10915818231224234
  117. Cosmetic Ingredient Review. Safety Assessment of Ascorbic Acid and Ascorbates as Used in Cosmetics. 2024.
  118. Cosmetic Ingredient Review. Safety Assessment of Capryloyl Salicylic Acid as Used in Cosmetics. Int J Toxicol. 2024. PubMed 38465458 · doi:10.1177/10915818241237794
  119. Cosmetic Ingredient Review. Safety Assessment of Ginkgo biloba-Derived Ingredients as Used in Cosmetics. Int J Toxicol. 2024. PubMed 37930133 · doi:10.1177/10915818231210792
  120. Cosmetic Ingredient Review. Safety Assessment of Methylxanthines as Used in Cosmetics. 2024.
  121. Cosmetic Ingredient Review. Safety Assessment of Myristoyl Pentapeptide-4, Palmitoyl Pentapeptide-4, and Pentapeptide-4 as Used in Cosmetics. 2024.
  122. Cosmetic Ingredient Review. Amended Safety Assessment of Synthetically Manufactured Amorphous Silica and Hydrated Silica as Used in Cosmetics. Int J Toxicol. 2025. PubMed 40932354 · doi:10.1177/10915818251356416
  123. Cosmetic Ingredient Review. Final Report of the Safety Assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorba. 2025.
  124. Cosmetic Ingredient Review. Safety Assessment of Ascorbyl Glucoside and Sodium Ascorbyl Glucoside as Used in Cosmetics. Int J Toxicol. 2025. PubMed 39513541 · doi:10.1177/10915818241297075
  125. Cosmetic Ingredient Review. Safety Assessment of Levulinic Acid and Sodium Levulinate as Used in Cosmetics. 2025.
  126. Cosmetic Ingredient Review. Re-Review Summary of Ascorbic Acid and Ascorbates. Int J Toxicol. 2026. PubMed 42773578 · doi:10.1177/10915818261486387
  127. Cosmetic Ingredient Review. Safety Assessment of Centaurea cyanus Flower-Derived Ingredients as Used in Cosmetics. 2026.
  128. Cosmetic Ingredient Review. Safety Assessment of Glycolactones as Used in Cosmetics. Int J Toxicol. 2026. PubMed 42249663 · doi:10.1177/10915818261455261
  129. Cosmetic Ingredient Review. Safety Assessment of Melaleuca alternifolia (Tea Tree)-Derived Ingredients as Used in Cosmetics. Int J Toxicol. 2026. PubMed 42389853 · doi:10.1177/10915818261460875
  130. Cosmetic Ingredient Review. Amended Safety Assessment of Kojic Acid as Used in Cosmetics.
  131. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Cetyl Lactate and Myristyl Lactate.
  132. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Octyl Palmitate, Cetyl Palmitate and Isopropyl Palmitate.

Moksliniai straipsniai pagal temas

Straipsnių iš viso: 662. Paspausk temą, kad matytum jos straipsnius.

Odos barjeras 25Raginio sluoksnio sandara, barjero lipidai (ceramidai, cholesterolis, riebalų rūgštys), vandens netekimas per odą, barjero atsistatymas.
  1. Akahane T, Watanabe D, Shimizu E, Tanaka K, Kaizu K. Efficacy of Pseudo-Ceramide Absorption Into the Stratum Corneum and Effects on Transepidermal Water Loss and the Ceramide Profile: A Randomized Controlled Trial. J Cosmet Dermatol. 2025;24(1):e16655. PubMed 39492723 · doi:10.1111/jocd.16655
  2. Berardesca E, Distante F, Vignoli GP, Oresajo C, Green B. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol. 1997;137(6):934-8. PubMed 9470910
  3. Cao Y, Wang P, Zhang G, Hu C, Zhang H, Wang X. Administration of skin care regimens containing β-glucan for skin recovery after fractional laser therapy: A split-face, double-blinded, vehicle-controlled study. J Cosmet Dermatol. 2021;20(6):1756-1762. PubMed 33128496 · doi:10.1111/jocd.13798
  4. Carneiro Rita, Salgado Ana, Raposo Sara, Marto Joana, Simões Sandra, Urbano Manuela, Ribeiro Helena M. Topical emulsions containing ceramides: Effects on the skin barrier function and anti‐inflammatory properties. European Journal of Lipid Science and Technology. 2011. doi:10.1002/EJLT.201000495
  5. de Jager MW, Gooris GS, Dolbnya IP, Bras W, Ponec M, Bouwstra JA. Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization. J Lipid Res. 2004;45(5):923-32. PubMed 14967818 · doi:10.1194/jlr.M300484-JLR200
  6. Gloor M. How do dermatological vehicles influence the horny layer?. Skin Pharmacol Physiol. 2004;17(6):267-73. PubMed 15528956 · doi:10.1159/000081111
  7. Groen D, Gooris GS, Bouwstra JA. Model membranes prepared with ceramide EOS, cholesterol and free fatty acids form a unique lamellar phase. Langmuir. 2010;26(6):4168-75. PubMed 20121267 · doi:10.1021/la9047038
  8. Hachem JP, Roelandt T, Schürer N, Pu X, Fluhr J, Giddelo C, et al. Acute acidification of stratum corneum membrane domains using polyhydroxyl acids improves lipid processing and inhibits degradation of corneodesmosomes. J Invest Dermatol. 2010;130(2):500-10. PubMed 19741713 · doi:10.1038/jid.2009.249
  9. Hirata K, Mohammed D, Hadgraft J, Lane ME. Influence of lidocaine hydrochloride and penetration enhancers on the barrier function of human skin. Int J Pharm. 2014;477(1-2):416-20. PubMed 25305378 · doi:10.1016/j.ijpharm.2014.10.012
  10. Kakuda L, Melo MO, Campos PMBGM. Hydrolipidic Characteristics and Clinical Efficacy of a Dermocosmetic Formulation for the Improvement of Homeostasis on Oily Mature Skin. Life (Basel). 2022;13(1). PubMed 36676036 · doi:10.3390/life13010087
  11. Kauth M, Trusova OV. Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review. Dermatol Ther (Heidelb). 2022;12(2):295-313. PubMed 35038127 · doi:10.1007/s13555-021-00676-9
  12. Kono T, Miyachi Y, Kawashima M. Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review. J Dermatol. 2021;48(12):1807-1816. PubMed 34596254 · doi:10.1111/1346-8138.16175
  13. Li N, Styczynski P, Gibb R, Li C, Marsh R. Study on percutaneous penetration of representative cosmetic ingredients in a baby wipe product in an in vitro diaper rash skin model. Toxicol In Vitro. 2024;100:105912. PubMed 39069215 · doi:10.1016/j.tiv.2024.105912
  14. Lim SH, Kim EJ, Lee CH, Park GH, Yoo KM, Nam SJ, et al. A Lipid Mixture Enriched by Ceramide NP with Fatty Acids of Diverse Chain Lengths Contributes to Restore the Skin Barrier Function Impaired by Topical Corticosteroid. Skin Pharmacol Physiol. 2022;35(2):112-123. PubMed 34348350 · doi:10.1159/000518517
  15. Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol. 1993;129(6):728-38. PubMed 8507075
  16. Man MQ M, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol. 1996;106(5):1096-101. PubMed 8618046 · doi:10.1111/1523-1747.ep12340135
  17. Mohammed D, Hirata K, Hadgraft J, Lane ME. Influence of skin penetration enhancers on skin barrier function and skin protease activity. Eur J Pharm Sci. 2014;51:118-22. PubMed 24063883 · doi:10.1016/j.ejps.2013.09.009
  18. Mojumdar EH, Gooris GS, Bouwstra JA. Phase behavior of skin lipid mixtures: the effect of cholesterol on lipid organization. Soft Matter. 2015;11(21):4326-36. PubMed 25947944 · doi:10.1039/c4sm02786h
  19. Ramis J, Conte L, Segado X, Forn J, Lauroba J, Calpena A, et al. Influence of formulation on the in vitro transdermal penetration of flutrimazole. Arzneimittelforschung. 1997;47(10):1139-44. PubMed 9368709
  20. Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19(6):296-302. PubMed 16864974 · doi:10.1159/000094670
  21. Schoenfelder H, Reuter M, Evers DH, Herbig ME, Lunter DJ. Ceramide Profiling of Porcine Skin and Systematic Investigation of the Impact of Sorbitan Esters (SEs) on the Barrier Function of the Skin. Mol Pharm. 2025;22(4):2019-2028. PubMed 40066742 · doi:10.1021/acs.molpharmaceut.4c01245
  22. Sigg M, Daniels R. Impact of Alkanediols on Stratum Corneum Lipids and Triamcinolone Acetonide Skin Penetration. Pharmaceutics. 2021;13(9). PubMed 34575527 · doi:10.3390/pharmaceutics13091451
  23. Sochorová M, Audrlická P, Červená M, Kováčik A, Kopečná M, Opálka L, et al. Permeability and microstructure of cholesterol-depleted skin lipid membranes and human stratum corneum. J Colloid Interface Sci. 2019;535:227-238. PubMed 30300812 · doi:10.1016/j.jcis.2018.09.104
  24. Turner GA, Moore AE, Marti VP, Paterson SE, James AG. Impact of shaving and anti-perspirant use on the axillary vault. Int J Cosmet Sci. 2007;29(1):31-8. PubMed 18489309 · doi:10.1111/j.1467-2494.2007.00361.x
  25. Watkinson A, Lee RS, Moore AE, Pudney PD, Paterson SE, Rawlings AV. Reduced barrier efficiency in axillary stratum corneum. Int J Cosmet Sci. 2002;24(3):151-61. PubMed 18498507 · doi:10.1046/j.1467-2494.2002.00133.x
Drėkikliai 38Glicerinas, karbamidas, hialurono rūgštis, propandiolis, betainas, pantenolis — kaip jie sulaiko vandenį odoje.
  1. Albèr C, Buraczewska-Norin I, Kocherbitov V, Saleem S, Lodén M, Engblom J. Effects of water activity and low molecular weight humectants on skin permeability and hydration dynamics - a double-blind, randomized and controlled study. Int J Cosmet Sci. 2014;36(5):412-8. PubMed 24786192 · doi:10.1111/ics.12136
  2. Baldwin H, Del Rosso J. Going Beyond Ceramides in Moisturizers: The Role of Natural Moisturizing Factors. J Drugs Dermatol. 2024;23(6):466-471. PubMed 38834224 · doi:10.36849/JDD.8358
  3. Björklund S, Andersson JM, Pham QD, Nowacka A, Topgaard D, Sparr E. Stratum corneum molecular mobility in the presence of natural moisturizers. Soft Matter. 2014;10(25):4535-46. PubMed 24817485 · doi:10.1039/c4sm00137k
  4. Camargo FB Jr, Gaspar LR, Maia Campos PM. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci. 2011;62(4):361-70. PubMed 21982351
  5. Choi EH, Man MQ, Wang F, Zhang X, Brown BE, Feingold KR, et al. Is endogenous glycerol a determinant of stratum corneum hydration in humans?. J Invest Dermatol. 2005;125(2):288-93. PubMed 16098039 · doi:10.1111/j.0022-202X.2005.23799.x
  6. Clar EJ, Fourtanier A. Pyrrolidone carboxylic acid and the skin. Int J Cosmet Sci. 1981;3(3):101-13. PubMed 19469932 · doi:10.1111/j.1467-2494.1981.tb00275.x
  7. Crowther JM. Understanding effects of topical ingredients on electrical measurement of skin hydration. Int J Cosmet Sci. 2016;38(6):589-598. PubMed 27028308 · doi:10.1111/ics.12324
  8. Czajkowska-Kośnik A, Perkowska P, Winnicka K. Trehalose in an Emulsion-Based Carrier: Effects on Skin Hydration and Transepidermal Water Loss. Cosmetics. 2026;13(4):196. doi:10.3390/cosmetics13040196
  9. Dayan N, Sivalenka R, Chase J. Skin moisturization by hydrogenated polyisobutene--quantitative and visual evaluation. J Cosmet Sci. 2009;60(1):15-24. PubMed 19296892
  10. Filatov V, Sokolova A, Savitskaya N, Olkhovskaya M, Varava A, Ilin E, et al. Synergetic Effects of Aloe Vera Extract with Trimethylglycine for Targeted Aquaporin 3 Regulation and Long-Term Skin Hydration. Molecules. 2024;29(7). PubMed 38611819 · doi:10.3390/molecules29071540
  11. Fluhr JW, Gloor M, Lehmann L, Lazzerini S, Distante F, Berardesca E. Glycerol accelerates recovery of barrier function in vivo. Acta Derm Venereol. 1999;79(6):418-21. PubMed 10598752 · doi:10.1080/000155599750009825
  12. Fluhr JW, Tfayli A, Darlenski R, Darvin ME, Joly-Tonetti N, Lachmann N. Glycerol and natural sugar-derived complex modulate differentially stratum corneum water-binding properties and structural parameters in an in vitro Raman-desorption model. J Biophotonics. 2023;16(1):e202200201. PubMed 36153668 · doi:10.1002/jbio.202200201
  13. Gao M, Gao N, Wang L, Yao T, Jing H, Liu H, et al. Evaluation of the Efficacy and Safety of a Panthenol-Enriched Mask for Skin Barrier Recovery After Facial Laser Treatment: Results of a Double-Blind Randomized Controlled Study. J Cosmet Dermatol. 2025;24(7):e70223. PubMed 40613435 · doi:10.1111/jocd.70223
  14. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung. 2000;50(7):659-63. PubMed 10965426 · doi:10.1055/s-0031-1300268
  15. Grether-Beck S, Mühlberg K, Brenden H, Krutmann J. [Urea plus ceramides and vitamins: improving the efficacy of a topical urea preparation by addition of ceramides and vitamins]. Hautarzt. 2008;59(9):717-8, 720-3. PubMed 18679637 · doi:10.1007/s00105-008-1594-z
  16. Hara M, Verkman AS. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice. Proc Natl Acad Sci U S A. 2003;100(12):7360-5. PubMed 12771381 · doi:10.1073/pnas.1230416100
  17. Hoeksema H, De Vos M, Verbelen J, Pirayesh A, Monstrey S. Scar management by means of occlusion and hydration: a comparative study of silicones versus a hydrating gel-cream. Burns. 2013;39(7):1437-48. PubMed 23639224 · doi:10.1016/j.burns.2013.03.025
  18. Hoggarth A, Waring M, Alexander J, Greenwood A, Callaghan T. A controlled, three-part trial to investigate the barrier function and skin hydration properties of six skin protectants. Ostomy Wound Manage. 2005;51(12):30-42. PubMed 16439809
  19. Johnson W Jr, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, et al. Safety assessment of 1,2-glycols as used in cosmetics. Int J Toxicol. 2012;31(5 Suppl):147S-68S. PubMed 23064773 · doi:10.1177/1091581812460409
  20. Kis N, Gunnarsson M, Berkó S, Sparr E. The effects of glycols on molecular mobility, structure, and permeability in stratum corneum. J Control Release. 2022;343:755-764. PubMed 35150813 · doi:10.1016/j.jconrel.2022.02.007
  21. Korponyai C. The role of polyols and amino acids in the maintenance of homeostasis in the skin. Daktaro disertacija, Segedo universitetas. 2016.
  22. Korponyai C, Szél E, Behány Z, Varga E, Mohos G, Dura Á, et al. Effects of Locally Applied Glycerol and Xylitol on the Hydration, Barrier Function and Morphological Parameters of the Skin. Acta Derm Venereol. 2017;97(2):182-187. PubMed 27349297 · doi:10.2340/00015555-2493
  23. Kuzmina N, Hagströmer L, Emtestam L. Urea and sodium chloride in moisturisers for skin of the elderly--a comparative, double-blind, randomised study. Skin Pharmacol Appl Skin Physiol. 2002;15(3):166-74. PubMed 12077469 · doi:10.1159/000063545
  24. Loden M. Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res. 1996;288(2):103-7. PubMed 8932589
  25. Lodén M, Wessman W. The influence of a cream containing 20% glycerin and its vehicle on skin barrier properties. Int J Cosmet Sci. 2001;23(2):115-9. PubMed 18498456 · doi:10.1046/j.1467-2494.2001.00060.x
  26. Loo Ch, Basri M, Ismail R, Lau H, Tejo B, Kanthimathi M, et al. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. Int J Nanomedicine. 2013;8:13-22. PubMed 23293516 · doi:10.2147/IJN.S35648
  27. Milani M, Sparavigna A. The 24-hour skin hydration and barrier function effects of a hyaluronic 1%, glycerin 5%, and Centella asiatica stem cells extract moisturizing fluid: an intra-subject, randomized, assessor-blinded study. Clin Cosmet Investig Dermatol. 2017;10:311-315. PubMed 28860834 · doi:10.2147/CCID.S144180
  28. Muizzuddin N, Ingrassia M, Marenus KD, Maes DH, Mammone T. Effect of seasonal and geographical differences on skin and effect of treatment with an osmoprotectant: Sorbitol. J Cosmet Sci. 2013;64(3):165-74. PubMed 23752031
  29. Pinto JR, Monteiro E Silva SA, Leonardi GR. Effects of 1,3-propanediol associated, or not, with butylene glycol and/or glycerol on skin hydration and skin barrier function. Int J Cosmet Sci. 2024;46(1):85-95. PubMed 37699769 · doi:10.1111/ics.12911
  30. Polaskova J, Pavlackova J, Egner P. Effect of vehicle on the performance of active moisturizing substances. Skin Res Technol. 2015;21(4):403-12. PubMed 25594355 · doi:10.1111/srt.12206
  31. Serup J. A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme. Acta Derm Venereol Suppl (Stockh). 1992;177:34-43. PubMed 1466184
  32. Stettler H, Kurka P, Lunau N, Manger C, Böhling A, Bielfeldt S, et al. A new topical panthenol-containing emollient: Results from two randomized controlled studies assessing its skin moisturization and barrier restoration potential, and the effect on skin microflora. J Dermatolog Treat. 2017;28(2):173-180. PubMed 27425824 · doi:10.1080/09546634.2016.1214235
  33. Sundaram H, Mackiewicz N, Burton E, Peno-Mazzarino L, Lati E, Meunier S. Pilot Comparative Study of the Topical Action of a Novel, Crosslinked Resilient Hyaluronic Acid on Skin Hydration and Barrier Function in a Dynamic, Three-Dimensional Human Explant Model. J Drugs Dermatol. 2016;15(4):434-41. PubMed 27050698
  34. Szél E, Danis J, Sőrés E, Tóth D, Korponyai C, Degovics D, et al. Protective effects of glycerol and xylitol in keratinocytes exposed to hyperosmotic stress. Clin Cosmet Investig Dermatol. 2019;12:323-331. PubMed 31190939 · doi:10.2147/CCID.S197946
  35. Tomiie A, Shinozaki M, Yamada T, Kuriyama J. Moisturizing Effects of Diglycerol Combined with Glycerol on Human Stratum Corneum. J Oleo Sci. 2016;65(8):681-4. PubMed 27430380 · doi:10.5650/jos.ess15253
  36. Ventura SA, Kasting GB. Dynamics of glycerine and water transport across human skin from binary mixtures. Int J Cosmet Sci. 2017;39(2):165-178. PubMed 27566278 · doi:10.1111/ics.12362
  37. Yoshimura T, Manabe C, Nagumo JI, Nagahama T, Sato T, Murakami S. Taurine accelerates the synthesis of ceramides and hyaluronic acid in cultured epidermis and dermal fibroblasts. Exp Ther Med. 2023;26(5):512. PubMed 37840567 · doi:10.3892/etm.2023.12211
  38. Zhu J, Tang X, Jia Y, Ho CT, Huang Q. Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery - A review. Int J Pharm. 2020;578:119127. PubMed 32036009 · doi:10.1016/j.ijpharm.2020.119127
Emolientai ir okliuzinės medžiagos 18Vazelinas, skvalanas, silikonai, augaliniai aliejai ir sviestai, vaškai, esteriai.
  1. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, et al. Safety assessment of silylates and surface-modified siloxysilicates. Int J Toxicol. 2013;32(3 Suppl):5S-24S. PubMed 23696579 · doi:10.1177/1091581813486299
  2. De Paepe K, Sieg A, Le Meur M, Rogiers V. Silicones as nonocclusive topical agents. Skin Pharmacol Physiol. 2014;27(3):164-71. PubMed 24457536 · doi:10.1159/000354914
  3. Ferreira T, Loureiro A, Noro J, Cavaco-Paulo A, Castro TG. Addressing the Structural Organization of Silicone Alternatives in Formulations by Molecular Dynamics Simulations and a Novel Equilibration Protocol. Polymers (Basel). 2023;15(4). PubMed 36850081 · doi:10.3390/polym15040796
  4. Fiume M, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Squalane and Squalene. Int J Toxicol. 2023;42(3_suppl):107S-109S. PubMed 37752766 · doi:10.1177/10915818231204276
  5. Frömder A, Lippold BC. Water vapour transmission and occlusivity in vivo of lipophilic excipients used in ointments. International Journal of Cosmetic Science. 1993. doi:10.1111/j.1468-2494.1993.tb00591.x
  6. Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol. 1992;26(3 Pt 2):387-96. PubMed 1564142 · doi:10.1016/0190-9622(92)70060-s
  7. Goussard V, Aubry JM, Nardello-Rataj V. Bio-based alternatives to volatile silicones: Relationships between chemical structure, physicochemical properties and functional performances. Adv Colloid Interface Sci. 2022;304:102679. PubMed 35512559 · doi:10.1016/j.cis.2022.102679
  8. Iyer BV. Investigation Of Lanolin Alcohol As A Film-Forming Delivery System: In Vitro Kinetics Of Triamcinolone Acetonide Release And Skin Penetration. . 1979.
  9. Léguillier T, Lecsö-Bornet M, Lémus C, Rousseau-Ralliard D, Lebouvier N, Hnawia E, et al. The Wound Healing and Antibacterial Activity of Five Ethnomedical Calophyllum inophyllum Oils: An Alternative Therapeutic Strategy to Treat Infected Wounds. PLoS One. 2015;10(9):e0138602. PubMed 26406588 · doi:10.1371/journal.pone.0138602
  10. Mancuso A, Tarsitano M, Udongo BP, Cristiano MC, Torella D, Paolino D, et al. A comparison between silicone-free and silicone-based emulsions: Technological features and in vivo evaluation. Int J Cosmet Sci. 2022;44(5):514-529. PubMed 35815903 · doi:10.1111/ics.12800
  11. Nong Y, Maloh J, Natarelli N, Gunt HB, Tristani E, Sivamani RK. A review of the use of beeswax in skincare. J Cosmet Dermatol. 2023;22(8):2166-2173. PubMed 36999457 · doi:10.1111/jocd.15718
  12. Ogorzałek M, Klimaszewska E, Mirowski M, Kulawik-Pióro A, Tomasiuk R. Natural or Synthetic Emollients? Physicochemical Properties of Body Oils in Relation to Selected Parameters of Epidermal Barrier Function. Appl Sci 2024;14(7):2783. doi:10.3390/app14072783
  13. Oliveira ALS, Valente D, Moreira HR, Pintado M, Costa P. Effect of squalane-based emulsion on polyphenols skin penetration: Ex vivo skin study. Colloids Surf B Biointerfaces. 2022;218:112779. PubMed 35994992 · doi:10.1016/j.colsurfb.2022.112779
  14. Pinto JR, Monteiro E Silva SA, Holsback VSS, Leonardi GR. Skin occlusive performance: Sustainable alternatives for petrolatum in skincare formulations. J Cosmet Dermatol. 2022;21(10):4775-4780. PubMed 35038372 · doi:10.1111/jocd.14782
  15. Rubio-Santoyo A, Sanabria-de la Torre R, Montero-Vílchez T, Girón-Prieto MS, Gómez-Farto A, Arias-Santiago S. Effects of Extra Virgin Olive Oil and Petrolatum on Skin Barrier Function and Microtopography. J Clin Med. 2025;14(13). PubMed 40649050 · doi:10.3390/jcm14134675
  16. Spruit D. The interference of some substances with the water vapour loss of human skin. Dermatologica. 1971;142(2):89-92. PubMed 5575285 · doi:10.1159/000252375
  17. Valerón-Almazán P, et al. Evolution of Post-Surgical Scars Treated with Pure Rosehip Seed Oil. J Cosmet Dermatol Sci Appl 2015;5:161. doi:10.4236/jcdsa.2015.52019
  18. Williams ML, Vogel JS, Ghadially R, Brown BE, Elias PM. Exogenous origin of n-alkanes in pathologic scale. Arch Dermatol. 1992;128(8):1065-71. PubMed 1497360
Tekstūra ir pojūtis ant odos 15Kaip emolientai jaučiasi ant odos, lengvos ir sunkios tekstūros, tinkamumas riebiai odai.
  1. Bom S, Fitas M, Martins AM, Pinto P, Ribeiro HM, Marto J. Replacing Synthetic Ingredients by Sustainable Natural Alternatives: A Case Study Using Topical O/W Emulsions. Molecules. 2020;25(21). PubMed 33105792 · doi:10.3390/molecules25214887
  2. Bom S, Gouveia LF, Pinto P, Martins AM, Ribeiro HM, Marto J. A mathematical modeling strategy to predict the spreading behavior on skin of sustainable alternatives to personal care emollients. Colloids Surf B Biointerfaces. 2021;205:111865. PubMed 34044331 · doi:10.1016/j.colsurfb.2021.111865
  3. César FCS, Maia Campos PMBG. Influence of vegetable oils in the rheology, texture profile and sensory properties of cosmetic formulations based on organogel. Int J Cosmet Sci. 2020;42(5):494-500. PubMed 32696456 · doi:10.1111/ics.12654
  4. Dederen JC, Chavan B, Rawlings AV. Emollients are more than sensory ingredients: the case of isostearyl isostearate. Int J Cosmet Sci. 2012;34(6):502-10. PubMed 22913650 · doi:10.1111/j.1468-2494.2012.00744.x
  5. Douguet M, Picard C, Savary G, Merlaud F, Loubat-Bouleuc N, Grisel M. Spreading properties of cosmetic emollients: Use of synthetic skin surface to elucidate structural effect. Colloids Surf B Biointerfaces. 2017;154:307-314. PubMed 28371727 · doi:10.1016/j.colsurfb.2017.03.028
  6. Gerken A, Libby E, Vigilante P, Safee R, Szoboszlai M, Baki G. Sensory contribution of emollient cascades in skin creams evaluated by CATA analysis. Int J Cosmet Sci. 2026. PubMed 42554169 · doi:10.1111/ics.70123
  7. Goldemberg RL, de la Rosa CP. Correlation of Skin Feel of Emollients to Their Chemical Structure. J Soc Cosmet Chem 1971;22:635-654.
  8. Gore E, Picard C, Savary G. Complementary approaches to understand the spreading behavior on skin of O/W emulsions containing different emollientss. Colloids Surf B Biointerfaces. 2020;193:111132. PubMed 32446159 · doi:10.1016/j.colsurfb.2020.111132
  9. Huber P, Reinau D, Brodard Z, Meier CR, Surber C. How to Choose an Emollient? Pharmaceutical and Sensory Attributes for Product Selection. Skin Pharmacol Physiol. 2025;38(1-2):1-9. PubMed 39832490 · doi:10.1159/000543653
  10. Huynh A, Garcia AG, Young LK, Szoboszlai M, Liberatore MW, Baki G. Measurements meet perceptions: rheology-texture-sensory relations when using green, bio-derived emollients in cosmetic emulsions. Int J Cosmet Sci. 2021;43(1):11-19. PubMed 32886359 · doi:10.1111/ics.12661
  11. Meneguello TG, Palma NK, Santos YR, Carvalho AF, Ladeira ADDS, Bonsanto FP, et al. Physicochemical and Sensory Evaluation of Sustainable Plant-Based Homopolymers as an Alternative to Traditional Emollients in Topical Emulsions. Pharmaceutics. 2025;17(2). PubMed 40006631 · doi:10.3390/pharmaceutics17020265
  12. Parente ME, Gámbaro A, Solana G. Study of sensory properties of emollients used in cosmetics and their correlation with physicochemical properties. J Cosmet Sci. 2005;56(3):175-82. PubMed 16116522
  13. Parente ME, Gámbaro A, Ares G. Sensory characterization of emollients. J Sens Stud 2008;23(2):149-161. doi:10.1111/j.1745-459x.2007.00136.x
  14. Savary G, Grisel M, Picard C. Impact of emollients on the spreading properties of cosmetic products: a combined sensory and instrumental characterization. Colloids Surf B Biointerfaces. 2013;102:371-8. PubMed 23174669 · doi:10.1016/j.colsurfb.2012.07.028
  15. Seo JI, Ham HI, Baek JH, Shin MK. An objective skin-type classification based on non-invasive biophysical parameters. J Eur Acad Dermatol Venereol. 2022;36(3):444-452. PubMed 34747517 · doi:10.1111/jdv.17793
Prausikliai ir paviršinio aktyvumo medžiagos 94Natrio laurilsulfatas ir kitos stiprios medžiagos, švelnūs prausikliai, muilas ir sintetiniai prausikliai, medžiagos, mažinančios prausiklio poveikį odai.
  1. Agner T, Serup J. Sodium lauryl sulphate for irritant patch testing--a dose-response study using bioengineering methods for determination of skin irritation. J Invest Dermatol. 1990;95(5):543-7. PubMed 2230217 · doi:10.1111/1523-1747.ep12504896
  2. Agner T, Johansen JD, Overgaard L, Vølund A, Basketter D, Menné T. Combined effects of irritants and allergens. Synergistic effects of nickel and sodium lauryl sulfate in nickel- sensitized individuals. Contact Dermatitis. 2002;47(1):21-6. PubMed 12225409 · doi:10.1034/j.1600-0536.2002.470105.x
  3. Ananthapadmanabhan KP, Moore DJ, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther. 2004;17 Suppl 1:16-25. PubMed 14728695 · doi:10.1111/j.1396-0296.2004.04s1002.x
  4. Anderheggen B, Jassoy C, Waldmann-Laue M, Förster T, Wadle A, Doering T. Taurine improves epidermal barrier properties stressed by surfactants-a role for osmolytes in barrier homeostasis. J Cosmet Sci. 2006;57(1):1-10. PubMed 16676119
  5. Atrux-Tallau N, Romagny C, Padois K, Denis A, Haftek M, Falson F, et al. Effects of glycerol on human skin damaged by acute sodium lauryl sulphate treatment. Arch Dermatol Res. 2010;302(6):435-41. PubMed 20043170 · doi:10.1007/s00403-009-1021-z
  6. Baranda L, González-Amaro R, Torres-Alvarez B, Alvarez C, Ramírez V. Correlation between pH and irritant effect of cleansers marketed for dry skin. Int J Dermatol. 2002;41(8):494-9. PubMed 12207765 · doi:10.1046/j.1365-4362.2002.01555.x
  7. Barba C, Semenzato A, Baratto G, Coderch L. Action of surfactants on the mammal epidermal skin barrier. G Ital Dermatol Venereol. 2019;154(4):405-412. PubMed 30249078 · doi:10.23736/S0392-0488.18.05874-1
  8. Barel AO, Lambrecht R, Clarys P, Morrison BM Jr, Paye M. A comparative study of the effects on the skin of a classical bar soap and a syndet cleansing bar in normal use conditions and in the soap chamber test. Skin Res Technol. 2001;7(2):98-104. PubMed 11393212 · doi:10.1034/j.1600-0846.2001.70208.x
  9. Bhoyrul B, Solman L, Kirk S, Orton D, Wilkinson M. Patch testing with alkyl glucosides: Concomitant reactions are common but not ubiquitous. Contact Dermatitis. 2019;80(5):286-290. PubMed 30460735 · doi:10.1111/cod.13186
  10. Bárány E, Lindberg M, Lodén M. Biophysical characterization of skin damage and recovery after exposure to different surfactants. Contact Dermatitis. 1999;40(2):98-103. PubMed 10048655 · doi:10.1111/j.1600-0536.1999.tb05999.x
  11. Charbonnier V, Morrison BM Jr, Paye M, Maibach HI. Subclinical, non-erythematous irritation with an open assay model (washing): sodium lauryl sulfate (SLS) versus sodium laureth sulfate (SLES). Food Chem Toxicol. 2001;39(3):279-86. PubMed 11278060 · doi:10.1016/s0278-6915(00)00132-0
  12. Clemmensen A, Andersen F, Petersen TK, Hagberg O, Andersen KE. Applicability of an exaggerated forearm wash test for efficacy testing of two corticosteroids, tacrolimus and glycerol, in topical formulations against skin irritation induced by two different irritants. Skin Res Technol. 2011;17(1):56-62. PubMed 20923463 · doi:10.1111/j.1600-0846.2010.00465.x
  13. Corazza M, Lauriola MM, Bianchi A, Zappaterra M, Virgili A. Irritant and sensitizing potential of eight surfactants commonly used in skin cleansers: an evaluation of 105 patients. Dermatitis. 2010;21(5):262-8. PubMed 20920412
  14. Cornwell PA. A review of shampoo surfactant technology: consumer benefits, raw materials and recent developments. Int J Cosmet Sci. 2018;40(1):16-30. PubMed 29095493 · doi:10.1111/ics.12439
  15. Cosmetic Ingredient Review. Final Report on the Safety Assessment of Sodium Lauryl Sulfate and Ammonium Lauryl Sulfate. Journal of the American College of Toxicology. 1983. doi:10.3109/10915818309142005
  16. Danby SG, Brown K, Wigley AM, Chittock J, Pyae PK, Flohr C, et al. The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects. J Invest Dermatol. 2018;138(1):68-77. PubMed 28927888 · doi:10.1016/j.jid.2017.08.037
  17. de Jongh CM, Jakasa I, Verberk MM, Kezic S. Variation in barrier impairment and inflammation of human skin as determined by sodium lauryl sulphate penetration rate. Br J Dermatol. 2006;154(4):651-7. PubMed 16536807 · doi:10.1111/j.1365-2133.2005.06989.x
  18. de Groot AC, Ipenburg NA, Rustemeyer T. Contact Allergy to Alkyl Glucosides: A Review-Part 1. Dermatitis. 2026:17103568261471296. PubMed 42522363 · doi:10.1177/17103568261471296
  19. de Groot AC, Ipenburg NA, Rustemeyer T. Contact Allergy to Alkyl Glucosides: A Review. Part 2. Dermatitis. 2026:17103568261464823. PubMed 42697835 · doi:10.1177/17103568261464823
  20. Del Rosso JQ. The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection. J Clin Aesthet Dermatol. 2013;6(12):19-27. PubMed 24765221
  21. Domínguez JG, Balaguer F, Parra JL, Pelejero CM. The inhibitory effect of some amphoteric surfactants on the irritation potential of alkylsulphates. Int J Cosmet Sci. 1981;3(2):57-68. PubMed 19469927 · doi:10.1111/j.1467-2494.1981.tb00268.x
  22. Draelos Z, Hornby S, Walters RM, Appa Y. Hydrophobically modified polymers can minimize skin irritation potential caused by surfactant-based cleansers. J Cosmet Dermatol. 2013;12(4):314-21. PubMed 24305430 · doi:10.1111/jocd.12061
  23. Filipović M, Gledović A, Lukić M, Tasić-Kostov M, Isailović T, Pantelić I, et al. Alp Rose stem cells, olive oil squalene and a natural alkyl polyglucoside emulsifier: Are they appropriate ingredients of skin moisturizers - in vivo efficacy on normal and sodium lauryl sulfate - irritated skin?. Vojnosanit Pregl. 2016;73(11):991-1002. PubMed 29328637 · doi:10.2298/VSP150116122F
  24. Foti C, Bonamonte D, Mascolo G, Corcelli A, Lobasso S, Rigano L, et al. The role of 3-dimethylaminopropylamine and amidoamine in contact allergy to cocamidopropylbetaine. Contact Dermatitis. 2003;48(4):194-8. PubMed 12786723 · doi:10.1034/j.1600-0536.2003.00078.x
  25. Fowler JF, Fowler LM, Hunter JE. Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study. Contact Dermatitis. 1997;37(6):276-81. PubMed 9455630 · doi:10.1111/j.1600-0536.1997.tb02464.x
  26. Fowler JF Jr, Zug KM, Taylor JS, Storrs FJ, Sherertz EA, Sasseville DA, et al. Allergy to cocamidopropyl betaine and amidoamine in North America. Dermatitis. 2004;15(1):5-6. PubMed 15573641 · doi:10.2310/6620.2004.20410
  27. Frosch PJ, Lahti A, Hannuksela M, Andersen KE, Wilkinson JD, Shaw S, et al. Chloromethylisothiazolone/methylisothiazolone (CMI/MI) use test with a shampoo on patch-test-positive subjects. Results of a multicentre double-blind crossover trial. Contact Dermatitis. 1995;32(4):210-7. PubMed 7600776 · doi:10.1111/j.1600-0536.1995.tb00671.x
  28. Ghosh S, Hornby S, Grove G, Zerwick C, Appa Y, Blankschtein D. Ranking of aqueous surfactant-humectant systems based on an analysis of in vitro and in vivo skin barrier perturbation measurements. J Cosmet Sci. 2007;58(6):599-620. PubMed 18305874
  29. Ghosh S, Blankschtein D. The role of sodium dodecyl sulfate (SDS) micelles in inducing skin barrier perturbation in the presence of glycerol. J Cosmet Sci. 2007;58(2):109-33. PubMed 17520152
  30. Ghosh S, Blankschtein D. Why is sodium cocoyl isethionate (SCI) mild to the skin barrier? - An in vitro investigation based on the relative sizes of the SCI micelles and the skin aqueous pores. J Cosmet Sci. 2007;58(3):229-44. PubMed 17598025
  31. Ghosh S, Kim D, So P, Blankschtein D. Visualization and quantification of skin barrier perturbation induced by surfactant–humectant systems using two-photon fluorescence microscopy. J Cosmet Sci 2008; 59: 263–289.
  32. Gijbels D, Timmermans A, Serrano P, Verreycken E, Goossens A. Allergic contact dermatitis caused by alkyl glucosides. Contact Dermatitis. 2014;70(3):175-82. PubMed 24588370 · doi:10.1111/cod.12154
  33. Goodman G. Cleansing and moisturizing in acne patients. Am J Clin Dermatol. 2009;10 Suppl 1:1-6. PubMed 19209947 · doi:10.2165/0128071-200910001-00001
  34. Hall-Manning TJ, Holland GH, Rennie G, Revell P, Hines J, Barratt MD, et al. Skin irritation potential of mixed surfactant systems. Food Chem Toxicol. 1998;36(3):233-8. PubMed 9609395 · doi:10.1016/s0278-6915(97)00144-0
  35. Heydorn S, Andersen KE, Johansen JD, Menné T. A stronger patch test elicitation reaction to the allergen hydroxycitronellal plus the irritant sodium lauryl sulfate. Contact Dermatitis. 2003;49(3):133-9. PubMed 14678209 · doi:10.1111/j.0105-1873.2003.00175.x
  36. Hornby S, Walters R, Tierney N, Appa Y, Dorfman G, Kamath Y. Effect of commercial cleansers on skin barrier permeability. Skin Res Technol. 2016;22(2):196-202. PubMed 26094702 · doi:10.1111/srt.12250
  37. Iijima S, Murayama K, Takayama N, Akiyama T, Ikarashi Y, Sugiyama M, et al. Analysis of patch testing with cocamidopropyl betaine and its impurities in patients with intractable scalp dermatitis in a single clinic in Japan. Contact Dermatitis. 2023;89(5):368-373. PubMed 37550079 · doi:10.1111/cod.14393
  38. Iijima S, Murayama K, Takayama N, Sugiyama M, Matsunaga K. Two Cases of Allergic Contact Dermatitis Caused by Coco Betaine in Clobetasol Propionate Shampoo. Case Rep Dermatol Med. 2026;2026:9953943. PubMed 41488827 · doi:10.1155/crdm/9953943
  39. Ipenburg NA, de Groot AC, Rustemeyer T. High Frequency of Sensitisation to Decyl and Lauryl Glucoside in Routine Patch Testing in the Netherland. Contact Dermatitis. 2026. PubMed 42830235 · doi:10.1111/cod.70260
  40. Jacob SE, Amini S. Cocamidopropyl betaine. Dermatitis. 2008;19(3):157-60. PubMed 18627690
  41. Jurek I, Szuplewska A, Chudy M, Wojciechowski K. Soapwort (Saponaria officinalis L.) Extract vs. Synthetic Surfactants-Effect on Skin-Mimetic Models. Molecules. 2021;26(18). PubMed 34577098 · doi:10.3390/molecules26185628
  42. Kanokrungsee S, Leysen J, Aerts O, Dendooven E. Frequent Positive Patch Test Reactions to Glucosides in Children: A Call for Caution?. Contact Dermatitis. 2025;93(2):148-158. PubMed 40394829 · doi:10.1111/cod.14812
  43. Kawasaki Y, Quan D, Sakamoto K, Cooke R, Maibach HI. Influence of surfactant mixtures on intercellular lipid fluidity and skin barrier function. Skin Research and Technology 1999; 5: 96–101.
  44. Khosrowpour Z, Ahmad Nasrollahi S, Samadi A, Ayatollahi A, Shamsipour M, Rajabi-Esterabadi A, et al. Skin biophysical assessments of four types of soaps by forearm in-use test. J Cosmet Dermatol. 2022;21(7):3127-3132. PubMed 34741581 · doi:10.1111/jocd.14589
  45. Korting HC, Ponce-Pöschl E, Klövekorn W, Schmötzer G, Arens-Corell M, Braun-Falco O. The influence of the regular use of a soap or an acidic syndet bar on pre-acne. Infection. 1995;23(2):89-93. PubMed 7622270 · doi:10.1007/BF01833872
  46. Lakshmi C, Srinivas CR, Anand CV, Mathew AC. Irritancy ranking of 31 cleansers in the Indian market in a 24-h patch test. Int J Cosmet Sci. 2008;30(4):277-83. PubMed 18713074 · doi:10.1111/j.1468-2494.2008.00448.x
  47. Lee CH, Kawasaki Y, Maibach HI. Effect of surfactant mixtures on irritant contact dermatitis potential in man: sodium lauroyl glutamate and sodium lauryl sulphate. Contact Dermatitis. 1994;30(4):205-9. PubMed 8033544 · doi:10.1111/j.1600-0536.1994.tb00644.x
  48. Lemery E, Briançon S, Chevalier Y, Oddos T, Gohier A, Boyron O, et al. Surfactants have multi-fold effects on skin barrier function. Eur J Dermatol. 2015;25(5):424-35. PubMed 26109150 · doi:10.1684/ejd.2015.2587
  49. Löffler H, Happle R. Profile of irritant patch testing with detergents: sodium lauryl sulfate, sodium laureth sulfate and alkyl polyglucoside. Contact Dermatitis. 2003;48(1):26-32. PubMed 12641575 · doi:10.1034/j.1600-0536.2003.480105.x
  50. Limtanakool P, Boonchai W, Leelathanakorn K, Bunyavaree M, Khamkaen C, Kanokrungsee S. Evolving Surfactant Trends in the Thai Personal Care Market Over 15 Years and Their Association with Clinical Patch Test Reactivity. Dermatitis. 2026:17103568261484376. PubMed 42697836 · doi:10.1177/17103568261484376
  51. Liu L. Penetration of Surfactants into Skin. J Cosmet Sci 2020; 71: 91–109.
  52. Lodén M, Bárány E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm Venereol. 2000;80(6):412-5. PubMed 11243632 · doi:10.1080/000155500300012774
  53. Lu G, Moore DJ. Study of surfactant-skin interactions by skin impedance measurements. Int J Cosmet Sci. 2012;34(1):74-80. PubMed 21923733 · doi:10.1111/j.1468-2494.2011.00683.x
  54. Lévêque JL, de Rigal J, Saint-Léger D, Billy D. How does sodium lauryl sulfate alter the skin barrier function in man? A multiparametric approach. Skin Pharmacol. 1993;6(2):111-5. PubMed 8352948 · doi:10.1159/000211095
  55. McFadden JP, Ross JS, White IR, Basketter DA. Clinical allergy to cocamidopropyl betaine: reactivity to cocamidopropylamine and lack of reactivity to 3-dimethylaminopropylamine. Contact Dermatitis. 2001;45(2):72-4. PubMed 11553115 · doi:10.1034/j.1600-0536.2001.045002072.x
  56. Mehling A, Chkarnat C, Degwert J, Ennen J, Fink E, Matthies W, et al. Interlaboratory studies with a proposed patch test design to evaluate the irritation potential of surfactants. Contact Dermatitis. 2010;62(3):157-64. PubMed 20565502 · doi:10.1111/j.1600-0536.2009.01656.x
  57. Moore PN, Shiloach A, Puvvada S, Blankschtein D. Penetration of mixed micelles into the epidermis: effect of mixing sodium dodecyl sulfate with dodecyl hexa(ethylene oxide). J Cosmet Sci. 2003;54(2):143-59. PubMed 12715092
  58. Morris SAV, Ananthapadmanabhan KP, Kasting GB. Anionic Surfactant-Induced Changes in Skin Permeability. J Pharm Sci. 2019;108(11):3640-3648. PubMed 31374320 · doi:10.1016/j.xphs.2019.06.030
  59. Morris SAV, Bobbitt JR, Ananthapadmanabhan KP, Kasting GB. The effect of prolonged exposure on sodium dodecyl sulfate penetration into human skin. Toxicol In Vitro. 2021;77:105246. PubMed 34562601 · doi:10.1016/j.tiv.2021.105246
  60. Mukherjee SS, Chandrashekar BS, Gaikwad RP. Cleansers: To use or not to. Indian J Paediatr Dermatol 2015; 16: 193–197. doi:10.4103/2319-7250.165611
  61. Nicander I, Rantanen I, Rozell BL, Söderling E, Ollmar S. The ability of betaine to reduce the irritating effects of detergents assessed visually, histologically and by bioengineering methods. Skin Res Technol. 2003;9(1):50-8. PubMed 12535285 · doi:10.1034/j.1600-0846.2003.00367.x
  62. Nicander I, Åberg P, Ollmar S. The use of different concentrations of betaine as a reducing irritation agent in soaps monitored visually and non-invasively. Skin Research and Technology 2003; 9: 43–49.
  63. Pedersen LK, Held E, Johansen JD, Agner T. Less skin irritation from alcohol-based disinfectant than from detergent used for hand disinfection. Br J Dermatol. 2005;153(6):1142-6. PubMed 16307649 · doi:10.1111/j.1365-2133.2005.06875.x
  64. Pedersen LK, Held E, Johansen JD, Agner T. Short-term effects of alcohol-based disinfectant and detergent on skin irritation. Contact Dermatitis. 2005;52(2):82-7. PubMed 15725285 · doi:10.1111/j.0105-1873.2005.00504.x
  65. Proksch E, Nissen HP. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. J Dermatolog Treat. 2002;13(4):173-8. PubMed 19753737 · doi:10.1080/09546630212345674
  66. Purohit P, Chandar P, Vilinska A, Ananthapadmanabhan KP, Somasundaran P. Effect of mixed surfactants on stratum corneum: a drying stress and Raman spectroscopy study. Int J Cosmet Sci. 2014;36(4):379-85. PubMed 24828034 · doi:10.1111/ics.12139
  67. Rhein LD, Simion FA, Hill RL, Cagan RH, Mattai J, Maibach HI. Human cutaneous response to a mixed surfactant system: role of solution phenomena in controlling surfactant irritation. Dermatologica. 1990;180(1):18-23. PubMed 2137799 · doi:10.1159/000247979
  68. Ribaud C, Garson JC, Doucet J, Lévêque JL. Organization of stratum corneum lipids in relation to permeability: influence of sodium lauryl sulfate and preheating. Pharm Res. 1994;11(10):1414-8. PubMed 7855044 · doi:10.1023/a:1018987721531
  69. Savic S, Weber C, Tamburic S, Savic M, Müller-Goymann C. Topical vehicles based on natural surfactant/fatty alcohols mixed emulsifier: The influence of two polyols on the colloidal structure and in vitro/in vivo skin performance. J Pharm Sci. 2009;98(6):2073-90. PubMed 18937361 · doi:10.1002/jps.21591
  70. Savica S, Tamburic S, Savic M, Cekic N, Milic J, Vuleta G. Vehicle-controlled effect of urea on normal and SLS-irritated skin. Int J Pharm. 2004;271(1-2):269-80. PubMed 15129994 · doi:10.1016/j.ijpharm.2003.11.033
  71. Schnuch A, Lessmann H, Geier J, Uter W. Is cocamidopropyl betaine a contact allergen? Analysis of network data and short review of the literature. Contact Dermatitis. 2011;64(4):203-11. PubMed 21392028 · doi:10.1111/j.1600-0536.2010.01863.x
  72. Slotosch CM, Kampf G, Löffler H. Effects of disinfectants and detergents on skin irritation. Contact Dermatitis. 2007;57(4):235-41. PubMed 17868216 · doi:10.1111/j.1600-0536.2007.01200.x
  73. Stringer T, Nagler A, Orlow SJ, Oza VS. Clinical evidence for washing and cleansers in acne vulgaris: a systematic review. J Dermatolog Treat. 2018;29(7):688-693. PubMed 29460655 · doi:10.1080/09546634.2018.1442552
  74. Subramanyan K. Role of mild cleansing in the management of patient skin. Dermatol Ther. 2004;17 Suppl 1:26-34. PubMed 14728696 · doi:10.1111/j.1396-0296.2004.04s1003.x
  75. Suuronen K, Pesonen M, Aalto-Korte K. Occupational contact allergy to cocamidopropyl betaine and its impurities. Contact Dermatitis. 2012;66(5):286-92. PubMed 22364510 · doi:10.1111/j.1600-0536.2011.02036.x
  76. Szél E, Polyánka H, Szabó K, Hartmann P, Degovics D, Balázs B, et al. Anti-irritant and anti-inflammatory effects of glycerol and xylitol in sodium lauryl sulphate-induced acute irritation. J Eur Acad Dermatol Venereol. 2015;29(12):2333-41. PubMed 26370610 · doi:10.1111/jdv.13225
  77. Tabata N, Tagami H, Kligman AM. A twenty-four-hour occlusive exposure to 1% sodium lauryl sulfate induces a unique histopathologic inflammatory response in the xerotic skin of atopic dermatitis patients. Acta Derm Venereol. 1998;78(4):244-7. PubMed 9689289 · doi:10.1080/000155598441792
  78. Takagi Y, Kaneda K, Miyaki M, Matsuo K, Kawada H, Hosokawa H. The long-term use of soap does not affect the pH-maintenance mechanism of human skin. Skin Res Technol. 2015;21(2):144-8. PubMed 25073884 · doi:10.1111/srt.12170
  79. Tarun J, Susan J, Suria J, Susan VJ, Criton S. Evaluation of pH of Bathing Soaps and Shampoos for Skin and Hair Care. Indian J Dermatol. 2014;59(5):442-4. PubMed 25284846 · doi:10.4103/0019-5154.139861
  80. Thune P, Nilsen T, Hanstad IK, Gustavsen T, Lövig Dahl H. The water barrier function of the skin in relation to the water content of stratum corneum, pH and skin lipids. The effect of alkaline soap and syndet on dry skin in elderly, non-atopic patients. Acta Derm Venereol. 1988;68(4):277-83. PubMed 2459871
  81. Tupker RA, Pinnagoda J, Coenraads PJ, Nater JP. The influence of repeated exposure to surfactants on the human skin as determined by transepidermal water loss and visual scoring. Contact Dermatitis. 1989;20(2):108-14. PubMed 2706957 · doi:10.1111/j.1600-0536.1989.tb03117.x
  82. Tupker RA, Pinnagoda J, Nater JP. The transient and cumulative effect of sodium lauryl sulphate on the epidermal barrier assessed by transepidermal water loss: inter-individual variation. Acta Dermato-Venereologica. 1990. doi:10.2340/000155557015
  83. Tupker RA, Vermeulen K, Fidler V, Coenraads PJ. Irritancy testing of sodium laurate and other anionic detergents using an open exposure model. Skin Res Technol. 1997;3(2):133-6. PubMed 27333375 · doi:10.1111/j.1600-0846.1997.tb00175.x
  84. Tupker RA, Bunte EE, Fidler V, Wiechers JW, Coenraads PJ. Irritancy ranking of anionic detergents using one-time occlusive, repeated occlusive and repeated open tests. Contact Dermatitis. 1999;40(6):316-22. PubMed 10385334 · doi:10.1111/j.1600-0536.1999.tb06082.x
  85. Turkoglu M, Pekmezci E, Sakr A. Evaulation of irritation potential of surfactant mixtures. Int J Cosmet Sci. 1999;21(6):371-82. PubMed 18503452 · doi:10.1046/j.1467-2494.1999.211920.x
  86. Vater C, Apanovic A, Riethmüller C, Litschauer B, Wolzt M, Valenta C, et al. Changes in Skin Barrier Function after Repeated Exposition to Phospholipid-Based Surfactants and Sodium Dodecyl Sulfate In Vivo and Corneocyte Surface Analysis by Atomic Force Microscopy. Pharmaceutics. 2021;13(4). PubMed 33804924 · doi:10.3390/pharmaceutics13040436
  87. Vozmediano JM, Carbajo JM, Franco R, Milán VJ, Padilla M, Sarmiento C. Evaluation of the irritant capacity of decyl polyglucoside. International Journal of Cosmetic Science 2000; 22: 73–81.
  88. Walters RM, Mao G, Gunn ET, Hornby S. Cleansing formulations that respect skin barrier integrity. Dermatol Res Pract. 2012;2012:495917. PubMed 22927835 · doi:10.1155/2012/495917
  89. Warshaw EM, Xiong M, Atwater AR, DeKoven JG, Pratt MD, Maibach HI, et al. Patch testing with glucosides: The North American Contact Dermatitis Group experience, 2009-2018. J Am Acad Dermatol. 2022;87(5):1033-1041. PubMed 35551968 · doi:10.1016/j.jaad.2022.04.058
  90. Wedekind R, Fischer A, Mewes KR, Brenneisen P, Holtkötter O. Investigating the surfactant antagonism with the Open Source Reconstructed Epidermis (OS-Rep) model. Toxicol In Vitro. 2023;88:105557. PubMed 36681289 · doi:10.1016/j.tiv.2023.105557
  91. Wilhelm KP, Cua AB, Wolff HH, Maibach HI. Surfactant-induced stratum corneum hydration in vivo: prediction of the irritation potential of anionic surfactants. J Invest Dermatol. 1993;101(3):310-5. PubMed 8370967 · doi:10.1111/1523-1747.ep12365467
  92. Wilhelm KP, Freitag G, Wolff HH. Surfactant-induced skin irritation and skin repair. Evaluation of the acute human irritation model by noninvasive techniques. J Am Acad Dermatol. 1994;30(6):944-9. PubMed 8188884 · doi:10.1016/s0190-9622(94)70114-8
  93. Yanase K, Hatta I. Disruption of human stratum corneum lipid structure by sodium dodecyl sulphate. Int J Cosmet Sci. 2018;40(1):44-49. PubMed 28922453 · doi:10.1111/ics.12430
  94. Yang L, Mao-Qiang M, Taljebini M, Elias PM, Feingold KR. Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br J Dermatol. 1995;133(5):679-85. PubMed 8555016 · doi:10.1111/j.1365-2133.1995.tb02738.x
Kvapiosios medžiagos ir eteriniai aliejai 60Kvapieji alergenai, jų oksidacija laikui bėgant, nuplaunami ir ant odos paliekami produktai, eterinių aliejų poveikis odai.
  1. Andersch Björkman Y, Hagvall L, Siwmark C, Niklasson B, Karlberg AT, Bråred Christensson J. Air-oxidized linalool elicits eczema in allergic patients - a repeated open application test study. Contact Dermatitis. 2014;70(3):129-38. PubMed 24588367 · doi:10.1111/cod.12163
  2. Andersen KE, Johansen JD, Bruze M, Frosch PJ, Goossens A, Lepoittevin JP, et al. The time-dose-response relationship for elicitation of contact dermatitis in isoeugenol allergic individuals. Toxicol Appl Pharmacol. 2001;170(3):166-71. PubMed 11162781 · doi:10.1006/taap.2000.9095
  3. Antelmi A, Trave I, Gallo R, Cozzani E, Parodi A, Bruze M, et al. Prevalence of Contact Allergy to Propolis-Testing With Different Propolis Patch Test Materials. Contact Dermatitis. 2025;92(5):349-357. PubMed 40024247 · doi:10.1111/cod.14773
  4. Api AM, Basketter D, Bridges J, Cadby P, Ellis G, Gilmour N, et al. Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials. Regul Toxicol Pharmacol. 2020;118:104805. PubMed 33075411 · doi:10.1016/j.yrtph.2020.104805
  5. Api AM, Bartlett A, Belsito D, Botelho D, Bruze M, Bryant-Friedrich A, et al. 2nd update to RIFM fragrance ingredient safety assessment, linalool, CAS Registry number 78-70-6. Food Chem Toxicol. 2025;206 Suppl 1:115841. PubMed 41223921 · doi:10.1016/j.fct.2025.115841
  6. Barbaud A, Kurihara F, Raison-Peyron N, Milpied B, Valois A, Assier H, et al. Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch tests with an essential oil series. Results of a French study of the DAG (Dermato-Allergology group of the French Society of Dermatology). Contact Dermatitis. 2023;89(3):190-197. PubMed 37403438 · doi:10.1111/cod.14377
  7. Bennike NH, Palangi L, Christensson JB, Nilsson U, Zachariae C, Johansen JD, et al. Allergic contact dermatitis caused by hydroperoxides of limonene and dose-response relationship-A repeated open application test (ROAT) study. Contact Dermatitis. 2019;80(4):208-216. PubMed 30378136 · doi:10.1111/cod.13168
  8. Bonefeld CM, Nielsen MM, Rubin IM, Vennegaard MT, Dabelsteen S, Gimenéz-Arnau E, et al. Enhanced sensitization and elicitation responses caused by mixtures of common fragrance allergens. Contact Dermatitis. 2011;65(6):336-42. PubMed 21767274 · doi:10.1111/j.1600-0536.2011.01945.x
  9. Botvid S, Søgaard R, Schwensen JFB, Johansen JD. Ten Years of Patch Testing to Hydroperoxides of Limonene and Linalool: Prevalence, Patterns and Clinical Insights. Contact Dermatitis. 2026;94(5):504-514. PubMed 41638887 · doi:10.1111/cod.70102
  10. Botvid S, Bennike NH, Johansen JD, Seibel AT, Vaher H, Bonefeld CM, et al. Repeated Exposure to Hydroperoxides of Linalool Induces Immunologically Verified Allergic Contact Dermatitis. Contact Dermatitis. 2026;94(6):652-661. PubMed 41713461 · doi:10.1111/cod.70119
  11. Bråred Christensson J, Andersen KE, Bruze M, Johansen JD, Garcia-Bravo B, Gimenez Arnau A, et al. Air-oxidized linalool: a frequent cause of fragrance contact allergy. Contact Dermatitis. 2012;67(5):247-59. PubMed 22906042 · doi:10.1111/j.1600-0536.2012.02134.x
  12. Bråred Christensson J, Andersen KE, Bruze M, Johansen JD, Garcia-Bravo B, Gimenez Arnau A, et al. Positive patch test reactions to oxidized limonene: exposure and relevance. Contact Dermatitis. 2014;71(5):264-72. PubMed 25099087 · doi:10.1111/cod.12285
  13. Bråred Christensson J, Karlberg AT, Andersen KE, Bruze M, Johansen JD, Garcia-Bravo B, et al. Oxidized limonene and oxidized linalool - concomitant contact allergy to common fragrance terpenes. Contact Dermatitis. 2016;74(5):273-80. PubMed 26918793 · doi:10.1111/cod.12545
  14. Christensson JB, Matura M, Gruvberger B, Bruze M, Karlberg AT. Linalool--a significant contact sensitizer after air exposure. Contact Dermatitis. 2010;62(1):32-41. PubMed 20136877 · doi:10.1111/j.1600-0536.2009.01657.x
  15. Christoffers WA, Blömeke B, Coenraads PJ, Schuttelaar ML. The optimal patch test concentration for ascaridole as a sensitizing component of tea tree oil. Contact Dermatitis. 2014;71(3):129-37. PubMed 24645715 · doi:10.1111/cod.12199
  16. de Groot AC, Schmidt E. Tea tree oil: contact allergy and chemical composition. Contact Dermatitis. 2016;75(3):129-43. PubMed 27173437 · doi:10.1111/cod.12591
  17. de Groot AC, Ipenburg NA, Rustemeyer T. Propolis and Beeswax in Cosmetics: A Market Survey and Literature Review on Their Relationship and Role in Allergic Contact Dermatitis. Contact Dermatitis. 2026;94(5):494-503. PubMed 41663074 · doi:10.1111/cod.70108
  18. de Groot A, Rustemeyer T. Contact Allergy to Propolis: Update 2013-2025. Dermatitis. 2026;37(4):563-588. PubMed 41346028 · doi:10.1177/17103568251392243
  19. DeKoven JG, DeKoven SJ, Warshaw EM, Atwater AR, Reeder MJ, Taylor JS, et al. Comparison Between Brazilian Propolis and Chinese Propolis: Results From the North American Contact Dermatitis Group 2019-2022. Dermatitis. 2026;37(4):589-595. PubMed 41346018 · doi:10.1177/17103568251403564
  20. Diepgen TL, Ofenloch R, Bruze M, Cazzaniga S, Coenraads PJ, Elsner P, et al. Prevalence of fragrance contact allergy in the general population of five European countries: a cross-sectional study. Br J Dermatol. 2015;173(6):1411-9. PubMed 26332456 · doi:10.1111/bjd.14151
  21. Dittmar D, Schuttelaar MLA. Contact sensitization to hydroperoxides of limonene and linalool: Results of consecutive patch testing and clinical relevance. Contact Dermatitis. 2019;80(2):101-109. PubMed 30378131 · doi:10.1111/cod.13137
  22. Downs AM, Sansom JE. Colophony allergy: a review. Contact Dermatitis. 1999;41(6):305-10. PubMed 10617209 · doi:10.1111/j.1600-0536.1999.tb06178.x
  23. Drechsel DA, Towle KM, Fung ES, Novick RM, Paustenbach DJ, Monnot AD. Skin Sensitization Induction Potential From Daily Exposure to Fragrances in Personal Care Products. Dermatitis. 2018;29(6):324-331. PubMed 30422886 · doi:10.1097/DER.0000000000000412
  24. Elliott JF, Ramzy A, Nilsson U, Moffat W, Suzuki K. Severe intractable eyelid dermatitis probably caused by exposure to hydroperoxides of linalool in a heavily fragranced shampoo. Contact Dermatitis. 2017;76(2):114-115. PubMed 28095632 · doi:10.1111/cod.12738
  25. Gerberick GF, Robinson MK, Felter SP, White IR, Basketter DA. Understanding fragrance allergy using an exposure-based risk assessment approach. Contact Dermatitis. 2001;45(6):333-40. PubMed 11846748 · doi:10.1034/j.1600-0536.2001.450603.x
  26. Gäfvert E, Shao LP, Karlberg AT, Nilsson U, Nilsson JL. Allergenicity of rosin (colophony) esters (II). Glyceryl monoabietate identified as contact allergen. Contact Dermatitis. 1994;31(1):11-7. PubMed 7924286 · doi:10.1111/j.1600-0536.1994.tb01897.x
  27. Gäfvert E, Bordalo O, Karlberg AT. Patch testing with allergens from modified rosin (colophony) discloses additional cases of contact allergy. Contact Dermatitis. 1996;35(5):290-8. PubMed 9007375 · doi:10.1111/j.1600-0536.1996.tb02391.x
  28. Hausen BM, Wollenweber E, Senff H, Post B. Propolis allergy. (II). The sensitizing properties of 1,1-dimethylallyl caffeic acid ester. Contact Dermatitis. 1987;17(3):171-7. PubMed 3677659 · doi:10.1111/j.1600-0536.1987.tb02700.x
  29. Hausen BM, Krueger A, Mohnert J, Hahn H, König WA. Contact allergy due to colophony (III). Sensitizing potency of resin acids and some related products. Contact Dermatitis. 1989;20(1):41-50. PubMed 2914435 · doi:10.1111/j.1600-0536.1989.tb03094.x
  30. Hausen BM, Mohnert J. Contact allergy due to colophony. (V). Patch test results with different types of colophony and modified-colophony products. Contact Dermatitis. 1989;20(4):295-301. PubMed 2752740 · doi:10.1111/j.1600-0536.1989.tb03149.x
  31. Hausen BM, Loll M. Contact allergy due to colophony (VIII). The sensitizing potency of commercial products: an investigation of French and German modified-colophony derivatives. Contact Dermatitis. 1993;29(4):189-91. PubMed 8281781 · doi:10.1111/j.1600-0536.1993.tb03535.x
  32. Hausen BM, Reichling J, Harkenthal M. Degradation products of monoterpenes are the sensitizing agents in tea tree oil. Am J Contact Dermat. 1999;10(2):68-77. PubMed 10357714 · doi:10.1016/s1046-199x(99)90002-7
  33. Hausen BM. Evaluation of the main contact allergens in propolis (1995 to 2005). Dermatitis. 2005;16(3):127-9. PubMed 16242084
  34. Heisterberg MV, Menné T, Andersen KE, Avnstorp C, Kristensen B, Kristensen O, et al. Deodorants are the leading cause of allergic contact dermatitis to fragrance ingredients. Contact Dermatitis. 2011;64(5):258-64. PubMed 21480912 · doi:10.1111/j.1600-0536.2011.01889.x
  35. Heydorn S, Johansen JD, Andersen KE, Bruze M, Svedman C, White IR, et al. Fragrance allergy in patients with hand eczema - a clinical study. Contact Dermatitis. 2003;48(6):317-23. PubMed 14531870 · doi:10.1034/j.1600-0536.2003.00133.x
  36. Heydorn S, Menné T, Andersen KE, Bruze M, Svedman C, Basketter D, et al. The fragrance hand immersion study - an experimental model simulating real-life exposure for allergic contact dermatitis on the hands. Contact Dermatitis. 2003;48(6):324-30. PubMed 14531871 · doi:10.1034/j.1600-0536.2003.00145.x
  37. Johansen JD, Rastogi SC, Andersen KE, Menné T. Content and reactivity to product perfumes in fragrance mix positive and negative eczema patients. A study of perfumes used in toiletries and skin-care products. Contact Dermatitis. 1997;36(6):291-6. PubMed 9237007 · doi:10.1111/j.1600-0536.1997.tb00003.x
  38. Johansen JD, Skov L, Volund A, Andersen K, Menné T. Allergens in combination have a synergistic effect on the elicitation response: a study of fragrance-sensitized individuals. Br J Dermatol. 1998;139(2):264-70. PubMed 9767240 · doi:10.1046/j.1365-2133.1998.02363.x
  39. Johansen JD, Rastogi SC, Bruze M, Andersen KE, Frosch P, Dreier B, et al. Deodorants: a clinical provocation study in fragrance-sensitive individuals. Contact Dermatitis. 1998;39(4):161-5. PubMed 9817220 · doi:10.1111/j.1600-0536.1998.tb05887.x
  40. Kern S, Dkhil H, Hendarsa P, Ellis G, Natsch A. Detection of potentially skin sensitizing hydroperoxides of linalool in fragranced products. Anal Bioanal Chem. 2014;406(25):6165-78. PubMed 25138721 · doi:10.1007/s00216-014-8066-3
  41. Kienhuis AS, Slob W, Gremmer ER, Vermeulen JP, Ezendam J. A Dose-Response Modeling Approach Shows That Effects From Mixture Exposure to the Skin Sensitizers Isoeugenol and Cinnamal Are in Line With Dose Addition and Not With Synergism. Toxicol Sci. 2015;147(1):68-74. PubMed 26048650 · doi:10.1093/toxsci/kfv109
  42. Kocabas G, Ipenburg NA, de Groot A, Rustemeyer T. Results of patch testing propolis in the European baseline series: A 4-year retrospective study. Contact Dermatitis. 2024;91(5):375-378. PubMed 39169523 · doi:10.1111/cod.14678
  43. Nagtegaal MJ, Pentinga SE, Kuik J, Kezic S, Rustemeyer T. The role of the skin irritation response in polysensitization to fragrances. Contact Dermatitis. 2012;67(1):28-35. PubMed 22435471 · doi:10.1111/j.1600-0536.2012.02055.x
  44. Nijkamp MM, Bokkers BG, Bakker MI, Ezendam J, Delmaar JE. Quantitative risk assessment of the aggregate dermal exposure to the sensitizing fragrance geraniol in personal care products and household cleaning agents. Regul Toxicol Pharmacol. 2015;73(1):9-18. PubMed 26107291 · doi:10.1016/j.yrtph.2015.06.004
  45. North-Root H, Demetrulias J, Wester R, Maibach H, Corbin N. Deposition of 3,4,4'-trichlorocarbanilide on human skin. Toxicol Lett. 1984;22(2):235-9. PubMed 6474513 · doi:10.1016/0378-4274(84)90072-9
  46. Nyman GSA, Tang M, Inerot A, Osmancevic A, Malmberg P, Hagvall L. Contact allergy to beeswax and propolis among patients with cheilitis or facial dermatitis. Contact Dermatitis. 2019;81(2):110-116. PubMed 31066083 · doi:10.1111/cod.13306
  47. Paulsen E. The sesquiterpene lactone mix: A review of past, present and future aspects. Contact Dermatitis. 2023;89(6):434-441. PubMed 37820718 · doi:10.1111/cod.14419
  48. Pereira TM, Flour M, Goossens A. Allergic contact dermatitis from modified colophonium in wound dressings. Contact Dermatitis. 2007;56(1):5-9. PubMed 17177702 · doi:10.1111/j.1600-0536.2007.01026.x
  49. Rajpara S, Wilkinson MS, King CM, Gawkrodger DJ, English JS, Statham BN, et al. The importance of propolis in patch testing--a multicentre survey. Contact Dermatitis. 2009;61(5):287-90. PubMed 19878244 · doi:10.1111/j.1600-0536.2009.01629.x
  50. Rutherford T, Nixon R, Tam M, Tate B. Allergy to tea tree oil: retrospective review of 41 cases with positive patch tests over 4.5 years. Australas J Dermatol. 2007;48(2):83-7. PubMed 17535193 · doi:10.1111/j.1440-0960.2007.00341.x
  51. Salapovic H, Geier J, Reznicek G. Quantification of Sesquiterpene Lactones in Asteraceae Plant Extracts: Evaluation of their Allergenic Potential. Sci Pharm. 2013;81(3):807-18. PubMed 24106675 · doi:10.3797/scipharm.1306-17
  52. Shao LP, Gäfvert E, Karlberg AT, Nilsson U, Nilsson JL. The allergenicity of glycerol esters and other esters of rosin (colophony). Contact Dermatitis. 1993;28(4):229-34. PubMed 8508634 · doi:10.1111/j.1600-0536.1993.tb03408.x
  53. Shiraishi E, Ishida K, Matsumaru D, Ido A, Hiromori Y, Nagase H, et al. Evaluation of the Skin-Sensitizing Potential of Brazilian Green Propolis. Int J Mol Sci. 2021;22(24). PubMed 34948335 · doi:10.3390/ijms222413538
  54. Sköld M, Börje A, Matura M, Karlberg AT. Studies on the autoxidation and sensitizing capacity of the fragrance chemical linalool, identifying a linalool hydroperoxide. Contact Dermatitis. 2002;46(5):267-72. PubMed 12084079 · doi:10.1034/j.1600-0536.2002.460504.x
  55. Sköld M, Börje A, Harambasic E, Karlberg AT. Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary oxidation products and the effect on skin sensitization. Chem Res Toxicol. 2004;17(12):1697-705. PubMed 15606147 · doi:10.1021/tx049831z
  56. Sukakul T, Bruze M, Mowitz M, Antelmi A, Bergendorff O, Björk J, et al. Contact allergy to oxidized linalool and oxidized limonene: Patch testing in consecutive patients with dermatitis. Contact Dermatitis. 2022;86(1):15-24. PubMed 34561893 · doi:10.1111/cod.13980
  57. Uter W, Yazar K, Kratz EM, Mildau G, Lidén C. Coupled exposure to ingredients of cosmetic products: I. Fragrances. Contact Dermatitis. 2013;69(6):335-41. PubMed 24102121 · doi:10.1111/cod.12125
  58. van Amerongen CCA, Ofenloch RF, Cazzaniga S, Elsner P, Gonçalo M, Naldi L, et al. Skin exposure to scented products used in daily life and fragrance contact allergy in the European general population - The EDEN Fragrance Study. Contact Dermatitis. 2021;84(6):385-394. PubMed 33576005 · doi:10.1111/cod.13807
  59. Warshaw EM, Zug KA, Belsito DV, Fowler JF Jr, DeKoven JG, Sasseville D, et al. Positive Patch-Test Reactions to Essential Oils in Consecutive Patients From North America and Central Europe. Dermatitis. 2017;28(4):246-252. PubMed 28614106 · doi:10.1097/DER.0000000000000293
  60. Zhao K, Singh J. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Release. 1999;62(3):359-66. PubMed 10528073 · doi:10.1016/s0168-3659(99)00171-6
Vėsinančios medžiagos 22Mentolis, kamparas ir kitos medžiagos, sukeliančios vėsumo ar dilgčiojimo pojūtį.
  1. Bharate SS, Bharate SB. Modulation of thermoreceptor TRPM8 by cooling compounds. ACS Chem Neurosci. 2012;3(4):248-67. PubMed 22860192 · doi:10.1021/cn300006u
  2. Craighead DH, Alexander LM. Topical menthol increases cutaneous blood flow. Microvasc Res. 2016;107:39-45. PubMed 27131832 · doi:10.1016/j.mvr.2016.04.010
  3. Fang C, Liu Y, Ye X, Rong ZX, Feng XM, Jiang CB, et al. Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. Eur J Pharm Biopharm. 2008;68(3):735-40. PubMed 17398083 · doi:10.1016/j.ejpb.2007.02.007
  4. Green BG. Sensory characteristics of camphor. J Invest Dermatol. 1990;94(5):662-6. PubMed 2324522 · doi:10.1111/1523-1747.ep12876242
  5. Green BG. The sensory effects of l-menthol on human skin. Somatosens Mot Res. 1992;9(3):235-44. PubMed 1414120 · doi:10.3109/08990229209144774
  6. Green BG, Schoen KL. Thermal and nociceptive sensations from menthol and their suppression by dynamic contact. Behav Brain Res. 2007;176(2):284-91. PubMed 17092576 · doi:10.1016/j.bbr.2006.10.013
  7. Hatem S, Attal N, Willer JC, Bouhassira D. Psychophysical study of the effects of topical application of menthol in healthy volunteers. Pain. 2006;122(1-2):190-6. PubMed 16527405 · doi:10.1016/j.pain.2006.01.026
  8. Johnson S, Tian M, Sheldon G, Dowd E. Trigeminal Receptor Study of High-Intensity Cooling Agents. J Agric Food Chem. 2018;66(10):2319-2323. PubMed 28042937 · doi:10.1021/acs.jafc.6b04838
  9. Kotaka T, Kimura S, Kashiwayanagi M, Iwamoto J. Camphor induces cold and warm sensations with increases in skin and muscle blood flow in human. Biol Pharm Bull. 2014;37(12):1913-8. PubMed 25451841 · doi:10.1248/bpb.b14-00442
  10. Liu DJ, Collaku A, Dosik JS. Skin Irritation and Sensitization Potential of Fixed-Dose Combination of Diclofenac 1% and Menthol 3% Topical Gel: Results of Two Phase I Patch Studies. Drug Res (Stuttg). 2017;67(2):119-126. PubMed 27887033 · doi:10.1055/s-0042-118861
  11. Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, et al. Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science. 2005;307(5714):1468-72. PubMed 15746429 · doi:10.1126/science.1108609
  12. Morimoto Y, Hayashi T, Kawabata S, Seki T, Sugibayashi K. Effect of l-menthol-ethanol-water system on the systemic absorption of flurbiprofen after repeated topical applications in rabbits. Biol Pharm Bull. 2000;23(10):1254-7. PubMed 11041263 · doi:10.1248/bpb.23.1254
  13. Namer B, Seifert F, Handwerker HO, Maihöfner C. TRPA1 and TRPM8 activation in humans: effects of cinnamaldehyde and menthol. Neuroreport. 2005;16(9):955-9. PubMed 15931068 · doi:10.1097/00001756-200506210-00015
  14. Olsen RV, Andersen HH, Møller HG, Eskelund PW, Arendt-Nielsen L. Somatosensory and vasomotor manifestations of individual and combined stimulation of TRPM8 and TRPA1 using topical L-menthol and trans-cinnamaldehyde in healthy volunteers. Eur J Pain. 2014;18(9):1333-42. PubMed 24664788 · doi:10.1002/j.1532-2149.2014.494.x
  15. Selescu T, Ciobanu AC, Dobre C, Reid G, Babes A. Camphor activates and sensitizes transient receptor potential melastatin 8 (TRPM8) to cooling and icilin. Chem Senses. 2013;38(7):563-75. PubMed 23828908 · doi:10.1093/chemse/bjt027
  16. Tey HL, Tay EY, Tan WD. Safety and Antipruritic Efficacy of a Menthol-Containing Moisturizing Cream. Skinmed. 2017;15(6):437-439. PubMed 29282180
  17. Tran A, Pratt M, DeKoven J. Acute allergic contact dermatitis of the lips from peppermint oil in a lip balm. Dermatitis. 2010;21(2):111-5. PubMed 20233551
  18. Warshaw EM, Peterson MY, DeKoven JG, Adler BL, Pratt MD, Belsito DV, et al. Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020). Dermatitis. 2025;36(1):46-52. PubMed 39172635 · doi:10.1089/derm.2024.0118
  19. Wasner G, Schattschneider J, Binder A, Baron R. Topical menthol--a human model for cold pain by activation and sensitization of C nociceptors. Brain. 2004;127(Pt 5):1159-71. PubMed 14985268 · doi:10.1093/brain/awh134
  20. Wright A, Benson HAE, Moss P. Development of a topical menthol stimulus to evaluate cold hyperalgesia. Musculoskelet Sci Pract. 2019;41:55-63. PubMed 31010570 · doi:10.1016/j.msksp.2019.03.010
  21. Xu H, Blair NT, Clapham DE. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci. 2005;25(39):8924-37. PubMed 16192383 · doi:10.1523/JNEUROSCI.2574-05.2005
  22. Yosipovitch G, Szolar C, Hui XY, Maibach H. Effect of topically applied menthol on thermal, pain and itch sensations and biophysical properties of the skin. Arch Dermatol Res. 1996;288(5-6):245-8. PubMed 8738567 · doi:10.1007/BF02530092
Konservantai 43Metilizotiazolinonas, formaldehido išskyrikliai, parabenai, fenoksietanolis, benzilo alkoholis, produktai „be konservantų“.
  1. Aalto-Korte K, Pesonen M. Patterns of positive patch test reactions to formaldehyde and formaldehyde releasers at the Finnish Institute of Occupational Health from 2007 to 2020. Contact Dermatitis. 2021;85(4):429-434. PubMed 33934369 · doi:10.1111/cod.13876
  2. Basketter DA, Marriott M, Gilmour NJ, White IR. Strong irritants masquerading as skin allergens: the case of benzalkonium chloride. Contact Dermatitis. 2004;50(4):213-7. PubMed 15186375 · doi:10.1111/j.0105-1873.2004.00331.x
  3. Bermond C, Cherrad S, Trainoy A, Ngari C, Poulet V. Real-time qPCR to evaluate bacterial contamination of cosmetic cream and the efficiency of protective ingredients. J Appl Microbiol. 2022;132(3):2106-2120. PubMed 34586708 · doi:10.1111/jam.15310
  4. Berthelot C, Zirwas MJ. Allergic contact dermatitis to chloroxylenol. Dermatitis. 2006;17(3):156-9. PubMed 16956470 · doi:10.2310/6620.2006.05057
  5. Chen T, Chang H. Deciphering trends in replacing preservatives in cosmetics intended for infants and sensitive population. Sci Rep. 2024;14(1):19053. PubMed 39153997 · doi:10.1038/s41598-024-69624-9
  6. Dear K, Palmer A, Nixon R. Contact allergy and allergic contact dermatitis from benzalkonium chloride in a tertiary dermatology center in Melbourne, Australia. Contact Dermatitis. 2021. PubMed 33656745 · doi:10.1111/cod.13826
  7. Dréno B, Zuberbier T, Gelmetti C, Gontijo G, Marinovich M. Safety review of phenoxyethanol when used as a preservative in cosmetics. J Eur Acad Dermatol Venereol. 2019;33 Suppl 7:15-24. PubMed 31588615 · doi:10.1111/jdv.15944
  8. Fang B, Yu M, Zhang W, Wang F. A new alternative to cosmetics preservation and the effect of the particle size of the emulsion droplets on preservation efficacy. Int J Cosmet Sci. 2016;38(5):496-503. PubMed 26940643 · doi:10.1111/ics.12317
  9. Frosch PJ, White IR, Rycroft RJ, Lahti A, Burrows D, Camarasa JG, et al. Contact allergy to Bronopol. Contact Dermatitis. 1990;22(1):24-6. PubMed 2323186 · doi:10.1111/j.1600-0536.1990.tb01500.x
  10. Gim H, Hong S, Park H, Im S, Kim JI. Synergistic/antagonistic antimicrobial effects of cosmetic ingredients in combination with 1,2-hexanediol. J Microorg Control. 2024;29(4):133-142. PubMed 39805611 · doi:10.4265/jmc.29.4_133
  11. Heratizadeh A, Killig C, Worm M, Soost S, Simon D, Bauer A, et al. Quantitative repeated open application testing with a rinse-off product in methyldibromo glutaronitrile-sensitive patients: results of the IVDK. Contact Dermatitis. 2010;62(6):330-7. PubMed 20557338 · doi:10.1111/j.1600-0536.2010.01726.x
  12. Jensen CD, Johansen JD, Menné T, Andersen KE. Methyldibromoglutaronitrile in rinse-off products causes allergic contact dermatitis: an experimental study. Br J Dermatol. 2004;150(1):90-5. PubMed 14746621 · doi:10.1111/j.1365-2133.2004.05727.x
  13. Karimian K, Isufi D, Jensen MB, Søgaard R, Johansen JD, Schwensen JFB. The Prevalence of Contact Allergy to Formaldehyde and Formaldehyde Releasers: A Systematic Review and Meta-Analysis. Contact Dermatitis. 2026;95(2):125-147. PubMed 42035787 · doi:10.1111/cod.70172
  14. Kireche M, Peiffer JL, Antonios D, Fabre I, Giménez-Arnau E, Pallardy M, et al. Evidence for chemical and cellular reactivities of the formaldehyde releaser bronopol, independent of formaldehyde release. Chem Res Toxicol. 2011;24(12):2115-28. PubMed 22034943 · doi:10.1021/tx2002542
  15. Kočevar Glavač N, Lunder M. Preservative efficacy of selected antimicrobials of natural origin in a cosmetic emulsion. Int J Cosmet Sci. 2018. PubMed 29729020 · doi:10.1111/ics.12461
  16. Langsrud S, Steinhauer K, Lüthje S, Weber K, Goroncy-Bermes P, Holck AL. Ethylhexylglycerin Impairs Membrane Integrity and Enhances the Lethal Effect of Phenoxyethanol. PLoS One. 2016;11(10):e0165228. PubMed 27783695 · doi:10.1371/journal.pone.0165228
  17. Lee E, An S, Choi D, Moon S, Chang I. Comparison of objective and sensory skin irritations of several cosmetic preservatives. Contact Dermatitis. 2007;56(3):131-6. PubMed 17295686 · doi:10.1111/j.1600-0536.2007.01001.x
  18. Levy SB, Dulichan AM, Helman M. Safety of a preservative system containing 1,2-hexanediol and caprylyl glycol. Cutan Ocul Toxicol. 2009;28(1):23-4. PubMed 19514921 · doi:10.1080/15569520802636082
  19. Liippo J, Kousa P, Lammintausta K. The relevance of chlorhexidine contact allergy. Contact Dermatitis. 2011;64(4):229-34. PubMed 21226717 · doi:10.1111/j.1600-0536.2010.01851.x
  20. Lynn L, Scholes RC, Kim JH, Wilson-Welder JH, Orts WJ, Hart-Cooper WM. Antimicrobial, Preservative, and Hazard Assessments from Eight Chemical Classes. ACS Omega. 2024;9(16):17869-17877. PubMed 38680319 · doi:10.1021/acsomega.3c08672
  21. Ma X, Wang H, Song Y, Pan Y. Skin irritation potential of cosmetic preservatives: An exposure-relevant study. J Cosmet Dermatol. 2021;20(1):195-203. PubMed 32492262 · doi:10.1111/jocd.13502
  22. Miller MA, Bhatt V, Kasting GB. Dose and airflow dependence of benzyl alcohol disposition on skin. J Pharm Sci. 2006;95(2):281-91. PubMed 16374850 · doi:10.1002/jps.20513
  23. Nadarzynski A, Scholz J, Schröder MS. Skin Barrier Enhancing Alternative Preservation Strategy of O/W Emulsions by Water Activity Reduction with Natural Multifunctional Ingredients. Cosmetics 2022;9(3):53. doi:10.3390/cosmetics9030053
  24. Nanayakkara GR, Bartlett A, Forbes B, Marriott C, Whitfield PJ, Brown MB. The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. Int J Pharm. 2005;301(1-2):129-39. PubMed 16019171 · doi:10.1016/j.ijpharm.2005.05.024
  25. Nimni ME, Ertl D, Oakes RA. Distribution of griseofulvin in the rat: comparison of the oral and topical route of administration. J Pharm Pharmacol. 1990;42(10):729-31. PubMed 1982148 · doi:10.1111/j.2042-7158.1990.tb06570.x
  26. Opstrup MS, Johansen JD, Zachariae C, Garvey LH. Contact allergy to chlorhexidine in a tertiary dermatology clinic in Denmark. Contact Dermatitis. 2016;74(1):29-36. PubMed 26560642 · doi:10.1111/cod.12487
  27. Papageorgiou S, Varvaresou A, Tsirivas E, Demetzos C. New alternatives to cosmetics preservation. J Cosmet Sci. 2010;61(2):107-23. PubMed 20447363
  28. Pedersen LK, Haslund P, Johansen JD, Held E, Vølund A, Agner T. Influence of a detergent on skin response to methyldibromo glutaronitrile in sensitized individuals. Contact Dermatitis. 2004;50(1):1-5. PubMed 15059095 · doi:10.1111/j.0105-1873.2004.00259.x
  29. Riccio BVF, Tonani L, Chellegatti MADSC, Teixeira MVS, Pereira KDC, Furtado NAJC, et al. Susceptibility of representative skin-resident microorganisms to cosmetic preservatives and in vitro assessment of consumer-relevant toxicity. J Appl Microbiol. 2026;137(9). PubMed 42570232 · doi:10.1093/jambio/lxag195
  30. Rothe H, Ryan CA, Page L, Vinall J, Goebel C, Scheffler H, et al. Application of in vitro skin penetration measurements to confirm and refine the quantitative skin sensitization risk assessment of methylisothiazolinone. Regul Toxicol Pharmacol. 2017;91:197-207. PubMed 29080845 · doi:10.1016/j.yrtph.2017.10.024
  31. Saitoh I, Ikeda K, Takagishi Y. Effect of benzyl alcohol on rat skin as a solvent of liquid droplet dispersion ointment. Biol Pharm Bull. 1995;18(2):321-5. PubMed 7742806 · doi:10.1248/bpb.18.321
  32. Schnuch A, Lessmann H, Geier J, Uter W. Contact allergy to preservatives. Analysis of IVDK data 1996-2009. Br J Dermatol. 2011;164(6):1316-25. PubMed 21332463 · doi:10.1111/j.1365-2133.2011.10253.x
  33. Schwensen JF, Uter W, Bruze M, Svedman C, Goossens A, Wilkinson M, et al. The epidemic of methylisothiazolinone: a European prospective study. Contact Dermatitis. 2017;76(5):272-279. PubMed 28032337 · doi:10.1111/cod.12733
  34. Sigg M, Daniels R. Investigations on Alkanediols as Alternative Preservatives in a Nonionic Hydrophilic Cream. Pharmaceutics. 2020;12(11). PubMed 33233527 · doi:10.3390/pharmaceutics12111117
  35. Tafuro G, Costantini A, Piatto M, Lucchetti S, Francescato S, Busata L, Baratto G, Semenzato A. Eco-Designing Cosmetic Products while Preserving the Sensorial-Application Properties: An Instrumental Approach toward Sustainable Formulations. Cosmetics 2024;11(2):60. doi:10.3390/cosmetics11020060
  36. Townsend N, Hazan A, Dell'Acqua G. New Topicals to Support a Healthy Scalp While Preserving the Microbiome: A Report of Clinical and in Vitro Studies. J Clin Aesthet Dermatol. 2023;16(10 Suppl 1):S4-S11. PubMed 38495927
  37. Uter W, Lessmann H, Geier J, Schnuch A. Is the irritant benzalkonium chloride a contact allergen? A contribution to the ongoing debate from a clinical perspective. Contact Dermatitis. 2008;58(6):359-63. PubMed 18503686 · doi:10.1111/j.1600-0536.2008.01327.x
  38. van 't Veen AJ, van Joost T. Sensitization to thimerosal (Merthiolate) is still present today. Contact Dermatitis. 1994;31(5):293-8. PubMed 7867326 · doi:10.1111/j.1600-0536.1994.tb02022.x
  39. Walters RM, Khanna P, Hamilton M, Mays DA, Telofski L. Human Cumulative Irritation Tests of Common Preservatives Used in Personal Care Products: A Retrospective Analysis of Over 45 000 Subjects. Toxicol Sci. 2015;148(1):101-7. PubMed 26206148 · doi:10.1093/toxsci/kfv158
  40. Warshaw EM, Han J, Kullberg SA, DeKoven JG, Adler BL, Silverberg JI, et al. Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015-2020. Dermatitis. 2023;34(6):501-508. PubMed 37279017 · doi:10.1089/derm.2023.0077
  41. Yamano T, Shimizu M, Noda T. Allergenicity evaluation of p-chloro-m-cresol and p-chloro-m-xylenol by non-radioactive murine local lymph-node assay and multiple-dose guinea pig maximization test. Toxicology. 2003;190(3):259-66. PubMed 12927380 · doi:10.1016/s0300-483x(03)00161-6
  42. Yazar K, Lundov MD, Faurschou A, Matura M, Boman A, Johansen JD, et al. Methylisothiazolinone in rinse-off products causes allergic contact dermatitis: a repeated open-application study. Br J Dermatol. 2015;173(1):115-22. PubMed 25708973 · doi:10.1111/bjd.13751
  43. Youenou B, Chauviat A, Ngari C, Poulet V, Nazaret S. In vitro study to evaluate the antimicrobial activity of various multifunctional cosmetic ingredients and chlorphenesin on bacterial species at risk in the cosmetic industry. J Appl Microbiol. 2022;132(2):933-948. PubMed 34333822 · doi:10.1111/jam.15245
Kontaktinė alergija 43Odos jautrinimas, lopų mėginių tyrimų tinklų Europoje ir Šiaurės Amerikoje duomenys, alergija pažeistame barjere.
  1. Allenby CF, Basketter DA. An arm immersion model of compromised skin (II). Influence on minimal eliciting patch test concentrations of nickel. Contact Dermatitis. 1993;28(3):129-33. PubMed 8462286 · doi:10.1111/j.1600-0536.1993.tb03371.x
  2. Barbaud A, Collet E, Le Coz CJ, Meaume S, Gillois P. Contact allergy in chronic leg ulcers: results of a multicentre study carried out in 423 patients and proposal for an updated series of patch tests. Contact Dermatitis. 2009;60(5):279-87. PubMed 19397620 · doi:10.1111/j.1600-0536.2009.01541.x
  3. Bizjak M, Aerts O, Pesqué D, Muñoz M, Asero R, Gonçalo M, et al. Contact Urticaria and Related Conditions: Clinical Review. Contact Dermatitis. 2025;93(2):87-107. PubMed 40174899 · doi:10.1111/cod.14794
  4. Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I, et al. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol. 2007;127(6):1430-5. PubMed 17273160 · doi:10.1038/sj.jid.5700726
  5. Botham P, Urtizberea M, Wiemann C, Manciaux X, Tilbury L, Vohr HW, et al. A comparative study of the sensitivity of the 3-induction and 9-induction Buehler test procedures for assessing skin sensitisation potential. Food Chem Toxicol. 2005;43(1):65-75. PubMed 15582197 · doi:10.1016/j.fct.2004.08.013
  6. Carlsen BC, Fischer LA, Sosted H, Vølund A, Menné T, Johansen JD. Patch test dose-response study: polysensitized individuals do not express lower elicitation thresholds than single/double-sensitized individuals. Br J Dermatol. 2009;160(1):103-6. PubMed 19014397 · doi:10.1111/j.1365-2133.2008.08921.x
  7. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47(2):198-208. PubMed 12140465 · doi:10.1067/mjd.2002.124617
  8. Clemmensen O, Hjorth N. Perioral contact urticaria from sorbic acid and benzoic acid in a salad dressing. Contact Dermatitis. 1982;8(1):1-6. PubMed 7067435 · doi:10.1111/j.1600-0536.1982.tb04126.x
  9. Dooms-Goossens A, Degreef H, Luytens E. Dihydroabietyl alcohol (Abitol): a sensitizer in mascara. Contact Dermatitis. 1979;5(6):350-3. PubMed 527327 · doi:10.1111/j.1600-0536.1979.tb04903.x
  10. European Multicentre Photopatch Test Study (EMCPPTS) Taskforce. A European multicentre photopatch test study. Br J Dermatol. 2012;166(5):1002-9. PubMed 22283432 · doi:10.1111/j.1365-2133.2012.10857.x
  11. Fartasch M, Diepgen TL, Kuhn M, Basketter DA. Provocative use tests in CAPB-allergic subjects with CAPB-containing product. Contact Dermatitis. 1999;41(1):30-4. PubMed 10416705 · doi:10.1111/j.1600-0536.1999.tb06204.x
  12. Fischer LA, Menné T, Avnstorp C, Kasting GB, Johansen JD. Hydroxyisohexyl 3-cyclohexene carboxaldehyde allergy: relationship between patch test and repeated open application test thresholds. Br J Dermatol. 2009;161(3):560-7. PubMed 19486000 · doi:10.1111/j.1365-2133.2009.09256.x
  13. Fischer LA, Voelund A, Andersen KE, Menné T, Johansen JD. The dose-response relationship between the patch test and ROAT and the potential use for regulatory purposes. Contact Dermatitis. 2009;61(4):201-8. PubMed 19825091 · doi:10.1111/j.1600-0536.2009.01607.x
  14. Fischer LA, Menné T, Voelund A, Johansen JD. Can exposure limitations for well-known contact allergens be simplified? An analysis of dose-response patch test data. Contact Dermatitis. 2011;64(6):337-42. PubMed 21535006 · doi:10.1111/j.1600-0536.2011.01876.x
  15. Goebel C, Coenraads PJ, Rothe H, Kunze G, Kock M, Schlatter H, et al. Elicitation of the immune response to p-phenylenediamine in allergic patients: the role of dose and exposure time. Br J Dermatol. 2010;163(6):1205-11. PubMed 20795999 · doi:10.1111/j.1365-2133.2010.10009.x
  16. Gunatheesan S, Tam MM, Tate B, Tversky J, Nixon R. Retrospective study of oral lichen planus and allergy to spearmint oil. Australas J Dermatol. 2012;53(3):224-8. PubMed 22686635 · doi:10.1111/j.1440-0960.2012.00908.x
  17. Hachem JP, De Paepe K, Vanpée E, Kaufman L, Rogiers V, Roseeuw D. Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements. Dermatology. 2001;202(4):314-9. PubMed 11455143 · doi:10.1159/000051664
  18. Hextall JM, Alagaratnam NJ, Glendinning AK, Holloway DB, Blaikie L, Basketter DA, et al. Dose-time relationships for elicitation of contact allergy to para-phenylenediamine. Contact Dermatitis. 2002;47(2):96-9. PubMed 12423407 · doi:10.1034/j.1600-0536.2002.470207.x
  19. Houle MC, DeKoven JG, Atwater AR, Reeder MJ, Warshaw EM, Pratt MD, et al. North American Contact Dermatitis Group Patch Test Results: 2021-2022. Dermatitis. 2025;36(5):464-476. PubMed 40274377 · doi:10.1089/derm.2024.0474
  20. Jensen MB, Kursawe Larsen C, Hamann CR, Johansen JD, Quaade AS. Association Between Atopic Dermatitis and Contact Sensitization: An Updated Systematic Review and Meta-Analysis. Contact Dermatitis. 2026;94(3):201-225. PubMed 41423749 · doi:10.1111/cod.70074
  21. Jensen MB, Alfonso JH, Seibel AT, Mollerup S, Wilks MF, Selvestrel G, et al. Chemical Mixture Exposures and Their Effects on Sensitisation and Elicitation Responses: A Systematic Review. Contact Dermatitis. 2026;94(2):105-119. PubMed 41392231 · doi:10.1111/cod.70069
  22. Krob HA, Fleischer AB Jr, D'Agostino R Jr, Haverstock CL, Feldman S. Prevalence and relevance of contact dermatitis allergens: a meta-analysis of 15 years of published T.R.U.E. test data. J Am Acad Dermatol. 2004;51(3):349-53. PubMed 15337975 · doi:10.1016/j.jaad.2003.11.069
  23. Krogh Pedersen M, Schwensen JFB, Alfonso JH, Mollerup S, Selvestrel G, Rudén C, et al. Legislation and Current Practices Concerning Risk Assessment of Skin Sensitizers in the European Union: A Comparative and Survey Study. Contact Dermatitis. 2025;92(6):446-459. PubMed 39917955 · doi:10.1111/cod.14754
  24. Kroona L, Isaksson M, Ahlgren C, Dahlin J, Bruze M, Warfvinge G. Carvone Contact Allergy in Southern Sweden: A 21-year Retrospective Study. Acta Derm Venereol. 2018;98(10):938-942. PubMed 30085320 · doi:10.2340/00015555-3009
  25. Kroona L, Ahlgren C, Dahlin J, Isaksson M, Bruze M. Use test with l-carvone in toothpaste on sensitized individuals. Contact Dermatitis. 2023;88(6):463-471. PubMed 36929649 · doi:10.1111/cod.14302
  26. Lagrelius M, Wahlgren CF, Matura M, Bergström A, Kull I, Lidén C. Atopic dermatitis at preschool age and contact allergy in adolescence: a population-based cohort study. Br J Dermatol. 2019;180(4):782-789. PubMed 30467841 · doi:10.1111/bjd.17449
  27. Lagrelius M, Wahlgren CF, Bradley M, Melén E, Kull I, Bergström A, et al. Filaggrin gene mutations in relation to contact allergy and hand eczema in adolescence. Contact Dermatitis. 2020;82(3):147-152. PubMed 31782153 · doi:10.1111/cod.13444
  28. Lepoittevin JP, Benezra C, Asakawa Y. Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiol. Arch Dermatol Res. 1989;281(4):227-30. PubMed 2774654 · doi:10.1007/BF00431055
  29. McFadden JP, Basketter DA. Contact allergy, irritancy and 'danger'. Contact Dermatitis. 2000;42(3):123-7. PubMed 10727161 · doi:10.1034/j.1600-0536.2000.042003123.x
  30. McLelland J, Shuster S, Matthews JN. 'Irritants' increase the response to an allergen in allergic contact dermatitis. Arch Dermatol. 1991;127(7):1016-9. PubMed 2064399
  31. Mowitz M, Hosseini S, Siemund I, Ulriksdotter J, Svedman C. New device, 'old' allergens. Allergic contact dermatitis caused by the Dexcom G7 glucose sensor. Contact Dermatitis. 2024;90(5):495-500. PubMed 38316128 · doi:10.1111/cod.14514
  32. Paulsen E. Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis. 2002;47(4):189-98. PubMed 12492516 · doi:10.1034/j.1600-0536.2002.470401.x
  33. Paulsen E, Chistensen LP, Andersen KE. Cosmetics and herbal remedies with Compositae plant extracts - are they tolerated by Compositae-allergic patients?. Contact Dermatitis. 2008;58(1):15-23. PubMed 18154553 · doi:10.1111/j.1600-0536.2007.01250.x
  34. Paulsen E, Otkjaer A, Andersen KE. The coumarin herniarin as a sensitizer in German chamomile [Chamomilla recutita (L.) Rauschert, Compositae]. Contact Dermatitis. 2010;62(6):338-42. PubMed 20557339 · doi:10.1111/j.1600-0536.2010.01730.x
  35. Reeder MJ, Broman AT, Adler BL, Houle MC, Pratt M, Warshaw EM, et al. North American Contact Dermatitis Group Patch Test Results: 2023-2024. Dermatitis. 2026:17103568261486176. PubMed 42817757 · doi:10.1177/17103568261486176
  36. Reider N, Komericki P, Hausen BM, Fritsch P, Aberer W. The seamy side of natural medicines: contact sensitization to arnica (Arnica montana L.) and marigold (Calendula officinalis L.). Contact Dermatitis. 2001;45(5):269-72. PubMed 11722485 · doi:10.1034/j.1600-0536.2001.450503.x
  37. Schötz K. Quantification of allergenic urushiols in extracts of Ginkgo biloba leaves, in simple one-step extracts and refined manufactured material (EGb 761). Phytochem Anal. 2004;15(1):1-8. PubMed 14979519 · doi:10.1002/pca.733
  38. Thyssen JP, Johansen JD, Linneberg A, Menné T, Nielsen NH, Meldgaard M, et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol. 2010;162(6):1278-85. PubMed 20346018 · doi:10.1111/j.1365-2133.2010.09708.x
  39. Thyssen JP, Linneberg A, Engkilde K, Menné T, Johansen JD. Contact sensitization to common haptens is associated with atopic dermatitis: new insight. Br J Dermatol. 2012;166(6):1255-61. PubMed 22283138 · doi:10.1111/j.1365-2133.2012.10852.x
  40. Towle KM, Drechsel DA, Warshaw EM, Fung ES, Novick RM, Paustenbach DJ, et al. Risk Assessment of the Skin Sensitization Induction Potential of Kathon CG in Rinse-off and Leave-on Personal Care and Cosmetic Products. Dermatitis. 2018;29(3):132-138. PubMed 29570489 · doi:10.1097/DER.0000000000000359
  41. Uter W, Wilkinson SM, Bauer A, Borrego L, Brans R, Buhl T, et al. Patch Test Results With Additions to the European Baseline Series, 2021/22-Joint European Results of the ESSCA(A) and the EBS(B) Working Groups of the ESCD, and the GEIDAC(C). Contact Dermatitis. 2026;95(3):276-285. PubMed 42135251 · doi:10.1111/cod.70183
  42. Uter W, Wilkinson SM, Aerts O, Bauer A, Borrego L, Brans R, et al. Patch Test Results With the European Baseline Series, 2021/2022-Joint European Results of the ESSCA(A) and the EBS(B) Working Groups of the ESCD, and the GEIDAC(C). Contact Dermatitis. 2026;95(1):17-32. PubMed 41819607 · doi:10.1111/cod.70134
  43. Verhulst L, Goossens A. Cosmetic components causing contact urticaria: a review and update. Contact Dermatitis. 2016;75(6):333-344. PubMed 27593503 · doi:10.1111/cod.12679
Odos dirginimas 11Dirginimo tyrimai su savanoriais, kartotinio naudojimo poveikis, kelių medžiagų dirginimas kartu.
  1. Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Anti-irritants I: Dose-response in acute irritation. Contact Dermatitis. 2006;55(3):148-54. PubMed 16918613 · doi:10.1111/j.1600-0536.2006.00752.x
  2. Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Anti-irritants II: Efficacy against cumulative irritation. Contact Dermatitis. 2006;55(3):155-9. PubMed 16918614 · doi:10.1111/j.1600-0536.2006.00756.x
  3. Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Comparison of the effect of glycerol and triamcinolone acetonide on cumulative skin irritation in a randomized trial. J Am Acad Dermatol. 2007;56(2):228-35. PubMed 17156893 · doi:10.1016/j.jaad.2006.08.063
  4. Hwang JH, Jeong H, Jung YO, Nam KT, Lim KM. Skin irritation and inhalation toxicity of biocides evaluated with reconstructed human epidermis and airway models. Food Chem Toxicol. 2021;150:112064. PubMed 33596452 · doi:10.1016/j.fct.2021.112064
  5. Kartono F, Maibach HI. Irritants in combination with a synergistic or additive effect on the skin response: an overview of tandem irritation studies. Contact Dermatitis 2006; 54: 303–312.
  6. Lee E, An S, Cho SA, Yun Y, Han J, Hwang YK, et al. The influence of alkane chain length on the skin irritation potential of 1,2-alkanediols. Int J Cosmet Sci. 2011;33(5):421-5. PubMed 21585401 · doi:10.1111/j.1468-2494.2011.00646.x
  7. Löffler H, Kampf G, Schmermund D, Maibach HI. How irritant is alcohol?. Br J Dermatol. 2007;157(1):74-81. PubMed 17578437 · doi:10.1111/j.1365-2133.2007.07944.x
  8. Martinović M, Nešić I, Tadić VM, Žugić A, Tasić-Kostov M, Blagojević S, et al. Skin Performance of Innovative NaDES-Based Gels: In Vivo Evaluation of Anti-Irritation Potential and Short-Term Efficacy. Gels. 2025;11(11). PubMed 41294554 · doi:10.3390/gels11110869
  9. Reynertson KA, Garay M, Nebus J, Chon S, Kaur S, Mahmood K, et al. Anti-inflammatory activities of colloidal oatmeal (Avena sativa) contribute to the effectiveness of oats in treatment of itch associated with dry, irritated skin. J Drugs Dermatol. 2015;14(1):43-8. PubMed 25607907
  10. Wu PC, Chang JS, Huang YB, Chai CY, Tsai YH. Evaluation of percutaneous absorption and skin irritation of ketoprofen through rat skin: in vitro and in vivo study. Int J Pharm. 2001;222(2):225-35. PubMed 11427353 · doi:10.1016/s0378-5173(01)00707-4
  11. Yoshizawa Y, Tanojo H, Kim SJ, Maibach HI. Sea water or its components alter experimental irritant dermatitis in man. Skin Research and Technology 2001; 7: 36–39.
Rūgštys ir šveitimas 29Glikolio, pieno, salicilo rūgštys, polihidroksi rūgštys, cheminiai pilingai, mechaninis šveitimas.
  1. Abels C, Kaszuba A, Michalak I, Werdier D, Knie U, Kaszuba A. A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial. J Cosmet Dermatol. 2011;10(3):202-9. PubMed 21896132 · doi:10.1111/j.1473-2165.2011.00572.x
  2. American Academy of Dermatology. [Puslapiai pacientams apie spuogų odos priežiūrą: patarimai ir įpročiai]. aad.org (pacientams). 2022. www.aad.org
  3. American Academy of Dermatology. [Puslapis pacientams apie saugų šveitimą namuose]. aad.org (pacientams). 2026. www.aad.org
  4. Dal Belo SE, Kanoun-Copy L, Lambert C, Cornillon C, Muller B, Jouni H, et al. Efficacy of a multitargeted, salicylic acid-based dermocosmetic cream compared to benzoyl peroxide 5% in Acne vulgaris: Results from a randomized study. J Cosmet Dermatol. 2024;23(3):891-897. PubMed 37941097 · doi:10.1111/jocd.16052
  5. Davies MA. Salicylic acid deposition from wash-off products: comparison of in vivo and porcine deposition models. Int J Cosmet Sci. 2015;37(5):526-31. PubMed 25899428 · doi:10.1111/ics.12229
  6. Ding DM, Tu Y, Man MQ, Wu WJ, Lu FY, Li X, et al. Association between lactic acid sting test scores, self-assessed sensitive skin scores and biophysical properties in Chinese females. Int J Cosmet Sci. 2019;41(4):398-404. PubMed 31194883 · doi:10.1111/ics.12550
  7. Eady EA, Burke BM, Pulling K, Cunliffe WJ. The benefit of 2% salicylic acid lotion in acne — a placebo-controlled study. Journal of Dermatological Treatment 1996;7(2):93-6. doi:10.3109/09546639609089537
  8. Fulghum DD, Catalano PM, Childers RC, Cullen SI, Engel MF. Abrasive cleansing in the management of acne vulgaris. Arch Dermatol. 1982;118(9):658-9. PubMed 6214216
  9. Hu M, Tu Y, Man MQ, He Y, Wu P, He L, et al. Rosacea and seborrheic dermatitis differentially respond to lactic acid sting and capsaicin tests in Chinese women. J Cosmet Dermatol. 2023;22(12):3505-3510. PubMed 37464957 · doi:10.1111/jocd.15878
  10. Hunt MJ, Barnetson RS. A comparative study of gluconolactone versus benzoyl peroxide in the treatment of acne. Australas J Dermatol. 1992;33(3):131-4. PubMed 1303072 · doi:10.1111/j.1440-0960.1992.tb00100.x
  11. Hussain R, Miller D, Shyr T, Friscia D, Li WH, Parsa R, et al. Novel 2% Salicylic Acid Cleanser With Polymeric Cleansing Technology Treats Acne Without Compromising Skin Barrier. J Drugs Dermatol. 2025;24(6):570-578. PubMed 40465501 · doi:10.36849/JDD.9019
  12. Khammari A, Demessant-Flavigny A, Kerob D, Seité S, Dréno B. A Salicylic Acid-Based Dermocosmetic is Effective as an Adjunct to Benzoyl Peroxide for Mild to Moderate Acne and as Monotherapy in Maintenance Post Benzoyl Peroxide. J Drugs Dermatol. 2023;22(12):1172-1177. PubMed 38051857 · doi:10.36849/JDD.7449
  13. Kim HS, Lim SH, Song JY, Kim MY, Lee JH, Park JG, et al. Skin barrier function recovery after diamond microdermabrasion. J Dermatol. 2009;36(10):529-33. PubMed 19785706 · doi:10.1111/j.1346-8138.2009.00695.x
  14. Kitsongsermthon J, Duangweang K, Kreepoke J, Tansirikongkol A. In vivo cleansing efficacy of biodegradable exfoliating beads assessed by skin bioengineering techniques. Skin Res Technol. 2017;23(4):525-530. PubMed 28303604 · doi:10.1111/srt.12365
  15. Kitsongsermthon J, Kreepoke J, Duangweang K, Tansirikongkol A. In vivo exfoliating efficacy of biodegradable beads and the correlation with user's satisfaction. Skin Res Technol. 2018;24(1):26-30. PubMed 28543622 · doi:10.1111/srt.12386
  16. Kulthanan K, Trakanwittayarak S, Tuchinda P, Chularojanamontri L, Limphoka P, Varothai S. A Double-Blinded, Randomized, Vehicle-Controlled Study of the Efficacy of Moisturizer Containing Licochalcone A, Decanediol, L-Carnitine, and Salicylic Acid for Prevention of Acne Relapse in Asian Population. Biomed Res Int. 2020;2020:2857812. PubMed 33150170 · doi:10.1155/2020/2857812
  17. Li Q, Xu Y, Shu H, Li N, Gu H, He L, et al. Lactic acid sting test and capsaicin test differentially induce facial erythematous reaction in subjects with sensitive skin. J Cosmet Dermatol. 2024;23(3):1009-1014. PubMed 38059312 · doi:10.1111/jocd.16047
  18. Li L, Huang Y, Lai J, Lin X. Effectiveness of Photodynamic Therapy, 2% Salicylic Acid, and Their Combination for Moderate Acne. Clin Cosmet Investig Dermatol. 2025;18:1783-1790. PubMed 40734985 · doi:10.2147/CCID.S532029
  19. Mahler V, Erfurt-Berge C, Schiemann S, Michael S, Egloffstein A, Kuss O. Dirt-binding particles consisting of hydrogenated castor oil beads constitute a nonirritating alternative for abrasive cleaning of recalcitrant oily skin contamination in a three-step programme of occupational skin protection. Br J Dermatol. 2010;162(4):812-8. PubMed 19995365 · doi:10.1111/j.1365-2133.2009.09602.x
  20. Perricone NV, DiNardo JC. Photoprotective and antiinflammatory effects of topical glycolic acid. Dermatol Surg. 1996;22(5):435-7. PubMed 8634805 · doi:10.1111/j.1524-4725.1996.tb00343.x
  21. Rajan P, Grimes PE. Skin barrier changes induced by aluminum oxide and sodium chloride microdermabrasion. Dermatol Surg. 2002;28(5):390-3. PubMed 12030870 · doi:10.1046/j.1524-4725.2002.01239.x
  22. Saint-Léger D, Lévêque JL, Verschoore M. The use of hydroxy acids on the skin: characteristics of C8-lipohydroxy acid. J Cosmet Dermatol. 2007;6(1):59-65. PubMed 17348998 · doi:10.1111/j.1473-2165.2007.00296.x
  23. Shalita AR. Treatment of mild and moderate acne vulgaris with salicylic acid in an alcohol-detergent vehicle. Cutis. 1981;28(5):556-8, 561. PubMed 6458457
  24. Shalita AR. Comparison of a salicylic acid cleanser and a benzoyl peroxide wash in the treatment of acne vulgaris. Clin Ther. 1989;11(2):264-7. PubMed 2525420
  25. Song JY, Kang HA, Kim MY, Park YM, Kim HO. Damage and recovery of skin barrier function after glycolic acid chemical peeling and crystal microdermabrasion. Dermatol Surg. 2004;30(3):390-4. PubMed 15008867 · doi:10.1046/j.1076-0512.2003.30107.x
  26. Stiller MJ, Bartolone J, Stern R, Smith S, Kollias N, Gillies R, et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Arch Dermatol. 1996;132(6):631-6. PubMed 8651713
  27. Tasic-Kostov M, Savic S, Lukic M, Tamburic S, Pavlovic M, Vuleta G. Lactobionic acid in a natural alkylpolyglucoside-based vehicle: assessing safety and efficacy aspects in comparison to glycolic acid. J Cosmet Dermatol. 2010;9(1):3-10. PubMed 20367666 · doi:10.1111/j.1473-2165.2010.00474.x
  28. Tasić-Kostov M, Lukić M, Savić S. A 10% Lactobionic acid-containing moisturizer reduces skin surface pH without irritation-An in vivo/in vitro study. J Cosmet Dermatol. 2019;18(6):1705-1710. PubMed 30859734 · doi:10.1111/jocd.12908
  29. Zander E, Weisman S. Treatment of acne vulgaris with salicylic acid pads. Clin Ther. 1992;14(2):247-53. PubMed 1535287
Retinoidai 42Retinolis ir jo dariniai, tretinoinas, adapalenas — poveikis odai, dirginimas, naudojimas.
  1. Akhavan A, Levitt J. Assessing retinol stability in a hydroquinone 4%/retinol 0.3% cream in the presence of antioxidants and sunscreen under simulated-use conditions: a pilot study. Clin Ther. 2008;30(3):543-7. PubMed 18405792 · doi:10.1016/j.clinthera.2008.03.010
  2. Ash K, Lord J, Zukowski M, McDaniel DH. Comparison of topical therapy for striae alba (20% glycolic acid/0.05% tretinoin versus 20% glycolic acid/10% L-ascorbic acid). Dermatol Surg. 1998;24(8):849-56. PubMed 9723049 · doi:10.1111/j.1524-4725.1998.tb04262.x
  3. Bertolani MB, Rodighiero E, Gandolfi M, Lotti T, Pedrazzi G, Puviani M, et al. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study. Dermatol Ther. 2021;34(1):e14724. PubMed 33377285 · doi:10.1111/dth.14724
  4. Chularojanamontri L, Tuchinda P, Kulthanan K, Varothai S, Winayanuwattikun W. A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel. J Dermatolog Treat. 2016;27(2):140-5. PubMed 26293170 · doi:10.3109/09546634.2015.1079298
  5. Del Rosso J, Sugarman J, Green L, Lain T, Levy-Hacham O, Mizrahi R, et al. Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: Results from two phase 3 double-blind, randomized, vehicle-controlled studies. J Am Acad Dermatol. 2023;89(4):719-727. PubMed 37356627 · doi:10.1016/j.jaad.2023.05.093
  6. Dhaliwal S, Rybak I, Ellis SR, Notay M, Trivedi M, Burney W, et al. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. Br J Dermatol. 2019;180(2):289-296. PubMed 29947134 · doi:10.1111/bjd.16918
  7. Draelos Z, Tanghetti E, Guenin E. Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream. J Drugs Dermatol. 2022;21(8):875-880. PubMed 35946981 · doi:10.36849/JDD.6945
  8. Dréno B, Nocera T, Verrière F, Vienne MP, Ségard C, Vitse S, et al. Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients. Dermatology. 2005;210 Suppl 1:22-9. PubMed 15724104 · doi:10.1159/000081500
  9. Effendy I, Kwangsukstith C, Lee JY, Maibach HI. Functional changes in human stratum corneum induced by topical glycolic acid: comparison with all-trans retinoic acid. Acta Derm Venereol. 1995;75(6):455-8. PubMed 8651024 · doi:10.2340/0001555575455458
  10. Fetil E, Ilknur T, Altiner D, Ozkan S, Güneş AT. Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB. J Dermatol. 2005;32(11):868-74. PubMed 16361746 · doi:10.1111/j.1346-8138.2005.tb00863.x
  11. Garofalo V, Cannizzaro MV, Mazzilli S, Bianchi L, Campione E. Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study. Clin Cosmet Investig Dermatol. 2019;12:363-369. PubMed 31190944 · doi:10.2147/CCID.S182317
  12. Griffiths CEM, Maddin S, Wiedow O, Marks R, Donald AE, Kahlon G. Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens. J Dermatol Treat 2005;16:79–86.
  13. Hayashi N, Kawashima M. Study of the usefulness of moisturizers on adherence of acne patients treated with adapalene. J Dermatol. 2014;41(7):592-7. PubMed 24930436 · doi:10.1111/1346-8138.12520
  14. Herndon JH Jr, Jiang LI, Kononov T, Fox T. An Open Label Clinical Trial to Evaluate the Efficacy and Tolerance of a Retinol and Vitamin C Facial Regimen in Women With Mild-to-Moderate Hyperpigmentation and Photodamaged Facial Skin. J Drugs Dermatol. 2016;15(4):476-82. PubMed 27050703
  15. Kafi R, Kwak HS, Schumacher WE, Cho S, Hanft VN, Hamilton TA, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007;143(5):606-12. PubMed 17515510 · doi:10.1001/archderm.143.5.606
  16. Kantikosum K, Chongpison Y, Chottawornsak N, Asawanonda P. The efficacy of glycolic acid, salicylic acid, gluconolactone, and licochalcone A combined with 0.1% adapalene vs adapalene monotherapy in mild-to-moderate acne vulgaris: a double-blinded within-person comparative study. Clin Cosmet Investig Dermatol. 2019;12:151-161. PubMed 30858720 · doi:10.2147/CCID.S193730
  17. Kim H, Koh J, Baek J, Seo Y, Kim B, Kim J, et al. Retinyl retinoate, a novel hybrid vitamin derivative, improves photoaged skin: a double-blind, randomized-controlled trial. Skin Res Technol. 2011;17(3):380-5. PubMed 21435021 · doi:10.1111/j.1600-0846.2011.00512.x
  18. Kim H, Kim M, Quan Y, Moon T, Mun J, Cho H, Park N, Moon W, Lee K, Kim H, Lee J, Ryoo H, Jung H. Novel anti-wrinkle effect of cosmeceutical product with new retinyl retinoate microsphere using biodegradable polymer. Skin Res Technol 2012;18:70–76.
  19. Kong R, Cui Y, Fisher GJ, Wang X, Chen Y, Schneider LM, et al. A comparative study of the effects of retinol and retinoic acid on histological, molecular, and clinical properties of human skin. J Cosmet Dermatol. 2016;15(1):49-57. PubMed 26578346 · doi:10.1111/jocd.12193
  20. Kosmoski G, Miller D, Coret C, Atillasoy E. A Topical Combination Regimen of Benzoyl Peroxide and Retinol Moisturizer for Mild to Moderate Acne. J Drugs Dermatol. 2022;21(12):1340-1346. PubMed 36468957 · doi:10.36849/JDD.6845
  21. Laquieze S, Czernielewski J, Rueda MJ. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne. J Drugs Dermatol. 2006;5(10):985-90. PubMed 17373148
  22. Marks R, Hill S, Barton SP. The effects of an abrasive agent on normal skin and on photoaged skin in comparison with topical tretinoin. Br J Dermatol. 1990;123(4):457-66. PubMed 2095177 · doi:10.1111/j.1365-2133.1990.tb01450.x
  23. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol. 1998;139 Suppl 52:8-11. PubMed 9990414 · doi:10.1046/j.1365-2133.1998.1390s2008.x
  24. Milosheska D, Roškar R. Use of Retinoids in Topical Antiaging Treatments: A Focused Review of Clinical Evidence for Conventional and Nanoformulations. Adv Ther. 2022;39(12):5351-5375. PubMed 36220974 · doi:10.1007/s12325-022-02319-7
  25. Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327-48. PubMed 18046911 · doi:10.2147/ciia.2006.1.4.327
  26. Murray J, Potts A. The phototoxic and photoallergy potential of clindamycin phosphate 1.2%/ tretinoin 0.025% gel for facial acne: results of two single-center, evaluator-blinded, randomized, vehicle-controlled phase 1 studies in healthy volunteers. J Drugs Dermatol. 2014;13(1):16-22. PubMed 24385115
  27. Nighland M, Yusuf M, Wisniewski S, Huddleston K, Nyirady J. The effect of simulated solar UV irradiation on tretinoin in tretinoin gel microsphere 0.1% and tretinoin gel 0.025%. Cutis. 2006;77(5):313-6. PubMed 16776288
  28. Nyirady J, Lucas C, Yusuf M, Mignone P, Wisniewski S. The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis. 2002;70(5):295-8. PubMed 12469785
  29. Pi rard GE, Kligman AM, Stoudemayer T, Lévêque JL. Comparative effects of retinoic acid, glycolic acid and a lipophilic derivative of salicylic acid on photodamaged epidermis. Dermatology. 1999;199(1):50-3. PubMed 10449958 · doi:10.1159/000018178
  30. Ruamrak C, Lourith N, Natakankitkul S. Comparison of clinical efficacies of sodium ascorbyl phosphate, retinol and their combination in acne treatment. Int J Cosmet Sci. 2009;31(1):41-6. PubMed 19134126 · doi:10.1111/j.1468-2494.2008.00479.x
  31. Seité S, Bredoux C, Compan D, Zucchi H, Lombard D, Medaisko C, et al. Histological evaluation of a topically applied retinol-vitamin C combination. Skin Pharmacol Physiol. 2005;18(2):81-7. PubMed 15767769 · doi:10.1159/000083708
  32. Sitohang IBS, Norawati L, Yenny SW, Kusumawardani A, Murlistyarini S, Setiawan SV, et al. Effectiveness and Safety of a Dermocosmetic Cream as an Adjunct to Adapalene for Mild and Moderate Acne in Indonesia: Results of a Multicenter Randomized Controlled Study. Clin Cosmet Investig Dermatol. 2024;17:2283-2296. PubMed 39430644 · doi:10.2147/CCID.S474331
  33. Slade HB, Shroot B, Feldman SR, Cargill DI, Stanfield J. Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials. Photodermatol Photoimmunol Photomed. 2009;25(3):146-52. PubMed 19438994 · doi:10.1111/j.1600-0781.2009.00433.x
  34. Smit JV, de Jong EM, de Jongh GJ, van de Kerkhof PC. Topical all-trans retinoic acid does not influence minimal erythema doses for UVB light in normal skin. Acta Derm Venereol. 2000;80(1):66-7. PubMed 10721847 · doi:10.1080/000155500750012658
  35. Soler-Orenes JA, Rodríguez-Muñiz GM, Hernández-Gil J, Miranda MA, Andreu I, Lhiaubet-Vallet V. Photosensitizing Properties of the Topical Retinoid Drug Adapalene. Chem Res Toxicol. 2024;37(12):2013-2021. PubMed 39614821 · doi:10.1021/acs.chemrestox.4c00384
  36. Sorg O, Tran C, Carraux P, Grand D, Hügin A, Didierjean L, et al. Spectral properties of topical retinoids prevent DNA damage and apoptosis after acute UV-B exposure in hairless mice. Photochem Photobiol. 2005;81(4):830-6. PubMed 15760277 · doi:10.1111/j.1751-1097.2005.tb01450.x
  37. Temova Rakuša Ž, Škufca P, Kristl A, Roškar R. Retinoid stability and degradation kinetics in commercial cosmetic products. J Cosmet Dermatol. 2021;20(7):2350-2358. PubMed 33206444 · doi:10.1111/jocd.13852
  38. Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57(5):791-9. PubMed 17655969 · doi:10.1016/j.jaad.2007.06.006
  39. Tolleson WH, Cherng SH, Xia Q, Boudreau M, Yin JJ, Wamer WG, et al. Photodecomposition and phototoxicity of natural retinoids. Int J Environ Res Public Health. 2005;2(1):147-55. PubMed 16705812 · doi:10.3390/ijerph2005010147
  40. Tran C, Kasraee B, Grand D, Carraux P, Didierjean L, Sorg O, et al. Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid. Dermatology. 2005;210 Suppl 1:6-13. PubMed 15724102 · doi:10.1159/000082542
  41. Waller JM, Dreher F, Behnam S, Ford C, Lee C, Tiet T, et al. 'Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol. 2006;19(5):283-9. PubMed 16778460 · doi:10.1159/000093984
  42. Wang Q, Hu F, Hu X, Xie Y, Du L, Ye R. The synergistic effect of retinyl propionate and hydroxypinacolone retinoate on skin aging. J Cosmet Dermatol. 2023;22(7):2040-2049. PubMed 36762391 · doi:10.1111/jocd.15662
Vitaminas C ir antioksidantai 25Askorbo rūgštis ir jos dariniai, jų stabilumas, vitaminas E ir kiti antioksidantai.
  1. Austria R, Semenzato A, Bettero A. Stability of vitamin C derivatives in solution and topical formulations. J Pharm Biomed Anal. 1997;15(6):795-801. PubMed 9172105 · doi:10.1016/s0731-7085(96)01904-8
  2. Boghosian T, Mendez H, Boghosian N, Sayegh M, Beer J, Tosti A. Clinical Applications of Vitamin C in Dermatology: A Systematic Review. J Clin Aesthet Dermatol. 2026;19(7):10-15. PubMed 42761976
  3. de Souza AC, Sipoli CC, Samulewski RB, Raimundini Aranha AC, Defendi RO, Suzuki RM. Effect of Squalane as a Carrier in O/W Nanoemulsions for Dermal Delivery of Vitamin E. ACS Omega. 2025;10(49):60707-60722. PubMed 41427219 · doi:10.1021/acsomega.5c08561
  4. Dong X, Zhang T, Wei H, Dang L. Stability of sodium ascorbyl phosphate in the water-glycerol system. J Pharm Biomed Anal. 2020;181:113103. PubMed 31981829 · doi:10.1016/j.jpba.2020.113103
  5. Duclairoir C, Orecchioni AM, Depraetere P, Nakache E. α-Tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles. J Microencapsulation 2002; 19(1): 53–60.
  6. Ghali M, Abdelmalik B, Hubbert LRS, Ghali H, Temiz LA, Lipman ZM, Lin A, Albers SE. A comprehensive approach to skin protection against ultraviolet radiation: Integrating sunscreens, antioxidants, DNA repair agents, oral supplements, and probiotics. Dermatol Online J 2026;32(1):Article 3.
  7. Haftek M, Mac-Mary S, Le Bitoux MA, Creidi P, Seité S, Rougier A, et al. Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with ascorbic acid and madecassoside in photoaged human skin. Exp Dermatol. 2008;17(11):946-52. PubMed 18503551 · doi:10.1111/j.1600-0625.2008.00732.x
  8. Hahn HJ, Jung HJ, Schrammek-Drusios MC, Lee SN, Kim JH, Kwon SB, et al. Instrumental evaluation of anti-aging effects of cosmetic formulations containing palmitoyl peptides, Silybum marianum seed oil, vitamin E and other functional ingredients on aged human skin. Exp Ther Med. 2016;12(2):1171-1176. PubMed 27446338 · doi:10.3892/etm.2016.3447
  9. Han B, Nimni ME. Transdermal delivery of amino acids and antioxidants enhance collagen synthesis: in vivo and in vitro studies. Connect Tissue Res. 2005;46(4-5):251-7. PubMed 16546829 · doi:10.1080/03008200500416716
  10. Humbert PG, Haftek M, Creidi P, Lapière C, Nusgens B, Richard A, et al. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Exp Dermatol. 2003;12(3):237-44. PubMed 12823436 · doi:10.1034/j.1600-0625.2003.00008.x
  11. Iliopoulos F, Sil BC, Moore DJ, Lucas RA, Lane ME. 3-O-ethyl-l-ascorbic acid: Characterisation and investigation of single solvent systems for delivery to the skin. Int J Pharm X. 2019;1:100025. PubMed 31517290 · doi:10.1016/j.ijpx.2019.100025
  12. Khan H, Akhtar N, Ali A. Assessment of Combined Ascorbyl Palmitate (AP) and Sodium Ascorbyl Phosphate (SAP) on Facial Skin Sebum Control in Female Healthy Volunteers. Drug Res (Stuttg). 2017;67(1):52-58. PubMed 27756097 · doi:10.1055/s-0042-118171
  13. Kumano Y, Sakamoto T, Egawa M, Iwai I, Tanaka M, Yamamoto I. In vitro and in vivo prolonged biological activities of novel vitamin C derivative, 2-O-alpha-D-glucopyranosyl-L-ascorbic acid (AA-2G), in cosmetic fields. J Nutr Sci Vitaminol (Tokyo). 1998;44(3):345-59. PubMed 9742456 · doi:10.3177/jnsv.44.345
  14. Liao WC, Huang YT, Lu LP, Huang WY. Antioxidant Ability and Stability Studies of 3-O-Ethyl Ascorbic Acid, a Cosmetic Tyrosinase Inhibitor. J Cosmet Sci. 2018;69(4):233-243. PubMed 30311899
  15. Liu C, Boo J, Kim H, Hwang S, Yan X, Brieva P, et al. A Double-Blinded, Split-Face Clinical Trial Evaluating the Effects of a Vitamin C, E, and Ferulic Acid Serum Combined with Microneedling on Facial Photoaging. Clin Cosmet Investig Dermatol. 2026;19:565035. PubMed 41710525 · doi:10.2147/CCID.S565035
  16. Loza-Rodríguez N, Millán-Sánchez A, Mallandrich M, Calpena AC, López O. Lipid-Based Gels for Delivery of 3-O-Ethyl L-Ascorbic acid in Topical Applications. Pharmaceutics. 2024;16(9). PubMed 39339223 · doi:10.3390/pharmaceutics16091187
  17. Montenegro L, Rapisarda L, Ministeri C, Puglisi G. Effects of Lipids and Emulsifiers on the Physicochemical and Sensory Properties of Cosmetic Emulsions Containing Vitamin E. Cosmetics 2015;2(1):35-47. doi:10.3390/cosmetics2010035
  18. Nayama S, Takehana M, Kanke M, Itoh S, Ogata E, Kobayashi S. Protective effects of sodium-L-ascorbyl-2 phosphate on the development of UVB-induced damage in cultured mouse skin. Biol Pharm Bull. 1999;22(12):1301-5. PubMed 10746160 · doi:10.1248/bpb.22.1301
  19. Pinnell SR, Yang H, Omar M, Monteiro-Riviere N, DeBuys HV, Walker LC, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg. 2001;27(2):137-42. PubMed 11207686 · doi:10.1046/j.1524-4725.2001.00264.x
  20. Pullar JM, Carr AC, Vissers MCM. The Roles of Vitamin C in Skin Health. Nutrients. 2017;9(8). PubMed 28805671 · doi:10.3390/nu9080866
  21. Spiclin P, Homar M, Zupancic-Valant A, Gasperlin M. Sodium ascorbyl phosphate in topical microemulsions. Int J Pharm. 2003;256(1-2):65-73. PubMed 12695012 · doi:10.1016/s0378-5173(03)00063-2
  22. Stolić Jovanović A, Martinović M, Žugić A, Nešić I, Tosti T, Blagojević S, et al. Derivatives of L-Ascorbic Acid in Emulgel: Development and Comprehensive Evaluation of the Topical Delivery System. Pharmaceutics. 2023;15(3). PubMed 36986679 · doi:10.3390/pharmaceutics15030813
  23. Swindell WR, Randhawa M, Quijas G, Bojanowski K, Chaudhuri RK. Tetrahexyldecyl Ascorbate (THDC) Degrades Rapidly under Oxidative Stress but Can Be Stabilized by Acetyl Zingerone to Enhance Collagen Production and Antioxidant Effects. Int J Mol Sci. 2021;22(16). PubMed 34445461 · doi:10.3390/ijms22168756
  24. Takada M, Numano K, Nakano M, Yamamoto A, Imokawa G. Treatment with Ascorbyl Glucoside-Arginine Complex Ameliorates Solar Lentigos. Int J Mol Sci. 2024;25(24). PubMed 39769217 · doi:10.3390/ijms252413453
  25. Zerbinati N, Sommatis S, Maccario C, Di Francesco S, Capillo MC, Rauso R, et al. The Anti-Ageing and Whitening Potential of a Cosmetic Serum Containing 3-O-ethyl-l-ascorbic Acid. Life (Basel). 2021;11(5). PubMed 33946734 · doi:10.3390/life11050406
Niacinamidas 27Poveikis barjerui, riebalų išsiskyrimui, spuogams ir paraudimui.
  1. Ahmad I, Sheraz MA, Ahmed S, Bano R, Vaid FH. Photochemical interaction of ascorbic acid with riboflavin, nicotinamide and alpha-tocopherol in cream formulations. Int J Cosmet Sci. 2012;34(2):123-31. PubMed 22014159 · doi:10.1111/j.1468-2494.2011.00690.x
  2. Ahmad I, Mobeen MF, Sheraz MA, Ahmed S, Anwar Z, Shaikh RS, et al. Photochemical interaction of ascorbic acid and nicotinamide in aqueous solution: A kinetic study. J Photochem Photobiol B. 2018;182:115-121. PubMed 29660587 · doi:10.1016/j.jphotobiol.2018.04.011
  3. Albadawi Hadeel, Alrimthi Elaf, Alomran Shikhah, Algarni Thana, Alqurashi Turki, Alanazi Renad, Alwadie Rana, Ashour Talah. Evaluating the effectiveness of niacinamide containing emollients and cleansing gel in treating atopic dermatitis: a systematic review. International Journal of Medicine in Developing Countries. 2026. doi:10.24911/ijmdc.51-1768252893
  4. Barbosa M, de Amorim RP, Cassiano D, Dias M, de Abreu AF, Bagatin E, et al. Efficacy and Safety of Nicotinamide 10%, Associated with Magnesium Ascorbyl Phosphate 5% and Hyaluronic Acid 5%, Compared to Hydroquinone 4% in Women with Facial Melasma: A Randomized, Double-Blind, Controlled Clinical Trial. Clin Cosmet Investig Dermatol. 2024;17:2215-2223. PubMed 39376788 · doi:10.2147/CCID.S473224
  5. Berardesca E, Ardigo M, Cameli N, Mariano M, Agozzino M, Matts PJ. Randomized, double-blinded, vehicle-controlled, split-face study to evaluate the effects of topical application of a Gold Silk Sericin/Niacinamide/Signaline complex on biophysical parameters related to skin ageing. Int J Cosmet Sci. 2015;37(6):606-12. PubMed 25940759 · doi:10.1111/ics.12237
  6. Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26(5):231-8. PubMed 18492135 · doi:10.1111/j.1467-2494.2004.00228.x
  7. Bissett DL, Oblong JE, Berge CA. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31(7 Pt 2):860-5; discussion 865. PubMed 16029679 · doi:10.1111/j.1524-4725.2005.31732
  8. Cannizzaro MV, Dattola A, Garofalo V, Del Duca E, Bianchi L. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients. G Ital Dermatol Venereol. 2018;153(2):161-164. PubMed 29564872 · doi:10.23736/S0392-0488.17.05742-X
  9. Chen AC, Martin AJ, Dalziell RA, Halliday GM, Damian DL. Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial. Br J Dermatol. 2016;175(6):1363-1365. PubMed 27062605 · doi:10.1111/bjd.14648
  10. Chiu PC, Chan CC, Lin HM, Chiu HC. The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial. J Cosmet Dermatol. 2007;6(4):243-9. PubMed 18047609 · doi:10.1111/j.1473-2165.2007.00342.x
  11. Draelos ZD, Matsubara A, Smiles K. The effect of 2% niacinamide on facial sebum production. J Cosmet Laser Ther. 2006;8(2):96-101. PubMed 16766489 · doi:10.1080/14764170600717704
  12. Fu JJ, Hillebrand GG, Raleigh P, Li J, Marmor MJ, Bertucci V, et al. A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen. Br J Dermatol. 2010;162(3):647-54. PubMed 20374604 · doi:10.1111/j.1365-2133.2009.09436.x
  13. Ghasemiyeh P, Haghighi NF, Dastgheib L, Ranjbar S, Mohammadi-Samani S. Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trial. Sci Rep. 2025;15(1):42739. PubMed 41315336 · doi:10.1038/s41598-025-26693-8
  14. GUTTMAN DE, BROOKE D. SOLUTION PHASE INTERACTION OF NICOTINAMIDE WITH ASCORBIC ACID. J Pharm Sci. 1963;52:941-5. PubMed 14076500 · doi:10.1002/jps.2600521006
  15. Jacobson EL, Kim H, Kim M, Williams JD, Coyle DL, Coyle WR, et al. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp Dermatol. 2007;16(6):490-9. PubMed 17518989 · doi:10.1111/j.1600-0625.2007.00553.x
  16. Khodaeiani E, Fouladi RF, Amirnia M, Saeidi M, Karimi ER. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. Int J Dermatol. 2013;52(8):999-1004. PubMed 23786503 · doi:10.1111/ijd.12002
  17. Mohammed D, Crowther JM, Matts PJ, Hadgraft J, Lane ME. Influence of niacinamide containing formulations on the molecular and biophysical properties of the stratum corneum. Int J Pharm. 2013;441(1-2):192-201. PubMed 23220080 · doi:10.1016/j.ijpharm.2012.11.043
  18. Morganti P, Berardesca E, Guarneri B, Guarneri F, Fabrizi G, Palombo P, et al. Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial. Int J Cosmet Sci. 2011;33(5):467-76. PubMed 21668835 · doi:10.1111/j.1468-2494.2011.00658.x
  19. Permatasari Nabila Jingga, Tan Sukmawati Tansil. Efektivitas Niacinamide Topikal terhadap Hidrasi Kulit pada Individu dengan Akne Vulgaris. Malahayati Nursing Journal. 2024. doi:10.33024/mnj.v6i12.15839
  20. Rusic D, Ivic M, Slugan A, Leskur D, Modun D, Durdov T, et al. Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial. Life (Basel). 2024;14(12). PubMed 39768384 · doi:10.3390/life14121677
  21. Saraçoğlu ZN, Aksu AE, Köksüz T, Sabuncu I, Arıkan I. Efficacy and Safety of Topical Niacinamide for Acne Vulgaris. Turkderm-Turk Arch Dermatol Venereol 2011;45(2):93-96. doi:10.4274/turkderm.45.21
  22. Shahmoradi Z, Iraji F, Siadat AH, Ghorbaini A. Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial. J Res Med Sci. 2013;18(2):115-7. PubMed 23914212
  23. Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995;34(6):434-7. PubMed 7657446 · doi:10.1111/j.1365-4362.1995.tb04449.x
  24. Sitohang IBS, Yahya YF, Simanungkalit R, Adi Winarni DR, Madjid A. Efficacy and Tolerability of Topical Nicotinamide Plus Antibacterial Adhesive Agents and Zinc-Pyrrolidone Carboxylic Acid Versus Placebo as an Adjuvant Treatment for Moderate Acne Vulgaris in Indonesia: A Multicenter, Double-blind, Randomized, Controlled Trial. J Clin Aesthet Dermatol. 2020;13(7):27-31. PubMed 32983333
  25. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143(3):524-31. PubMed 10971324 · doi:10.1111/j.1365-2133.2000.03705.x
  26. Walocko FM, Eber AE, Keri JE, Al-Harbi MA, Nouri K. The role of nicotinamide in acne treatment. Dermatol Ther. 2017;30(5). PubMed 28220628 · doi:10.1111/dth.12481
  27. Załęcki Piotr, Jezusek Julia, Nowicka Danuta. Topical Niacinamide in Daily Skincare: A 3-Week Real-World Cosmetic Study. Applied Sciences. 2025. doi:10.3390/app15179729
Azelaino rūgštis 18Spuogai, rozacėja, pigmentinės dėmės.
  1. Cetiner S, Ilknur T, Ozkan S. Phototoxic effects of topical azelaic acid, benzoyl peroxide and adapalene were not detected when applied immediately before UVB to normal skin. Eur J Dermatol. 2004;14(4):235-7. PubMed 15319156
  2. Chilicka K, Rogowska AM, Szyguła R, Dzieńdziora-Urbińska I, Taradaj J. A comparison of the effectiveness of azelaic and pyruvic acid peels in the treatment of female adult acne: a randomized controlled trial. Sci Rep. 2020;10(1):12612. PubMed 32724156 · doi:10.1038/s41598-020-69530-w
  3. Draelos ZD. Noxious sensory perceptions in patients with mild to moderate rosacea treated with azelaic acid 15% gel. Cutis. 2004;74(4):257-60. PubMed 15551720
  4. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis. 1996;57(1 Suppl):20-35. PubMed 8654128
  5. Iraji F, Sadeghinia A, Shahmoradi Z, Siadat AH, Jooya A. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. Indian J Dermatol Venereol Leprol. 2007;73(2):94-6. PubMed 17456913 · doi:10.4103/0378-6323.31892
  6. King S, Campbell J, Rowe R, Daly ML, Moncrieff G, Maybury C. A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging. J Cosmet Dermatol. 2023;22(10):2650-2662. PubMed 37550898 · doi:10.1111/jocd.15923
  7. Liu RH, Smith MK, Basta SA, Farmer ER. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol. 2006;142(8):1047-52. PubMed 16924055 · doi:10.1001/archderm.142.8.1047
  8. Liu H, Yu H, Xia J, Liu L, Liu GJ, Sang H, et al. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Cochrane Database Syst Rev. 2020;5(5):CD011368. PubMed 32356369 · doi:10.1002/14651858.CD011368.pub2
  9. Mariano-Rodriguez C, Nava-Martinez P, Diaz-Molina VL. Azelaic Acid in Dermatology: A Review of Its Mechanism of Action. Cureus. 2025;17(10):e94491. PubMed 41089572 · doi:10.7759/cureus.94491
  10. Mayer-da-Silva A, Gollnick H, Detmar M, Gassmüller J, Parry A, Müller R, et al. Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin. An in vivo and in vitro study. Acta Derm Venereol Suppl (Stockh). 1989;143:20-30. PubMed 2475995
  11. Schaller M, Sebastian M, Ress C, Seidel D, Hennig M. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30(6):966-73. PubMed 26915831 · doi:10.1111/jdv.13541
  12. Shucheng H, Zhou X, Du D, Li J, Yu C, Jiang X. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris. Dermatol Ther (Heidelb). 2024;14(5):1293-1314. PubMed 38734843 · doi:10.1007/s13555-024-01176-2
  13. Sobhan M, Talebi-Ghane E, Poostiyan E. A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: A single-blinded randomized clinical trial. J Res Med Sci. 2023;28:18. PubMed 37213446 · doi:10.4103/jrms.jrms_443_22
  14. Spellman MC, Pincus SH. Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne. Clin Ther. 1998;20(4):711-21. PubMed 9737831 · doi:10.1016/s0149-2918(98)80134-3
  15. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol. 2003;48(6):836-45. PubMed 12789172 · doi:10.1067/mjd.2003.308
  16. Thiboutot D. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol. 2008;7(1):13-6. PubMed 18246693
  17. Thielitz A, Lux A, Wiede A, Kropf S, Papakonstantinou E, Gollnick H. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne. J Eur Acad Dermatol Venereol. 2015;29(4):789-96. PubMed 25399481 · doi:10.1111/jdv.12823
  18. Ziel K, Yelverton CB, Balkrishnan R, Feldman SR. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol. 2005;4(6):727-31. PubMed 16302558
Spuogai ir porų kimšimas 44Medžiagos, kurios gali užkimšti poras, tyrimų modeliai, prausikliai ir priežiūra spuogams linkusiai odai.
  1. Althwanay A, AlEdani EM, Kaur H, Kasapoglu M, Yadavalli R, Nawaz S, et al. Efficacy of Topical Treatments in the Management of Mild-to-Moderate Acne Vulgaris: A Systematic Review. Cureus. 2024;16(4):e57909. PubMed 38725769 · doi:10.7759/cureus.57909
  2. Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol. 2013;27 Suppl 2:6-11. PubMed 23731195 · doi:10.1111/jdv.12168
  3. Capitanio B, Sinagra JL, Weller RB, Brown C, Berardesca E. Randomized controlled study of a cosmetic treatment for mild acne. Clin Exp Dermatol. 2012;37(4):346-9. PubMed 22369176 · doi:10.1111/j.1365-2230.2011.04317.x
  4. Chiba K, Yoshizawa K, Makino I, Kawakami K, Onoue M. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci. 2000;25(2):77-83. PubMed 10845185 · doi:10.2131/jts.25.77
  5. Choi K, Liu H, Zhu Y, Jiang Z, Lu S. A Case-Control Study Exploring the Association Between Cosmetic Use and Acne Risk: Implications for Prevention and Clinical Practice. Clin Cosmet Investig Dermatol. 2025;18:1833-1843. PubMed 40765696 · doi:10.2147/CCID.S533950
  6. Chularojanamontri L, Tuchinda P, Kulthanan K, Pongparit K. Moisturizers for Acne: What are their Constituents?. J Clin Aesthet Dermatol. 2014;7(5):36-44. PubMed 24847408
  7. Detudom P, Kamanamool N, Paichitrojjana A, Udompataikul P, Udompataikul M. Efficacy of anti-sebum moisturizing cream containing 2% l-carnitine and 5% epigallocatechin gallate in seborrhea: A randomized clinical trial. J Cosmet Dermatol. 2023;22(11):3058-3064. PubMed 37194909 · doi:10.1111/jocd.15816
  8. Draelos ZD, Baalbaki N, Colon G, Dreno B. Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment. J Drugs Dermatol. 2023;22(6):554-558. PubMed 37276158 · doi:10.36849/JDD.7142
  9. Dull K, Lénárt K, Dajnoki Z, Póliska S, Uchiyama E, Hendrik Z, et al. Barrier function-related genes and proteins have an altered expression in acne-involved skin. J Eur Acad Dermatol Venereol. 2023;37(7):1415-1425. PubMed 36971768 · doi:10.1111/jdv.19062
  10. Eastman WJ, Malahias S, Delconte J, DiBenedetti D. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis. 2014;94(1):46-53. PubMed 25101344
  11. Fluhr JW, Mao-Qiang M, Brown BE, Wertz PW, Crumrine D, Sundberg JP, et al. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol. 2003;120(5):728-37. PubMed 12713573 · doi:10.1046/j.1523-1747.2003.12134.x
  12. Fulton JE Jr. Comedogenicity and irritancy of commonly used ingredients in skin care products. J Soc Cosmet Chem 40, 321-333 (November/December 1989).
  13. Goh CL, Abad-Casintahan F, Aw DC, Baba R, Chan LC, Hung NT, et al. South-East Asia study alliance guidelines on the management of acne vulgaris in South-East Asian patients. J Dermatol. 2015;42(10):945-53. PubMed 26211507 · doi:10.1111/1346-8138.12993
  14. Goh CL, Noppakun N, Micali G, Azizan NZ, Boonchai W, Chan Y, et al. Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy. J Cutan Aesthet Surg. 2016;9(2):85-92. PubMed 27398008 · doi:10.4103/0974-2077.184043
  15. Hayashi N, Imori M, Yanagisawa M, Seto Y, Nagata O, Kawashima M. Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. Eur J Dermatol. 2005;15(4):284-7. PubMed 16048760
  16. Kashyap S, Besra L, Kar HK. Evaluation of Risk Factors Associated With Adult-Onset Acne in Patients Attending a Tertiary Care Center in East India: A Case-Control Study. Cureus. 2024;16(1):e53296. PubMed 38435859 · doi:10.7759/cureus.53296
  17. Katoulis AC, Kakepis EM, Kintziou H, Kakepis ME, Stavrianeas NG. Comedogenicity of cosmetics: a review. J Eur Acad Dermatol Venereol 1996;7(2):115-119. doi:10.1111/j.1468-3083.1996.tb00606.x
  18. Kligman AM. Petrolatum is not comedogenic in rabbits or humans: A critical reappraisal of the rabbit ear assay and the concept of "acne cosmetica". J Soc Cosmet Chem 47, 41-48 (January/February 1996).
  19. Korting HC, Borelli C, Schöllmann C. [Acne vulgaris. Role of cosmetics]. Hautarzt. 2010;61(2):126-31. PubMed 20107752 · doi:10.1007/s00105-009-1832-z
  20. Mahmood T, Akhtar N, Khan BA, Khan HM, Saeed T. Outcomes of 3% green tea emulsion on skin sebum production in male volunteers. Bosn J Basic Med Sci. 2010;10(3):260-4. PubMed 20846135 · doi:10.17305/bjbms.2010.2697
  21. Mahmood T, Akhtar N, Moldovan C. A comparison of the effects of topical green tea and lotus on facial sebum control in healthy humans. Hippokratia. 2013;17(1):64-7. PubMed 23935347
  22. Melnik BC, Schmitz G, Zouboulis CC. Anti-acne agents attenuate FGFR2 signal transduction in acne. J Invest Dermatol. 2009;129(8):1868-77. PubMed 19225542 · doi:10.1038/jid.2009.8
  23. Mills OH, Klingman AM. Acne detergicans. Arch Dermatol. 1975;111(1):65-8. PubMed 123433
  24. Morris WE, Kwan SC. Use of the rabbit ear model in evaluating the comedogenic potential of cosmetic ingredients. J Soc Cosmet Chem. 1983;34:215–25. library.scconline.org
  25. Myung KB. Assessment of Comedogenicity of Cosmetics in Humans and Rabbits [straipsnis korėjiečių kalba]. Ewha Med J 1989;12(4):335-341. doi:10.12771/emj.1989.12.4.335
  26. Pappas A, Kendall AC, Brownbridge LC, Batchvarova N, Nicolaou A. Seasonal changes in epidermal ceramides are linked to impaired barrier function in acne patients. Exp Dermatol. 2018;27(8):833-836. PubMed 29356138 · doi:10.1111/exd.13499
  27. Peirano RI, Hamann T, Düsing HJ, Akhiani M, Koop U, Schmidt-Rose T, et al. Topically applied L-carnitine effectively reduces sebum secretion in human skin. J Cosmet Dermatol. 2012;11(1):30-6. PubMed 22360332 · doi:10.1111/j.1473-2165.2011.00597.x
  28. Perera MPN, Peiris WMDM, Pathmanathan D, Mallawaarachchi S, Karunathilake IM. Relationship between acne vulgaris and cosmetic usage in Sri Lankan urban adolescent females. J Cosmet Dermatol. 2018;17(3):431-436. PubMed 28941014 · doi:10.1111/jocd.12431
  29. Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. PubMed 38300170 · doi:10.1016/j.jaad.2023.12.017
  30. Rubin IK. Efficacy of a Non-Comedogenic Hair Care Regimen for the Reduction of Mild-to-Moderate Truncal and Facial Acne: A Single-Arm 8-Week Study. J Drugs Dermatol. 2021;20(6):690-693. PubMed 34076395 · doi:10.36849/JDD.2021.5772
  31. Saint-Jean M, Khammari A, Seite S, Moyal D, Dreno B. Characteristics of premenstrual acne flare-up and benefits of a dermocosmetic treatment: a double-blind randomised trial. Eur J Dermatol. 2017;27(2):144-149. PubMed 28251894 · doi:10.1684/ejd.2016.2952
  32. Schachner LA, Alexis AF, Andriessen A, Berson D, Gold M, Goldberg DJ, et al. Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide-containing skincare. J Cosmet Dermatol. 2023;22(11):2902-2909. PubMed 37605504 · doi:10.1111/jocd.15946
  33. Scherdin U, Presto S, Rippke F, Nielsen J, Strassner M, Imadojemun A, et al. In vivo assessment of the efficacy of an innovative face care system in subjects with mild acne vulgaris. Int J Cosmet Sci. 2004;26(5):221-9. PubMed 18492134 · doi:10.1111/j.1467-2494.2004.00225.x
  34. Singh S, Mann BK, Tiwary NK. Acne cosmetica revisited: a case-control study shows a dose-dependent inverse association between overall cosmetic use and post-adolescent acne. Dermatology. 2013;226(4):337-41. PubMed 23859829 · doi:10.1159/000350936
  35. Strauss JS, Goldman PH, Nacht S, Gans EH. A reexamination of the potential comedogenicity of sulfur. Arch Dermatol. 1978;114(9):1340-2. PubMed 150816
  36. Thadanipon K, Kitsongsermthon J. Comparative study into facial sebum level, pore size, and skin hydration between oily-skinned and dry-skinned Thai women. Skin Res Technol. 2020;26(2):163-168. PubMed 31562649 · doi:10.1111/srt.12792
  37. Thiboutot DM, Dréno B, Abanmi A, Alexis AF, Araviiskaia E, Barona Cabal MI, et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl 1):S1-S23.e1. PubMed 29127053 · doi:10.1016/j.jaad.2017.09.078
  38. Thiboutot D, Layton AM, Traore I, Gontijo G, Troielli P, Ju Q, et al. International expert consensus recommendations for the use of dermocosmetics in acne. J Eur Acad Dermatol Venereol. 2025;39(5):952-966. PubMed 38877766 · doi:10.1111/jdv.20145
  39. Triwatcharikorn J, Techamontrikul S, Ngamdumrongkiat N, Rerknimitr P. The efficacy of a bioactive moisturizer in mitigating side effects of acne therapies: a randomized, investigator-blind, split-face trial. Dermatol Reports. 2026. PubMed 41891349 · doi:10.4081/dr.2026.10491
  40. Uhoda E, Piérard-Franchimont C, Piérard GE. Comedolysis by a lipohydroxyacid formulation in acne-prone subjects. Eur J Dermatol. 2003;13(1):65-8. PubMed 12609785
  41. Visser WI, Kannenberg SM, Prevost A, Khoza N, Pillay L, Wiid KJ, et al. Dermocosmetics in Acne Vulgaris: South African Consensus Recommendations With a Focus on Skin of Color. J Cosmet Dermatol. 2026;25(2):e70696. PubMed 41689191 · doi:10.1111/jocd.70696
  42. Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res. 1995;287(2):214-8. PubMed 7763094 · doi:10.1007/BF01262335
  43. Yoon JY, Kwon HH, Min SU, Thiboutot DM, Suh DH. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes. J Invest Dermatol. 2013;133(2):429-40. PubMed 23096708 · doi:10.1038/jid.2012.292
  44. Zhang X, Zhang Z, Tao H, He X, Hsu K, Wang W, et al. Comprehensive assessment of the efficacy and safety of a clay mask in oily and acne skin. Skin Res Technol. 2023;29(11):e13513. PubMed 38009030 · doi:10.1111/srt.13513
Paraudimas ir rozacėja 16Paraudimą mažinančios ir jį sukeliančios medžiagos, jautri oda.
  1. Alinia H, Tuchayi SM, Patel NU, Patel N, Awosika O, Bahrami N, et al. Rosacea Triggers: Alcohol and Smoking. Dermatol Clin. 2018;36(2):123-126. PubMed 29499795 · doi:10.1016/j.det.2017.11.007
  2. American Academy of Dermatology. [Puslapis pacientams apie rozacėjos odos priežiūrą]. aad.org (pacientams). 2026. www.aad.org
  3. Cameli N, Mariano M, Zanniello R, Berardesca E. Clinical and noninvasive instrumental evaluation of the efficacy of a nonsteroidal anti-inflammatory 8-beta glycyrrhetinic acid cream for the treatment of erythema in rosacea. Dermatol Ther. 2020;33(6):e14224. PubMed 32833275 · doi:10.1111/dth.14224
  4. Dickel H, Kreft B, Geier J. Strip patch testing does not affect reaction profiles of standard allergens. Contact Dermatitis. 2015;73(1):36-43. PubMed 25824375 · doi:10.1111/cod.12384
  5. Enberg J, Hamnerius N, Kroona L, Svedman C. The use of carvone in consecutive patch testing. Contact Dermatitis. 2023;88(3):206-211. PubMed 36399045 · doi:10.1111/cod.14249
  6. Farage MA. The Prevalence of Sensitive Skin. Front Med (Lausanne). 2019;6:98. PubMed 31157225 · doi:10.3389/fmed.2019.00098
  7. Hagvall L, Rudbäck J, Bråred Christensson J, Karlberg AT. Patch testing with purified and oxidized citronellol. Contact Dermatitis. 2020;83(5):372-379. PubMed 32638395 · doi:10.1111/cod.13654
  8. Maggioni D, Cimicata A, Praticò A, Villa R, Bianchi FM, Busoli Badiale S, et al. A Preliminary Clinical Evaluation of a Topical Product for Reducing Slight Rosacea Imperfections. Clin Cosmet Investig Dermatol. 2020;13:299-308. PubMed 32368125 · doi:10.2147/CCID.S240784
  9. Marriott M, Holmes J, Peters L, Cooper K, Rowson M, Basketter DA. The complex problem of sensitive skin. Contact Dermatitis. 2005;53(2):93-9. PubMed 16033403 · doi:10.1111/j.0105-1873.2005.00653.x
  10. Misery L, Ständer S, Szepietowski JC, Reich A, Wallengren J, Evers AW, et al. Definition of Sensitive Skin: An Expert Position Paper from the Special Interest Group on Sensitive Skin of the International Forum for the Study of Itch. Acta Derm Venereol. 2017;97(1):4-6. PubMed 26939643 · doi:10.2340/00015555-2397
  11. Misery L, Weisshaar E, Brenaut E, Evers AWM, Huet F, Ständer S, et al. Pathophysiology and management of sensitive skin: position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI). J Eur Acad Dermatol Venereol. 2020;34(2):222-229. PubMed 31660659 · doi:10.1111/jdv.16000
  12. National Rosacea Society. Survey shows skin care products, ingredients may aggravate rosacea. Rosacea Review. 1997 (Summer). www.rosacea.org
  13. Silverberg JI, Hou A, Warshaw EM, DeKoven JG, Maibach HI, Belsito DV, et al. Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016. J Allergy Clin Immunol Pract. 2021;9(7):2853-2866.e14. PubMed 33781959 · doi:10.1016/j.jaip.2021.03.028
  14. Sulzberger M, Worthmann AC, Holtzmann U, Buck B, Jung KA, Schoelermann AM, et al. Effective treatment for sensitive skin: 4-t-butylcyclohexanol and licochalcone A. J Eur Acad Dermatol Venereol. 2016;30 Suppl 1:9-17. PubMed 26805417 · doi:10.1111/jdv.13529
  15. Uter W, Balzer C, Geier J, Frosch PJ, Schnuch A. Patch testing with patients' own cosmetics and toiletries--results of the IVDK*, 1998-2002. Contact Dermatitis. 2005;53(4):226-33. PubMed 16191021 · doi:10.1111/j.0105-1873.2005.00690.x
  16. Warshaw EM, Shaver RL, DeKoven JG, Maibach HI, Taylor JS, Atwater AR, et al. Patch Testing to Carvone: North American Contact Dermatitis Group Experience, 2009 to 2018. Dermatitis. 2022;33(1):42-50. PubMed 33867494 · doi:10.1097/DER.0000000000000741
Pigmentinės dėmės 8Arbutinas, kojo rūgštis, traneksamo rūgštis ir kitos šviesinančios medžiagos.
  1. Atefi N, Dalvand B, Ghassemi M, Mehran G, Heydarian A. Therapeutic Effects of Topical Tranexamic Acid in Comparison with Hydroquinone in Treatment of Women with Melasma. Dermatol Ther (Heidelb). 2017;7(3):417-424. PubMed 28748406 · doi:10.1007/s13555-017-0195-0
  2. Crocco EI, et al. Topical use of a blend of bleaches associated with moisturizers in immediate post-peeling care for melasma treatment. Surg Cosmet Dermatol 2020;12(4):359-365. doi:10.5935/scd1984-8773.20201242542
  3. Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci. 2014;19(8):753-7. PubMed 25422661
  4. Janney MS, Subramaniyan R, Dabas R, Lal S, Das NM, Godara SK. A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma. J Cutan Aesthet Surg. 2019;12(1):63-67. PubMed 31057273 · doi:10.4103/JCAS.JCAS_40_18
  5. Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012;14(3):150-4. PubMed 22506692 · doi:10.3109/14764172.2012.685478
  6. Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review. Acta Derm Venereol. 2017;97(7):776-781. PubMed 28374042 · doi:10.2340/00015555-2668
  7. Oresajo C, Yatskayer M, Hansenne I. Clinical tolerance and efficacy of capryloyl salicylic acid peel compared to a glycolic acid peel in subjects with fine lines/wrinkles and hyperpigmented skin. J Cosmet Dermatol. 2008;7(4):259-62. PubMed 19146601 · doi:10.1111/j.1473-2165.2008.00403.x
  8. Tantanasrigul P, Sripha A, Chongmelaxme B. The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study. J Cosmet Dermatol. 2025;24(1):e16562. PubMed 39555866 · doi:10.1111/jocd.16562
Peptidai ir raukšlės 32Peptidai, kolageną veikiančios medžiagos, odos senėjimas.
  1. Aung PZ, Nararatwanchai T. NoTox Tweakments: Evidence for Topical Neurocosmetic Peptides as Needle‐Free Neuromodulators for Facial Wrinkle Reduction—A Systematic Review. J Cosmet Dermatol 2026;25(9):e71137. doi:10.1111/jocd.71137
  2. Barba C, Méndez S, Roddick-Lanzilotta A, Kelly R, Parra JL, Coderch L. Cosmetic effectiveness of topically applied hydrolysed keratin peptides and lipids derived from wool. Skin Res Technol. 2008;14(2):243-8. PubMed 18412569 · doi:10.1111/j.1600-0846.2007.00280.x
  3. Bjerke DL, Li J, Gao Y, Hu P, Lintner K, Hakozaki T. A framework for the safety evaluation of peptides in cosmetics. Curr Res Toxicol. 2026;10:100291. PubMed 41953401 · doi:10.1016/j.crtox.2026.100291
  4. Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24(5):303-10. PubMed 18498523 · doi:10.1046/j.1467-2494.2002.00153.x
  5. Bucataru C, Ciobanasu C. Antimicrobial peptides: Opportunities and challenges in overcoming resistance. Microbiol Res. 2024;286:127822. PubMed 38986182 · doi:10.1016/j.micres.2024.127822
  6. DiNatale L, Idkowiak-Baldys J, Zhuang Y, Gonzalez A, Stephens TJ, Jiang LI, et al. Novel Rotational Combination Regimen of Skin Topicals Improves Facial Photoaging: Efficacy Demonstrated in Double-Blinded Clinical Trials and Laboratory Validation. Front Med (Lausanne). 2021;8:724344. PubMed 34604259 · doi:10.3389/fmed.2021.724344
  7. Edison BL, Green BA, Wildnauer RH, Sigler ML. A polyhydroxy acid skin care regimen provides antiaging effects comparable to an alpha-hydroxyacid regimen. Cutis. 2004;73(2 Suppl):14-7. PubMed 15002657
  8. Gallinger J, Kuhn A, Wessel S, Behm P, Heinecke S, Filbry A, et al. Depth-dependent hydration dynamics in human skin: Vehicle-controlled efficacy assessment of a functional 10% urea plus NMF moisturizer by near-infrared confocal spectroscopic imaging (KOSIM IR) and capacitance method complemented by volunteer perception. Skin Res Technol. 2022;28(2):342-349. PubMed 35034387 · doi:10.1111/srt.13137
  9. Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC. Skin anti-aging strategies. Dermatoendocrinol. 2012;4(3):308-19. PubMed 23467476 · doi:10.4161/derm.22804
  10. Grimes PE, Green BA, Wildnauer RH, Edison BL. The use of polyhydroxy acids (PHAs) in photoaged skin. Cutis. 2004;73(2 Suppl):3-13. PubMed 15002656
  11. Henseler H. Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia(®) Complexion Analysis camera system for objective skin analysis. GMS Interdiscip Plast Reconstr Surg DGPW. 2023;12:Doc09. PubMed 38024099 · doi:10.3205/iprs000179
  12. Hostynek JJ, Dreher F, Maibach HI. Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy. Inflamm Res. 2010;59(11):983-8. PubMed 20703511 · doi:10.1007/s00011-010-0214-4
  13. Kato S, Taira H, Aoshima H, Saitoh Y, Miwa N. Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. J Nanosci Nanotechnol. 2010;10(10):6769-74. PubMed 21137794 · doi:10.1166/jnn.2010.3053
  14. Kraeling ME, Zhou W, Wang P, Ogunsola OA. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol. 2015;34(1):46-52. PubMed 24754410 · doi:10.3109/15569527.2014.894521
  15. Lee HJ, Kim JY, Park KD, Lee WJ. Randomized controlled double-blind study of a cleanser composed of 5-aminolevulinic acid and peptides on mild and moderate acne vulgaris. J Cosmet Dermatol. 2020;19(7):1745-1750. PubMed 31778021 · doi:10.1111/jocd.13232
  16. Li X, Guo M, Chi J, Ma J. Bioactive Peptides from Walnut Residue Protein. Molecules. 2020;25(6). PubMed 32178315 · doi:10.3390/molecules25061285
  17. Lim SH, Sun Y, Thiruvallur Madanagopal T, Rosa V, Kang L. Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Sci Rep. 2018;8(1):1596. PubMed 29371611 · doi:10.1038/s41598-017-18454-z
  18. Lungu C, Considine E, Zahir S, Ponsati B, Arrastia S, Hallett M. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. Eur J Neurol. 2013;20(3):515-518. PubMed 23146065 · doi:10.1111/ene.12009
  19. Luo Y, Song Y. Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities. Int J Mol Sci. 2021;22(21). PubMed 34768832 · doi:10.3390/ijms222111401
  20. Mondon P, Hillion M, Peschard O, Andre N, Marchand T, Doridot E, et al. Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using matrix-assisted laser desorption/ionization mass spectrometric imaging, in vivo reflectance confocal microscopy, echography, and histology: effect of age and peptide applications. J Cosmet Dermatol. 2015;14(2):152-60. PubMed 25817264 · doi:10.1111/jocd.12135
  21. Najafi N, Maatouk H, Vardanyan KG, Vartanian KB, Agrawal DK. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials. Arch Intern Med Res. 2026;9(3):269-293. PubMed 42787770 · doi:10.26502/aimr.0255
  22. Nenoff P, Donaubauer K, Arndt T, Haustein UF. [Topically applied arginine hydrochloride. Effect on urea content of stratum corneum and skin hydration in atopic eczema and skin aging]. Hautarzt. 2004;55(1):58-64. PubMed 14749863 · doi:10.1007/s00105-003-0647-6
  23. Nguyen TQ, Zahr AS, Kononov T, Ablon G. A Randomized, Double-blind, Placebo-controlled Clinical Study Investigating the Efficacy and Tolerability of a Peptide Serum Targeting Expression Lines. J Clin Aesthet Dermatol. 2021;14(5):14-21. PubMed 34188744
  24. Nukaly HY, Halawani IR, Irtaza HM, Alturkistani T, Serafi MR, Alhawsawi W, et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306. PubMed 41924746 · doi:10.3389/fmed.2026.1618306
  25. Pavicic T, Gauglitz GG, Lersch P, Schwach-Abdellaoui K, Malle B, Korting HC, et al. Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. J Drugs Dermatol. 2011;10(9):990-1000. PubMed 22052267
  26. Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-60. PubMed 18492182 · doi:10.1111/j.1467-2494.2005.00261.x
  27. Taub A, Bucay V, Keller G, Williams J, Mehregan D. Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation. J Drugs Dermatol. 2018;17(4):426-441. PubMed 29601620
  28. van Walraven N, FitzGerald RJ, Danneel HJ, Amigo-Benavent M. Bioactive peptides in cosmetic formulations: Review of current in vitro and ex vivo evidence. Peptides. 2025;193:171440. PubMed 40946970 · doi:10.1016/j.peptides.2025.171440
  29. Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013;14(2):147-53. PubMed 23417317 · doi:10.1007/s40257-013-0009-9
  30. Wolosik K, Chalecka M, Gasiewska G, Palka J, Surazynski A. Squalane as a Promising Agent Protecting UV-Induced Inhibition of Collagen Biosynthesis and Wound Healing in Human Dermal Fibroblast. Molecules. 2025;30(9). PubMed 40363772 · doi:10.3390/molecules30091964
  31. Zahr AS, Iglesia S, Kononov T, Aguilera SB, Harper J, Schulz K. Treatment of Periorbital Facial Wrinkles in Female Subjects: A Randomized, Multi-Center, Double-Blinded, Placebo-Controlled, Split-Face Study Evaluating Procedure Pairing of a Peptide Anti-Aging Serum with Onabotulinumtoxina. J Clin Aesthet Dermatol. 2022;15(7):12-14. PubMed 35942019
  32. Zdzieblik D, Oesser S, Gollhofer A, König D. Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Appl Physiol Nutr Metab. 2017;42(6):588-595. PubMed 28177710 · doi:10.1139/apnm-2016-0390
Apsauga nuo saulės 19UV filtrai, jų dirginimas ir alergija, fototoksiškumas, apsaugos nuo saulės naudojimas.
  1. Antille C, Tran C, Sorg O, Carraux P, Didierjean L, Saurat JH. Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation. J Invest Dermatol. 2003;121(5):1163-7. PubMed 14708621 · doi:10.1046/j.1523-1747.2003.12519.x
  2. Avenel-Audran M, Dutartre H, Goossens A, Jeanmougin M, Comte C, Bernier C, et al. Octocrylene, an emerging photoallergen. Arch Dermatol. 2010;146(7):753-7. PubMed 20644036 · doi:10.1001/archdermatol.2010.132
  3. British Association of Dermatologists. Sun protection fact sheet. skinhealthinfo.org.uk. 2024. www.skinhealthinfo.org.uk
  4. British Association of Dermatologists. Skin cancer: how to reduce the risk of developing skin cancer (patient information leaflet). skinhealthinfo.org.uk. 2025. www.skinhealthinfo.org.uk
  5. Cestone E, Michelotti A, Zanoletti V, Zanardi A, Mantegazza R, Dossena M. Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study. J Cosmet Dermatol. 2017;16(2):265-270. PubMed 28133878 · doi:10.1111/jocd.12309
  6. Chen W, He M, Xie L, Li L. The optimal cleansing method for the removal of sunscreen:Water, cleanser or cleansing oil?. J Cosmet Dermatol. 2020;19(1):180-184. PubMed 31157512 · doi:10.1111/jocd.12995
  7. de Groot AC, Roberts DW. Contact and photocontact allergy to octocrylene: a review. Contact Dermatitis. 2014;70(4):193-204. PubMed 24628344 · doi:10.1111/cod.12205
  8. Fetil E, Ozka S, Soyal MC, Ilknur T, Erdem Y, Güneş AT. Effects of topical petrolatum and salicylic acid on the erythemogenicity of UVB. Eur J Dermatol. 2002;12(2):154-6. PubMed 11872412
  9. Foubert K, Dendooven E, Theunis M, Naessens T, Ivanova B, Pieters L, et al. The presence of benzophenone in sunscreens and cosmetics containing the organic UV filter octocrylene: A laboratory study. Contact Dermatitis. 2021;85(1):69-77. PubMed 33763894 · doi:10.1111/cod.13845
  10. Hughes TM, Stone NM. Benzophenone 4: an emerging allergen in cosmetics and toiletries?. Contact Dermatitis. 2007;56(3):153-6. PubMed 17295691 · doi:10.1111/j.1600-0536.2007.01017.x
  11. Kaidbey K, Sutherland B, Bennett P, Wamer WG, Barton C, Dennis D, et al. Topical glycolic acid enhances photodamage by ultraviolet light. Photodermatol Photoimmunol Photomed. 2003;19(1):21-7. PubMed 12713551 · doi:10.1034/j.1600-0781.2003.00013.x
  12. Karlsson I, Vanden Broecke K, Mårtensson J, Goossens A, Börje A. Clinical and experimental studies of octocrylene's allergenic potency. Contact Dermatitis. 2011;64(6):343-52. PubMed 21504434 · doi:10.1111/j.1600-0536.2011.01899.x
  13. Kornhauser A, Wei RR, Yamaguchi Y, Coelho SG, Kaidbey K, Barton C, et al. The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin. J Dermatol Sci. 2009;55(1):10-7. PubMed 19411163 · doi:10.1016/j.jdermsci.2009.03.011
  14. Kristensen B, Kristensen O. Topical salicylic acid interferes with UVB therapy for psoriasis. Acta Derm Venereol. 1991;71(1):37-40. PubMed 1676212
  15. Norman KG, Kaufman LE, D'Ruiz C, Loretz L, Kowcz A, Cohen SM, et al. Comprehensive review of avobenzone (butyl methoxydibenzoylmethane) toxicology data and human exposure assessment for personal care products. Crit Rev Toxicol. 2025;55(6):662-692. PubMed 40910486 · doi:10.1080/10408444.2025.2535394
  16. Petersen B, Wulf HC. Application of sunscreen--theory and reality. Photodermatol Photoimmunol Photomed. 2014;30(2-3):96-101. PubMed 24313722 · doi:10.1111/phpp.12099
  17. Tan C, Peng K, Lim T, Liu J, Ye Y, Lim L, et al. The combination of allantoin, bisabolol, D-panthenol and dipotassium glycyrrhizinate mitigates UVB-induced PGE(2) synthesis by keratinocytes. Int J Cosmet Sci. 2024;46(5):691-701. PubMed 38433250 · doi:10.1111/ics.12951
  18. Togni S, Maramaldi G, Bonetta A, Giacomelli L, Di Pierro F. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci. 2015;19(8):1338-44. PubMed 25967706
  19. Warshaw EM, Xiong M, Belsito DV, Adler BL, Atwater AR, DeKoven JG, et al. Patch Testing With Benzophenone-3 and -4: The North American Contact Dermatitis Group Experience, 2013-2020. Dermatitis. 2023;34(2):105-112. PubMed 36917534 · doi:10.1089/derm.2022.29013.ewa
Raminančios medžiagos ir augaliniai ekstraktai 8Azijinė centelė, avižos, alantoinas, bisabololas, alavijas, medetkos, ramunėlės ir kiti ekstraktai.
  1. Alvarez GV, Kang BY, Richmond AM, Hoss E, Sulewski R, Minkis K, et al. Skincare ingredients recommended by cosmetic dermatologists: A Delphi consensus study. J Am Acad Dermatol. 2025;93(6):1509-1525. PubMed 40233838 · doi:10.1016/j.jaad.2025.04.021
  2. Heuschkel S, Wohlrab J, Schmaus G, Neubert RH. Modulation of dihydroavenanthramide D release and skin penetration by 1,2-alkanediols. Eur J Pharm Biopharm. 2008;70(1):239-47. PubMed 18514497 · doi:10.1016/j.ejpb.2008.04.005
  3. Ilnytska O, Kaur S, Chon S, Reynertson KA, Nebus J, Garay M, et al. Colloidal Oatmeal (Avena Sativa) Improves Skin Barrier Through Multi-Therapy Activity. J Drugs Dermatol. 2016;15(6):684-90. PubMed 27272074
  4. Kolbe L, Immeyer J, Batzer J, Wensorra U, tom Dieck K, Mundt C, et al. Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res. 2006;298(1):23-30. PubMed 16552540 · doi:10.1007/s00403-006-0654-4
  5. Korting HC, Schäfer-Korting M, Hart H, Laux P, Schmid M. Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose. Eur J Clin Pharmacol. 1993;44(4):315-8. PubMed 8513841 · doi:10.1007/BF00316465
  6. Pedretti A, Capezzera R, Zane C, Facchinetti E, Calzavara-Pinton P. Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face study. Planta Med. 2010;76(6):555-60. PubMed 19918712 · doi:10.1055/s-0029-1240581
  7. Sfriso R, Claypool J, Roche M, Imfeld D. 5-α reductase inhibition by Epilobioum fleischeri extract modulates facial microbiota structure. Int J Cosmet Sci. 2022;44(4):440-452. PubMed 35499362 · doi:10.1111/ics.12777
  8. Sripanidkulchai B, Chaiittianan R, Suttanut K. Safety and efficacy assessment of skin gel containing nanoemulsion of Phyllanthus emblica extract: A randomized, double-blind, placebo-controlled study. Songklanakarin J Sci Technol 2020;42(2):305–313.
Sausa ir atopinė oda 20Emolientų terapija, atopinis dermatitas, odos sausumas.
  1. Breternitz M, Kowatzki D, Langenauer M, Elsner P, Fluhr JW. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation. Skin Pharmacol Physiol. 2008;21(1):39-45. PubMed 18025807 · doi:10.1159/000111134
  2. Capone K, Kirchner F, Klein SL, Tierney NK. Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties. J Drugs Dermatol. 2020;19(5):524-531. PubMed 32484623
  3. Danby SG, Brown K, Higgs-Bayliss T, Chittock J, Albenali L, Cork MJ. The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin. Skin Pharmacol Physiol. 2016;29(3):135-47. PubMed 27251427 · doi:10.1159/000445955
  4. Draelos ZD. A pilot study investigating the efficacy of botanical anti-inflammatory agents in an OTC eczema therapy. J Cosmet Dermatol. 2016;15(2):117-9. PubMed 26596512 · doi:10.1111/jocd.12199
  5. Gehring W, Wenz J, Gloor M. Influence of topically applied ceramide/phospholipid mixture on the barrier function of intact skin, atopic skin and experimentally induced barrier damage. International Journal of Cosmetic Science. 1997. doi:10.1111/j.1467-2494.1997.tb00178.x
  6. Gånemo A, Virtanen M, Vahlquist A. Improved topical treatment of lamellar ichthyosis: a double-blind study of four different cream formulations. Br J Dermatol. 1999;141(6):1027-32. PubMed 10606847 · doi:10.1046/j.1365-2133.1999.03200.x
  7. Jabbar-Lopez ZK, Ung CY, Alexander H, Gurung N, Chalmers J, Danby S, et al. The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta-analysis. Clin Exp Allergy. 2021;51(3):430-451. PubMed 33259122 · doi:10.1111/cea.13797
  8. Koppes SA, Charles F, Lammers L, Frings-Dresen M, Kezic S, Rustemeyer T. Efficacy of a Cream Containing Ceramides and Magnesium in the Treatment of Mild to Moderate Atopic Dermatitis: A Randomized, Double-blind, Emollient- and Hydrocortisone-controlled Trial. Acta Derm Venereol. 2016;96(7):948-953. PubMed 26939522 · doi:10.2340/00015555-2395
  9. Lindh JD, Bradley M. Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review. Am J Clin Dermatol. 2015;16(5):341-59. PubMed 26267423 · doi:10.1007/s40257-015-0146-4
  10. Lodén M, Andersson AC, Anderson C, Bergbrant IM, Frödin T, Ohman H, et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol. 2002;82(1):45-7. PubMed 12013198 · doi:10.1080/000155502753600885
  11. Lueangarun S, Tragulplaingam P, Sugkraroek S, Tempark T. The 24-hr, 28-day, and 7-day post-moisturizing efficacy of ceramides 1, 3, 6-II containing moisturizing cream compared with hydrophilic cream on skin dryness and barrier disruption in senile xerosis treatment. Dermatol Ther. 2019;32(6):e13090. PubMed 31585489 · doi:10.1111/dth.13090
  12. Morgado-Carrasco D, Balado-Simó P, Vivancos Cuadras F, Furmanczyk M, Delgado Ojeda J. Efficacy of a Topical Formulation on Skin Hydration and Barrier Function in Individuals With Xerosis: A 28-Day Randomized, Split-Leg, Untreated-Controlled Trial. J Cosmet Dermatol. 2026;25(5):e70898. PubMed 42108609 · doi:10.1111/jocd.70898
  13. Muhammad P, Novianto E, Setyorini M, Legiawati L, Yusharyahya SN, Menaldi SL, et al. Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial. Arch Dermatol Res. 2024;316(6):329. PubMed 38829483 · doi:10.1007/s00403-024-03003-2
  14. Nugroho WT, Sawitri S, Astindari A, Utomo B, Listiawan MY, Ervianti E, et al. The Efficacy of Moisturisers Containing Ceramide Compared with Other Moisturisers in the Management of Atopic Dermatitis: A Systematic Literature Review and Meta-Analysis. Indian J Dermatol. 2023;68(1):53-58. PubMed 37151263 · doi:10.4103/ijd.ijd_991_22
  15. Pellicoro C, Marsella R, Ahrens K. Pilot study to evaluate the effect of topical dimethicone on clinical signs and skin barrier function in dogs with naturally occurring atopic dermatitis. Vet Med Int. 2013;2013:239186. PubMed 23710417 · doi:10.1155/2013/239186
  16. Prakoeswa CRS, Damayanti, Anggraeni S, Umborowati MA, Sari M, Hendaria MP, et al. The Role of Moisturizer Containing Anti-inflammatory on Skin Hydration in Mild-Moderate Atopic Dermatitis Patients. Dermatol Res Pract. 2024;2024:3586393. PubMed 39741562 · doi:10.1155/drp/3586393
  17. Szepietowski JC, Tadini G. Basic Emollients for Xerosis Cutis Not Associated With Atopic Dermatitis: A Review of Clinical Studies. Int J Dermatol. 2025;64 Suppl 1:29-46. PubMed 40444760 · doi:10.1111/ijd.17794
  18. Udompataikul M, Srisatwaja W. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study. J Eur Acad Dermatol Venereol. 2011;25(6):660-5. PubMed 20840345 · doi:10.1111/j.1468-3083.2010.03845.x
  19. Vaillant L, Georgescou G, Rivollier C, Delarue A. Combined effects of glycerol and petrolatum in an emollient cream: A randomized, double-blind, crossover study in healthy volunteers with dry skin. J Cosmet Dermatol. 2020;19(6):1399-1403. PubMed 31532576 · doi:10.1111/jocd.13163
  20. Wollenberg A, Barbarot S, Torrelo A. Basic Emollients for Xerosis Cutis in Atopic Dermatitis: A Review of Clinical Studies. Int J Dermatol. 2025;64 Suppl 1(Suppl 1):13-28. PubMed 40265493 · doi:10.1111/ijd.17793
Priežiūros rutinos derinimas 5Kurias aktyvias medžiagas galima naudoti kartu, kurias geriau atskirti ryte ir vakare.
  1. Appa Y. Retinoid therapy: compatible skin care. Skin Pharmacol Appl Skin Physiol. 1999;12(3):111-9. PubMed 10393518 · doi:10.1159/000029864
  2. Del Rosso JQ, Pillai R, Moore R. Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%). J Clin Aesthet Dermatol. 2010;3(10):26-8. PubMed 20967192
  3. Isoda K, Seki T, Inoue Y, Umeda K, Nishizaka T, Tanabe H, et al. Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin. J Dermatol. 2015;42(2):181-8. PubMed 25483138 · doi:10.1111/1346-8138.12720
  4. Rachel JD, Jamora JJ. Skin rejuvenation regimens: a profilometry and histopathologic study. Arch Facial Plast Surg. 2003;5(2):145-9. PubMed 12633200 · doi:10.1001/archfaci.5.2.145
  5. Tempark T, Shem A, Lueangarun S. Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial. J Cosmet Dermatol. 2024;23(5):1758-1765. PubMed 38299457 · doi:10.1111/jocd.16212

Atnaujinimai

Sąrašas atnaujintas 2026-11-02. Jį pildome, kai įvertiname naujus šaltinius.

Žinai tyrimą, kurio čia trūksta? Parašyk mums — info@skinbarrierapp.com.